Bokkategorier
- Dokumentar
- Etikk
- Filosofi/idehistorie
- Gavebøker/skjønnlitt.
- Historie
- Kulturhistorie
- Lærebok
- Populærvitenskap
- Religion/livssyn
- Samtid/debatt
Bokserier
Fullstendig referanseliste for MAT - Bedre helse med steinalderkost av Staffan Lindberg
Copyright - Staffan Lindberg
1. Darwin, C, The origin of species. 1998, London: Wadsworth.
2. Mayr, E, What evolution is. 2001, London: Weidenfeld & Nicolson.
3. Nesse, RM and Williams, GC, Evolution and healing. The new science of darwinian medicine. 1996, London: Phoenix.
4. Kluger, MJ, Kozak, W, Conn, CA, Leon, LR, and Soszynski, D, The adaptive value of fever. Infect Dis Clin North Am, 1996; 10: 1-20.
5. Futuyama, DJ, Evolutionary biology. 1986, Sunderland, Mass: Sinauer.
6. Jones, S, Martin, R, and Pilbeam, D, eds. The Cambridge encyclopedia of human evolution. 1992, Cambridge University Press: Cambridge.
7. Gleadow, RM and Woodrow, IE, Constraints on effectiveness of cyanogenic glycosides in herbivore defense. J Chem Ecol, 2002; 28: 1301-13.
8. Dawkins, R, Den blinde urmakaren. 1988: Wahlström och Widstrand.
9. Hälso- och sjukvårdsrapport 2001. 2001: Socialstyrelsen.
10. Orth-Gomér, K and Perski, A, eds. Preventiv medicin i teori och praktik. 1999, Studentlitteratur.
11. Sackett, DL, Straus, S, Richardson, WS, Rosenberg, W, and Haynes, RB, Evidence-based Medicine. 2000, New York: Churchill Livingstone.
12. Godlee, F, ed. Clinical Evidence. Vol. 1. 1999, BMJ Publishing Group, ACP/ASIM: London.
13. Hansson, L, Zanchetti, A, Carruthers, SG, et al., Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet, 1998; 351: 1755-62
14. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group [see comments]. Lancet, 1998; 352: 837-53
15. McCormack, J and Greenhalgh, T, Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study. Bmj, 2000; 320: 1720-3.
16. Grady, D, Herrington, D, Bittner, V, et al., Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). Jama, 2002; 288: 49-57.
17. Waters, DD, Alderman, EL, Hsia, J, et al., Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. Jama, 2002; 288: 2432-40.
18.Hulley, S, Furberg, C, Barrett-Connor, E, et al., Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). Jama, 2002; 288: 58-66.
19.Torgerson, DJ and Bell-Syer, SE, Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. Jama, 2001; 285: 2891-7.
20. Grady, D and Cummings, SR, Postmenopausal hormone therapy for prevention of fractures: how good is the evidence? Jama, 2001; 285: 2909-10.
21. Laine, C, Postmenopausal hormone replacement therapy: how could we have been so wrong? Ann Intern Med, 2002; 137: 290.
22. Lingfors, H, Persson, LG, Lindstrom, K, Ljungquist, B, and Bengtsson, C, Time for a "vision zero" concerning premature death from ischaemic heart disease? Scand J Prim Health Care, 2002; 20: 28-32.
23. MacMahon, S, Blood pressure and the risks of cardiovascular disease, in Textbook of hypertension, J.D. Swales, Editor. 1994, Blackwell: Oxford. p. 46-54.
24. Lindeberg, S, Apparent absence of cerebrocardiovascular disease in Melanesians. Risk factors and nutritional considerations - the Kitava Study. 1994, University of Lund.
25. Becker, W, Näringsrekommendationer, in Näringslära för högskolan, A. L., et al., Editors. 1992, Almqvist & Wksell.
26. Harper, AE, Defining the essentiality of nutrients, in Modern nutrition in health and disease, M.E. Shils, et al., Editors. 1999, Lippincott Williams & Wilkins. p. 3-10.
27. Altman, DG, Practical statistics for medical research. 1991, London: Chapman and Hall. 611.
28. Simoons, FJ, Celiac disease as a geographic problem, in Food, nutrition and evolution, N. Walcher and N. Kretchmer, Editors. 1981, Masson: New York. p. 179-99.
29. Cronin, CC and Shanahan, F, Why is celiac disease so common in Ireland? Perspect Biol Med, 2001; 44: 342-52.
30. Olson, CM, Rennie, D, Cook, D, et al., Publication bias in editorial decision making. Jama, 2002; 287: 2825-8.
31. Egger, M, Davey Smith, G, Schneider, M, and Minder, C, Bias in meta-analysis detected by a simple, graphical test. Bmj, 1997; 315: 629-34.
32. Sterne, JA and Egger, M, Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol, 2001; 54: 1046-55.
33. ISIS-4 Collaborative Group, ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet, 1995; 345: 66985
34. Kjaergard, LL and Als-Nielsen, B, Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. Bmj, 2002; 325: 249.
35. Jenkins, DJ, Kendall, CW, Popovich, DG, et al., Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function. Metabolism, 2001; 50: 494-503.
36. de Lorgeril, M, Renaud, S, Mamelle, N, et al., Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet, 1994; ii: 1454-9
37. de Lorgeril, M, Salen, P, Martin, JL, Monjaud, I, Delaye, J, and Mamelle, N, Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study [see comments]. Circulation, 1999; 99: 779-85
38. Popper, K, The logic of scientific discovery. 1959: Rouledge.
39. Wynne-Edwards, KE, Evolutionary biology of plant defenses against herbivory and their predictive implications for endocrine disruptor susceptibility in vertebrates. Environ Health Perspect, 2001; 109: 443-8.
40. Little, DL, Reducing the effects of clover disease by strategic grazing of pastures. Aust Vet J, 1996; 73: 192-3.
41. Department of Health, NS, A diet manual for Papua New Guinea. 1989, Port Moresby: Department of health, Papua New Guinea.
42. Bartlett, C, Sterne, J, and Egger, M, What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers. Bmj, 2002; 325: 81-4.
43. Eaton, SB, Strassman, BI, Nesse, RM, et al., Evolutionary health promotion. Prev Med, 2002; 34: 109-18.
44. Eaton, SB, Cordain, L, and Lindeberg, S, Evolutionary health promotion: a consideration of common counterarguments. Prev Med, 2002; 34: 119-23.
45. Vrba, ES, Denton, GH, Partridge, TC, and Burckle, LH, eds. Paleoclimate and Evolution, with Emphasis on Human Origins. 1996, Yale University Press: New Haven.
46. Formicola, V and Giannecchini, M, Evolutionary trends of stature in upper Paleolithic and Mesolithic Europe. J Hum Evol, 1999; 36: 319-33.
47. Nelson, H and Jurmain, R, Introduction to physical anthropology. 1991, New York: West Publishing Co.
48. Saunders, SR and Katzenberg, MA, eds. Skeletal biology of past peoples: research methods. 1992, Wiley-Liss: New York. 264.
49. Morgan, E, The aquatic ape hypothesis. 1997: Independent Voices.
50. Cordain, L, Miller, JB, Eaton, SB, Mann, N, Holt, SH, and Speth, JD, Plant-animal subsistence ratios and macronutrient energy estimations in worldwide hunter-gatherer diets. Am J Clin Nutr, 2000; 71: 682-92
51. Stanford, CB, The hunting apes. Meat eating and the origins of human behaviour. 1999: Princeton.
52. Brand Miller, JC and Colagiuri, S, The carnivore connection: dietary carbohydrate in the evolution of NIDDM. Diabetologia, 1994; 37: 1280-6
53. Milton, K, Nutritional characteristics of wild primate foods: do the diets of our closest living relatives have lessons for us? Nutrition, 1999; 15: 488-98.
54. Wrangham, RW, Holland Jones, J, Laden, G, Pilbeam, D, and Conklin-Brittain, NL, The raw and the stolen. Cooking and the ecology of human origins. Current Anthropol, 1999; 40: 567-94
55. Gräslund, B, De första stegen. Urmänniskan och hennes värld. 2001, Stockholm: Atlantis.
56. Hult, M and Fessler, A, Sr/Ca mass ratio determination in bones using fast neutron activation analysis. Appl Radiat Isot, 1998; 49: 1319-23.
57. Schoeninger, MJ, Diet and the evolution of modern human form in the Middle East. Am J Phys Anthropol, 1982; 58: 37-52.
58. Winterhalder, B and Smithg, EA, eds. Hunter-gatherer foraging strategies. 1981, University of Chicago.
59. Milton, K, A Hypothesis to Explain the Role of Meat-Eating in Human Evolution. Evol Anthropol, 1999; 8: 11-21
60. Carpenter, KJ, The history of scurvy and vitamin C. 1986, Cambridge: Cambridge University Press.
61. Isaacs, J, Bush food. Aboriginal food and herbal medicine. 1987: Lansdowne.
62. DeFoliart, GR, Insects as food: why the western attitude is important. Annu Rev Entomol, 1999; 44: 21-50
63. Diamond, J, Vete, vapen och virus. 1999: Norstedts.
64. Van Damme, EJM, Peumans, WJ, Pusztai, A, and Bardocz, S, eds. Handbook of plant lectins: properties and biomedical applications. 1998, John Wiley: New York.
65. Smith, EO, Evolution, substance abuse, and addiction, in Evolutionary Medicine, W.R. Trevathan, E.O. Smith, and J.J. McKenna, Editors. 1999, Oxford University Press: Oxford. p. 375-405.
66. Eaton, SB and Eaton, SB, 3rd, Paleolithic vs. modern diets--selected pathophysiological implications. Eur J Nutr, 2000; 39: 67-70.
67. Hallberg, L, Brune, M, and Rossander, L, Iron absorption in man: ascorbic acid and dose-dependent inhibition by phytate. Am J Clin Nutr, 1989; 49: 140-4
68. Svenska näringsrekommendationer. 1997, Uppsala: Statens Livsmedelsverk.
69. Eaton, S and Konner, M, Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med, 1985; 312: 283-289
70. Mancilha-Carvalho, JJ, de Oliveira, R, and Esposito, RJ, Blood pressure and electrolyte excretion in the Yanomamo Indians, an isolated population. J Hum Hypertens, 1989; 3: 309-14
71. Al-Bander, SY, Nix, L, Katz, R, Korn, M, and Sebastian, A, Food chloride distribution in nature and its relation to sodium content. J Am Diet Assoc, 1988; 88: 472-5.
72. Frassetto, L, Morris, RC, Jr., Sellmeyer, DE, Todd, K, and Sebastian, A, Diet, evolution and aging--the pathophysiologic effects of the post- agricultural inversion of the potassium-to-sodium and base-to-chloride ratios in the human diet. Eur J Nutr, 2001; 40: 200-13.
73. Michell, AR, Physiological aspects of the requirement for sodium in mammals. Nutr Res Rev, 1989; 2: 149-60
74. Oliver, WJ, Cohen, EL, and Neel, JV, Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a "no-salt" culture. Circulation, 1975; 52: 146-51
75. Kirby, CR and Convertino, VA, Plasma aldosterone and sweat sodium concentrations after exercise and heat acclimation. J Appl Physiol, 1986; 61: 967-70.
76. Cordain, L, The Paleo Diet. 2002: Wiley.
77. Becker, W, Dietary guidelines and patterns of food and nutrient intake in Sweden. Br J Nutr, 1999; 81 Suppl 2: S113-7.
78. Garlick, PJ and Reeds, PJ, Proteins, in Human Nutrition and Dietetics, J.S. Garrow and W.P.T. James, Editors. 1993, Edinburgh: Edinburgh. p. 56-76.
79. Millward, DJ, Fereday, A, Gibson, NR, and Pacy, PJ, Human adult amino acid requirements: [1-13C]leucine balance evaluation of the efficiency of utilization and apparent requirements for wheat protein and lysine compared with those for milk protein in healthy adults. Am J Clin Nutr, 2000; 72: 112-21.
80. Abcouwer, SF and Souba, WW, Glutamine and arginine, in Modern nutrition in health and disease, M.E. Shils, et al., Editors. 1999, Lippincott Williams & Wilkins. p. 559-69.
81. Simopoulos, AP, Evolutionary aspects of diet and essential fatty acids. World Rev Nutr Diet, 2001; 88: 18-27
82. Cordain, L, Watkins, BA, Florant, GL, Kelher, M, Rogers, L, and Li, Y, Fatty acid analysis of wild ruminant tissues: evolutionary implications for reducing diet-related chronic disease. Eur J Clin Nutr, 2002; 56: 181-91.
83. Becker, W, Transfettsyror. Nya data visar att innehållet i svensk kost är lågt. Vår Föda, 1998: 20-23
84. Aro, A, Antoine, JM, Pizzoferrato, L, Reykdal, O, and van Poppel, G, Trans Fatty Acids in Dairy and Meat Products from 14 European Countries: The TRANSFAIR Study. J Food Composit Anal, 1998; 11: 150-60
85. Thorburn, AW, Brand, JC, and Truswell, AS, Slowly digested and absorbed carbohydrate in traditional bushfoods: a protective factor against diabetes? Am J Clin Nutr, 1987; 45: 98-106
86. Thorburn, AW, Brand, JC, O'Dea, K, Spargo, RM, and Truswell, AS, Plasma glucose and insulin responses to starchy foods in Australian aborigines: a population now at high risk of diabetes. Am J Clin Nutr, 1987; 46: 282-5
87. Soh, NL and Brand-Miller, J, The glycaemic index of potatoes: the effect of variety, cooking method and maturity. Eur J Clin Nutr, 1999; 53: 249-54
88. Foster-Powell, K, Holt, SH, and Brand-Miller, JC, International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr, 2002; 76:
5-56.
89. Pi-Sunyer, FX, Glycemic index and disease. Am J Clin Nutr, 2002; 76: 290S-8S.
90. Liu, S, Willett, WC, Stampfer, MJ, et al., A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr, 2000; 71: 1455-61.
91. Remer, T, Influence of nutrition on acid-base balance--metabolic aspects. Eur J Nutr, 2001; 40: 214-20.
92. Manz, F, History of nutrition and acid-base physiology. Eur J Nutr, 2001; 40: 189-99.
93. Englyst, HN and Hudson, GJ, Carbohydrates, in Human Nutrition and Dietetics, J.S. Garrow and W.P.T. James, Editors. 2000, Churchill Livingstone. p. 61-76.
94. Perantoni, AO, Carcinogenesis, in The Biological Basis of Cancer, R.G. McKinnell, et al., Editors. 1998, Cambridge University press. p. 79-114.
95. Ulijaszek, SJ and Strickland, SS, Nutritional Anthropology: Prospects and Perspectives. Prospects and perspectives in human nutrition. 1993, London: Smith-Gordon.
96. Chrispeels, MJ and Raikhel, NV, Lectins, lectin genes, and their role in plant defense. Plant Cell, 1991; 3: 1-9.
97. Grant, G, More, LJ, McKenzie, NH, and Pusztai, A, The effect of heating on the haemagglutinating activity and nutritional properties of bean (Phaseolus vulgaris) seeds. J Sci Food Agric, 1982; 33: 1324-6
98. Pusztai, A, Greer, F, and Grant, G, Specific uptake of dietary lectins into the systemic circulation of rats. Biochem Soc Trans, 1989; 17: 481-2
99. Wang, Q, Yu, LG, Campbell, BJ, Milton, JD, and Rhodes, JM, Identification of intact peanut lectin in peripheral venous blood. Lancet, 1998; 352: 1831-2.
100. Freed, DL, Do dietary lectins cause disease? Bmj, 1999; 318:
1023-4.
101. Gabor, F, Schwarzbauer, A, and Wirth, M, Lectin-mediated drug delivery: binding and uptake of BSA-WGA conjugates using the Caco-2 model. Int J Pharm, 2002; 237: 227-39.
102. Caron, M and Seve, A-P, eds. Lectins and Pathology. 2000, Taylor & Francis.
103. Cordain, L, Cereal grains: humanity's double-edged sword. World Rev Nutr Diet, 1999; 84: 19-73
104. Hallmans, G, Fytoöstrogener – förekomst och biologiska effekter, speciellt kopplat till cerealier. Scandinavian Journal of Nutrition/Näringsforskning, 1996; 40: 34-7
105. Normen, L, Dutta, P, Lia, A, and Andersson, H, Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel. Am J Clin Nutr, 2000; 71: 908-13.
106. Delange, F, Van Onderbergen, A, Shabana, W, et al., Silent iodine prophylaxis in Western Europe only partly corrects iodine deficiency; the case of Belgium. Eur J Endocrinol, 2000; 143: 189-96.
107. Fredlund, K, Inhibition of calcium and zinc absorption by phytate in man, in Department of Food Science. 2002, Göteborg: Göteborg.
108. Sandstead, HH, Fiber, phytates, and mineral nutrition. Nutr Rev, 1992; 50: 30-1
109. Spivey Fox, MR and Tao, S-H, Antinutritive effects of phytate and other phosphorylated derivatives, in Nutritional Toxicology, J.N. Hathcock, Editor. 1989, Academic Press: New York. p. 59-96.
110. Harland, BF, Dietary fibre and mineral bioavailability. Nutr Res Rev, 1989; 2: 133-47
111. Rossander, L, Sandberg, A-S, and Sandström, B, The influence of dietary fibre on mineral absorption and utilisation, in Dietary fibre - a component of food. Nutritional function in health and disease, T.F. Schweizer and C.A. Edwards, Editors. 1992: London.
112. Sandberg, AS, Hasselblad, C, Hasselblad, K, and Hulten, L, The effect of wheat bran on the absorption of minerals in the small intestine. Br J Nutr, 1982; 48: 185-91
113. Morris, ER, Phytate and dietary mineral bioavailability, in Phytic acid: Chemistry and applications, E. Graf, Editor. 1986, Pilatus Press: Minneapolis. p. 57-76.
114. Caprez, A and J., F-TS, The effect of heat treatment and particle size of bran on mineral absorption in rats. Br J Nutr, 1982; 48: 467-75
115. Iqbal, TH, Lewis, KO, and Cooper, BT, Phytase activity in the human and rat small intestine. Gut, 1994; 35: 1233-6
116. Isçan, MY and Kennedy, KAR, eds. Reconstruction of life from the human skeleton. 1989, Wiley-Liss: New York. 315.
117. Breinl, A, On the occurence and prevalence of diseases in British New Guinea. Ann Trop Med Parasitol, 1915; 9: 285-
118. Clements, FW, A Medical Survey in Papua: Report of the First Expedition by the School of Public Health and Tropical Medicine to Papua, 1935. Med J Aust, 1936; 1: 451-
119. Devine, HD, Rheumatic Heart Disease in New Guinea: Including a Cardiovascular Survey of 200 Native Papuans. Ann Intern Med, 1946; 24: 826-
120. Backhouse, TC, Melanesian natives and vascular disease: A note based on autopsy records, 1923-1934. Med J Aust, 1958: 36-
121. Whyte, H, Body fat and blood pressure of natives in New Guinea: Reflections on essential hypertension. Aust Ann Med, 1958; 7: 36-46
122. Barnes, R, Incidence of Heart Disease in a Native Hospital of Papua. Med J Aust, 1961; 2: 540-
123. Campbell, C and Arthur, R, A study of 2000 admissions to the medical ward of Port Moresby General Hospital. Med J Aust, 1964; 1: 989-992
124. Dewdney, JCH, Maprik Hospital - a review of 3888 consecutive admissions, February 1963 to July 1964. Papua New Guinea Med J, 1965; 8: 89-96
125. Kariks, J and McGovern, VJ, Heart disease in the territory of Papua-New Guinea: a preliminary report based on a necropsy study. Med J Aust, 1967; 1: 176-7
126. Vines, AP, An epidemiological sample survey of the highlands, mainland and island regions of the Territory of Papua and New Guinea. 1970, Department of Public Health, Territory of Papua and New Guinea, Port Moresby.
127. Aiken, GH, Lytton, DG, and Everingham, S, Atherosclerotic heart disease in urbanised Papua New Guineans. P N G Med J, 1974; 17: 248-50
128. Hornabrook, RW, Crane, GG, and Stanhope, JM, Karkar and Lufa: an epidemiological and health background to the human adaptability studies of the International Biological Programme. Philos Trans R Soc Lond Biol, 1974; 268: 293-308
129. Mathews, CL, Cardiovascular disease in Lae- a five year review. P N G Med J, 1974; 17: 251-62
130. Page, LB, Damon, A, and Moellering, RJ, Antecedents of cardiovascular disease in six Solomon Islands societies. Circulation, 1974; 49: 1132-46
131. Somers, K, Cardiology in Papua New Guinea. P N G Med J, 1974; 17: 235-41
132. Sinnett, P, The people of Murapin. Monograph Series No 4, ed. P.N.G.I.o.M. Research. 1977, Oxford: EW Classey Ltd.
133. Korner, N, Cardiovascular disease in Papua New Guinea. Med J Aust, 1980; 1: 1-7
134. Palmer, P, Autopsies at Goroka hospital from 1978-1982: a review. P N G Med J, 1982; 25: 166-7
135. Ree, GH, Elderly ailing Highlanders of Papua New Guinea. P N G Med J, 1982; 25: 93-6
136. Polunin, I, The medical natural history of Malayan aborigines. Med J Malaysia, 1953; 8: 55-174
137. Donnison, CP, Blood pressure in the African native. Its bearing upon the ætiology of hyperpiesia and arterio-sclerosis. Lancet, 1929; i: 6-7
138. Vint, FW, Postmortem findings in the natives of Kenya. East Afr Med J, 1937; 13: 332-40
139. Muwazi, E, Neurological disease among african natives of Uganda: A review of 269 cases. East Afr Med J, 1944; 21: 2-19
140. Davies, J, Pathology of central african natives. IX: Cardiovscular diseases. East Afr Med J, 1948; 25: 454-467
141. Trowell, HC, Non-infective diseases in Africa. 1960, London: Edward Arnold Ltd. 74-152.
142. Thomas, W, Davies, J, O’Nea, lR, and Dimakulangan, A, Incidence of myocardial infarction correlated with venous and pulmonary thrombosis and embolism. A geographic study based on autopsies in Uganda, East Africa and St Louis, USA. Am J Cardiol, 1960; 5: 41-47
143. Reef, H and Isaacson, C, Atherosclerosis in the Bantu. Circulation, 1962; 25: 66-72
144. Seftel, HC, Keeley, KJ, and Walker, ARP, Characteristics of South African Bantu who have suffered from myocardial infarction. Am J Cardiol, 1963; 12: 149-56
145. Tejada, C, Strong, JP, Montenegro, MR, Restrepo, C, and Solberg, LA, Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex. Lab Invest, 1968; 18: 509-26
146. Shaper, AG, Cardiovascular disease in the tropics. IV. Coronary heart disease. B M J, 1972; 4: 32-5
147. Dodu, S, Clinical aspects of ischaemic heart disease (IHD) in Ghana. Ghana Med J, 1972; 11: 203-214
148. Edginton, ME, Hodkinson, J, and Seftel, HC, Disease patterns in a South African rural Bantu population, including a commentary on comparisons with the pattern in urbanized Johannesburg Bantu. S Afr Med J, 1972; 46: 968-76
149. Okuwobi, B and Strasser, T, Heart disease in Nigeria. World Health, 1972: 24- 25
150. Walker, AR, The epidemiological emergence of ischemic arterial diseases. Am Heart J, 1975; 89: 133-6
151. Truswell, AS and Hansen, JDL, Medical research among the !Kung, in Kalahari Hunter-gatherers, R.B. Lee and I. DeVore, Editors. 1976, Harvard University Press: Cambridge, Mass. p. 166-95.
152. Isaacson, C, The changing pattern of heart disease in South African Blacks. S Afr Med J, 1977; 52: 793-8
153. Trowell, HC and Burkitt, DP, eds. Western diseases: their emergence and prevention. 1981, Edward Arnold: London.
154. Baruzzi, R and Franco, L, Amerindians of Brazil, in Western diseases: their emergence and prevention, H.C. Trowell and D.P. Burkitt, Editors. 1981, Edward Arnold: London. p. 138-153.
155. Groom, D, Cardiovascular observations on Tarahumara Indian runners--the modern Spartans. Am Heart J, 1971; 81: 304-14
156. Connor, WE, Cerqueira, MT, Connor, RW, Wallace, RB, Malinow, MR, and Casdorph, HR, The plasma lipids, lipoproteins, and diet of the Tarahumara indians of Mexico. Am J Clin Nutr, 1978; 31: 1131-42
157. Schaefer, O, Eskimos, in Western Diseases: their Emergence and Prevention, H.C. Trowell and D.P. Burkitt, Editors. 1981, Edward Arnold: London. p. 113-28.
158. Kromann, N and Green, A, Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand, 1980; 208: 401-6
159. Dyerberg, J, Coronary heart disease in Greenland Inuit: a paradox. Implications for western diet patterns. Arctic Med Res, 1989; 48: 47-54
160. Sinnett, P and Buck, L, Coronary heart disease in Papua New Guinea: present and future. P N G Med J, 1974; 17: 242-7
161. Malinowski, B, Baloma: The Spirits of the Dead in the Trobriand Islands. J Royal Anthropol Inst, 1916; 46: 353-430
162. Malinowski, B, Kula: The Circulating Exchange of Valuables in the Archipelagoes of Eastern New Guinea. Man, 1919; 20: 97-105
163. Malinowski, B, Argonauts of the Western Pacific. 1922, London: Routledge & Kegan Paul Ltd.
164. Malinowski, B, Magic, Science and Religion, in Science, Religion and Reality, J. Needham, Editor. 1925, Routledge & Kegan Paul Ltd: London.
165. Malinowski, B, Myth in Primitive Psychology. 1926, London: Routledge & Kegan Paul Ltd.
166. Malinowski, B, Sex and Repression in Savage Society. 1927, London: Routledge & Kegan Paul Ltd.
167. Malinowski, B, The Sexual Life of Savages in Northwestern Melanesia. 1929, London: Routledge & Kegan Paul Ltd.
168. Malinowski, B, Coral Gardens and their Magic. Vol. 1-2. 1935, London: George Allen & Unwin Ltd.
169. Mead, M, Sex and Temperament in Three Primitive Societies. 1935, New York: William Morrow and Company, Inc.
170. Powell, HA, An Analysis of Present-day Social Structure in the Trobriand Islands. 1956, University of London.
171. Powell, HA, Competitive Leadership in Trobriand Political Organization. J Royal Anthropol Inst, 1960; 90: 118-145
172. Powell, HA, Geneaology, Residence and Kinship in Kiriwina. Man, 1969; 4: 177-202
173. Powell, HA, Territory, Hierarchy and Kinship in Kiriwina. Man, 1969; 4: 580-604
174. Weiner, AB, Women of Value, Men of Renown. 1976, Austin: University of Texas Press.
175. Weiner, AB, The Trobrianders of Papua New Guinea. 1988, New York: Holt, Rinehart and Winston.
176. Montague, S, The Trobriand society. 1974, University of Chicago.
177. Schiefenhövel, W, Die Geburt aus ethnomedizinischer Sicht. Curare, 1983; 6: 143-50
178. Schiefenhövel, W, Schuler, J, and Pöschl, R, Traditionelle Heilkundige — Ärztliche Persönlichkeiten im Vergleich der Kulturen und medizinischen Systeme. Vol. 6. 1986, Braunscweig u. Wiesbaden: Vieweg. 143-50.
179. Schiefenhövel, W and Bell-Krannhals, I, Wer teilt, hat Teil an der Macht: Systeme der Yams-Vergabe auf den Trobriand Inseln, Papua-Neuguinea. Mitteilungen der Anthropologischen Gesellschaft in Wien, 1986; 116: 19-39
180. Siegmund, R, Beirmann, K, and Schiefenhövel, W, Ontogenic development of time patterns in food intake — a study of German infants and preliminary data from Trobriand infants (Papua New Guinea). J Interdiscipl Res, 1990; 21: 246-8
181. Jüptner, H and Quinell, C, Epidemiological observations during a measles epidemic in the Trobriand Islands (Papua). Med J Aust, 1965; 1: 538-40
182. Stanhope, JM, Mortality and population growth: Losuia area, Kiriwina, Trobriand Islands. Papua New Guinea Med J, 1969; 12: 42-48
183. Lindeberg, S and Lundh, B, Apparent absence of stroke and ischaemic heart disease in a traditional Melanesian island: a clinical study in Kitava. J Intern Med, 1993; 233: 269-75
184. Sinnett, PF and Whyte, HM, Epidemiological studies in a total highland population, Tukisenta, New Guinea. Cardiovascular disease and relevant clinical, electrocardiographic, radiological and biochemical findings. J Chronic Dis, 1973; 26: 265-90
185. Lindeberg, S, Nilsson-Ehle, P, and Ahren, B, Serum urate in traditional Pacific Islanders and in Swedes, submitted. J Intern Med, 2003;
186. Lindeberg, S and Vessby, B, Fatty acid composition of cholesterol esters and serum tocopherols in Melanesians apparently free from cardiovascular disease - the Kitava study. Nutr Metab Cardiovasc Dis, 1995; 5: 45-53
187. Lindeberg, S, Nilsson-Ehle, P, Terént, A, Vessby, B, and Scherstén, B, Cardiovascular risk factors in a Melanesian population apparently free from stroke and ischaemic heart disease — the Kitava study. J Intern Med, 1994; 236: 331-40
188. Becker, W, Svensk kost. 1982, Uppsala: Statens Livsmedelsverk.
189. Conyers, RA, Myocardial infarction in a New Guinean. Med J Aust, 1971; 2: 412-7
190. Sinnett, PF, Kevau, IH, and Tyson, D, Social change and the emergence of degenerative cardiovascular disease in Papua New Guinea, in Human Biology in Papua New Guinea. The Small Cosmos, R.D. Attenborough and M.P. Alpers, Editors. 1992, Clarendon Press: Oxford. p. 373-86.
191. Zimmet, P, Epidemiology of diabetes and its macrovascular manifestations in Pacific populations: the medical effects of social progress. Diabetes Care, 1979; 2: 144-53
192. Finlayson, PJ, Caterson, LD, Rhodes, KM, Plehwe, WE, Hannelly, T, and Silink, M, Diabetes, obesity and hypertension in Vanuatu. P N G Med J, 1988; 31: 9-18
193. Pathik, B and Ram, P, Acute myocardial infarction in Fiji: a review of 300 cases. Med J Aust, 1974; 2: 922-4
194. Beaglehole, R, Prior, IA, Foulkes, MA, and Eyles, EF, Death in the South Pacific. N Z Med J, 1980; 91: 375-8
195. Crews, DE and MacKeen, PC, Mortality related to cardiovascular disease and diabetes mellitus in a modernizing population. Soc Sci Med, 1982; 16: 175-81
196. Taylor, R and Thoma, K, Mortality patterns in the modernized Pacific Island nation of Nauru. Am J Public Health, 1985; 75: 149-55
197. Patel, MS, Diabetes, the emerging problem in Papua New Guinea [editorial]. P N G Med J, 1984; 27: 1-3
198. Kevau, IH, Cardiology in Papua New Guinea in the twenty-first century [editorial]. P N G Med J, 1990; 33: 271-4
199. Prior, IA, Cardiovascular epidemiology in New Zealand and the Pacific. N Z Med J, 1974; 80: 245-52
200. O'Dea, K, Diabetes in Australian Aborigines: impact of the western diet and life style. J Intern Med, 1992; 232: 103-117
201. INTERHEALTH Steering Committee, Demonstration projects for the integrated prevention and control of noncommunicable diseases (INTERHEALTH programme): epidemiological background and rationale. World Health Stat Q, 1991; 44: 48-54
202. Kevau, IH, Clinical documentation of twenty cases of acute myocardial infarction in Papua New Guineans. P N G Med J, 1990; 33: 275-80
203. Gelfand, M and Kaplan, M, Bantu coronary insufficiency. Report of a possible case. Central Afr J Med, 1958; 4: 157-9
204. el Hassan, AM and Wasfi, A, Cardiovascular disease in Khartoum. Post-mortem and clinical evidence. Trop Geogr Med, 1972; 24: 118-23
205. Mann, J, Diseases of the heart and circulation: the role of dietary factors in aetiology and management, in Human Nutrition and Dietetics, J.S. Garrow and W.P.T. James, Editors. 2000, Churchill Livingstone. p. 689-714.
206. Mertens, A and Holvoet, P, Oxidized LDL and HDL: antagonists in atherothrombosis. Faseb J, 2001; 15: 2073-84.
207. Sans, S, Watch the belly to protect the heart. Eur Heart J, 2002; 23: 687-9.
208. Stuhlinger, MC, Abbasi, F, Chu, JW, et al., Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. Jama, 2002; 287: 1420-6.
209. Ross, R, Atherosclerosis--an inflammatory disease. N Engl J Med, 1999; 340: 115-26.
210. Buffon, A, Biasucci, LM, Liuzzo, G, D'Onofrio, G, Crea, F, and Maseri, A, Widespread Coronary Inflammation in Unstable Angina. N Engl J Med, 2002; 347: 5-12.
211. Connor, WE and Connor, SL, Diet, atherosclerosis, and fish oil. Adv Intern Med, 1990; 35: 139-71
212. Marckmann, P, Sandström, B, and Jespersen, J, Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr, 1994; 59: 935-9
213. Boman, K, Life style and fibrinolysis, in Clinical Aspects of Fibrinolysis, T.K. Nilsson, K. Boman, and J.H. Jansson, Editors. 1991, Almqvist & Wiksell International: Stockholm. p. 55-66.
214. Beilin, LJ, Non-pharmacological management of hypertension, in Textbook of Hypertension, J.D. Swales, Editor. 1994, Blackwell: Oxford. p. 1165-77.
215. Vakili, BA, Okin, PM, and Devereux, RB, Prognostic implications of left ventricular hypertrophy. Am Heart J, 2001; 141: 334-41. t&artType=abs&id=a113218&target=
216. Ennezat, PV, Houel, R, Heloire, F, et al., [Effects of high sodium intake on ventricular remodeling in mice]. Arch Mal Coeur Vaiss, 1998; 91: 935-9.
217. Diez, J, Lopez, B, Gonzalez, A, and Querejeta, R, Clinical aspects of hypertensive myocardial fibrosis. Curr Opin Cardiol, 2001; 16: 328-35.
218. Zhou, YT, Grayburn, P, Karim, A, et al., Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A, 2000; 97: 1784-9
219. Charnock, JS, Omega-3 polyunsaturated fatty acids and ventricular fibrillation: the possible involvement of eicosanoids. Prostaglandins Leukot Essent Fatty Acids, 1999; 61: 243-7.
220. Eckel, RH, Barouch, WW, and Ershow, AG, Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. Circulation, 2002; 105: 2923-8.
221. Bucher, HC, Hengstler, P, Schindler, C, and Meier, G, N-3 polyunsaturated fatty acids in coronary heart disease: a meta- analysis of randomized controlled trials. Am J Med, 2002; 112: 298-304.
222. Burr, ML, Fehily, AM, Gilbert, JF, et al., Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART) [see comments]. Lancet, 1989; 2: 757-61
223. Ness, AR, Hughes, J, Elwood, PC, Whitley, E, Smith, GD, and Burr, ML, The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction trial (DART). Eur J Clin Nutr, 2002; 56: 512-8.
224. GISSI-Prevenzione Investigators, Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico [see comments]. Lancet, 1999; 354: 447-55
225. Schmidt, EB, Skou, HA, Christensen, JH, and Dyerberg, J, N-3 fatty acids from fish and coronary artery disease: implications for public health. Public Health Nutr, 2000; 3: 91-8.
226. Hu, FB, Manson, JE, and Willett, WC, Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr, 2001; 20: 5-19.
227. Marckmann, P and Gronbaek, M, Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur J Clin Nutr, 1999; 53: 585-90.
228. Demaison, L and Moreau, D, Dietary n-3 polyunsaturated fatty acids and coronary heart disease- related mortality: a possible mechanism of action. Cell Mol Life Sci, 2002; 59: 463-77.
229. Billman, GE, Kang, JX, and Leaf, A, Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation, 1999; 99: 2452-7.
230. Singh, RB, Rastogi, SS, Verma, R, et al., Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ, 1992; 304: 1015-9
231. Singh, RB, Dubnov, G, Niaz, MA, et al., Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet, 2002; 360: 1455-61.
232. Clinical Evidence writers on primary prevention, Primary prevention. Clinical Evidence, 2002; 7: 91-123
233. Rimm, EB, Fruit and vegetables-building a solid foundation. Am J Clin Nutr, 2002; 76: 1-2.
234. Law, MR and Morris, JK, By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease: response to commentary. Eur J Clin Nutr, 1999; 53: 903-4.
235. Ness, A, Egger, M, and Powles, J, Fruit and vegetables and ischaemic heart disease: systematic review or misleading meta-analysis? Eur J Clin Nutr, 1999; 53: 900-4.
236. Bazzano, LA, He, J, Ogden, LG, et al., Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr, 2002; 76: 93-9.
237. Joshipura, KJ, Hu, FB, Manson, JE, et al., The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med, 2001; 134: 1106-14.
238. Thorogood, M, Mann, J, Appleby, P, and McPherson, K, Risk of death from cancer and ischaemic heart disease in meat and non- meat eaters [see comments]. BMJ, 1994; 308: 1667-70
239. Dwyer, J, Convergence of plant-rich and plant-only diets. Am J Clin Nutr, 1999; 70: 620S-622S.
240. Key, TJ, Fraser, GE, Thorogood, M, et al., Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr, 1999; 70: 516S-524S.
241. Appleby, PN, Key, TJ, Thorogood, M, Burr, ML, and Mann, J, Mortality in British vegetarians. Public Health Nutr, 2002; 5: 29-36.
242. Menotti, A, Kromhout, D, Blackburn, H, Fidanza, F, Buzina, R, and Nissinen, A, Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the Seven Countries Study. The Seven Countries Study Research Group. Eur J Epidemiol, 1999; 15: 507-15.
243. Kafatos, A, Verhagen, H, Moschandreas, J, Apostolaki, I, and Van Westerop, JJ, Mediterranean diet of Crete: foods and nutrient content. J Am Diet Assoc, 2000; 100: 1487-93.
244. de Lorgeril, M and Salen, P, Modified Cretan Mediterranean diet in the prevention of coronary heart disease and cancer. World Rev Nutr Diet, 2000; 87: 1-23
245. Simopoulos, AP, The Mediterranean diets: What is so special about the diet of Greece? The scientific evidence. J Nutr, 2001; 131: 3065S-73S.
246. Naughton, JM, O'Dea, K, and Sinclair, AJ, Animal foods in traditional Australian aboriginal diets: polyunsaturated and low in fat. Lipids, 1986; 21: 684-90.
247. Mann, N, Dietary lean red meat and human evolution. Eur J Nutr, 2000; 39: 71-9.
248. Moss, M and Freed, D, The cow and the coronary: epidemiology, biochemistry and immunology. Int J Cardiol, 2003; 87: 203-16
249. Keys, A, Seven Countries. A Multivariate Analysis of Death and Coronary Heart Disease. 1980, Cambridge, Mass.: Harvard University Press. 381.
250. Hu, FB, Rimm, EB, Stampfer, MJ, Ascherio, A, Spiegelman, D, and Willett, WC, Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr, 2000; 72: 912-21.
251. Truswell, AS, Dietary fiber and health. World Rev Nutr Diet, 1993; 72: 148-64
252. Burkitt, DP, Walker, AR, and Painter, NS, Dietary fiber and disease. Jama, 1974; 229: 1068-74.
253. Truswell, AS, Cereal grains and coronary heart disease. Eur J Clin Nutr, 2002; 56: 1-14.
254. Liu, S, Buring, JE, Sesso, HD, Rimm, EB, Willett, WC, and Manson, JE, A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coll Cardiol, 2002; 39: 49-56.
255. Fernandez, ML, Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol, 2001; 12: 35-40.
256. Brown, L, Rosner, B, Willett, WW, and Sacks, FM, Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr, 1999; 69: 30-42
257. Howarth, NC, Saltzman, E, and Roberts, SB, Dietary fiber and weight regulation. Nutr Rev, 2001; 59: 129-39.
258. Edwards, CA, Tomlin, J, and Read, NW, Fibre and constipation. Br J Clin Pract, 1988; 42: 26-32
259. Slavin, JL, Martini, MC, Jacobs, DR, Jr., and Marquart, L, Plausible mechanisms for the protectiveness of whole grains. Am J Clin Nutr, 1999; 70: 459S-463S.
260. Kris-Etherton, PM, Zhao, G, Binkoski, AE, Coval, SM, and Etherton, TD, The effects of nuts on coronary heart disease risk. Nutr Rev, 2001; 59: 103-11.
261. Tunstall-Pedoe, H, Nuts to you (...and you, and you). Eating nuts may be beneficial-though it is unclear why. Bmj, 1998; 317: 1332-3.
262. Fraser, GE, Sabate, J, Beeson, WL, and Strahan, TM, A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study [see comments]. Arch Intern Med, 1992; 152: 1416-24
263. Kushi, LH, Folsom, AR, Prineas, RJ, Mink, PJ, Wu, Y, and Bostick, RM, Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med, 1996; 334: 1156-62.
264. Hu, FB, Stampfer, MJ, Manson, JE, et al., Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. Bmj, 1998; 317: 1341-5.
265. Albert, CM, Gaziano, JM, Willett, WC, and Manson, JE, Nut consumption and decreased risk of sudden cardiac death in the physicians' health study. Arch Intern Med, 2002; 162: 1382-7.
266. Singh, RB, Niaz, MA, Rastogi, SS, Bajaj, S, Gaoli, Z, and Shoumin, Z, Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr, 1998; 17: 564-70.
267. Shechter, M, Sharir, M, Labrador, MJ, Forrester, J, Silver, B, and Bairey Merz, CN, Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation, 2000; 102: 2353-8.
268. Elin, RJ and Hosseini, JM, Is the magnesium content of nuts a factor for coronary heart disease? Arch Intern Med, 1993; 153: 779-80
269. Jenkins, DJ, Popovich, DG, Kendall, CW, et al., Effect of a diet high in vegetables, fruit, and nuts on serum lipids. Metabolism, 1997; 46: 530-7
270. Tribble, DL, AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasison vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association. Circulation, 1999; 99: 591-5.
271. Gey, KF, Puska, P, Jordan, P, and Moser, UK, Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr, 1991; 53: 326S-34S
272. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 2002; 360: 23-33
273. Muntwyler, J, Hennekens, CH, Manson, JE, Buring, JE, and Gaziano, JM, Vitamin Supplement Use in a Low-Risk Population of US Male Physicians and Subsequent Cardiovascular Mortality. Arch Intern Med, 2002; 162: 1472-6.
274. Asplund, K, Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med, 2002; 251: 372-92.
275. Steinberg, D and Witztum, JL, Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation, 2002; 105: 2107-11.
276. Kris-Etherton, PM, AHA Science Advisory. Monounsaturated fatty acids and risk of cardiovascular disease. American Heart Association. Nutrition Committee. Circulation, 1999; 100: 1253-8.
277. Reaven, GM, Diet and Syndrome X. Curr Atheroscler Rep, 2000; 2: 503-7.
278. Di Castelnuovo, A, Rotondo, S, Iacoviello, L, Donati, MB, and De Gaetano, G, Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation, 2002; 105: 2836-44.
279. Sasaki, S, Alcohol and its relation to all-cause and cardiovascular mortality. Acta Cardiol, 2000; 55: 151-6
280. Popham, RE, Variation in mortality from ischaemic heart disease in relation to alcohol and milk consumption. Med Hypotheses, 1983; 12: 321-9
281. Segall, JJ, Dietary lactose as a possible risk factor for ischaemic heart disease: review of epidemiology. Int J Cardiol, 1994; 46: 197-207
282. Duffy, SJ, Keaney, JF, Jr., Holbrook, M, et al., Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation, 2001; 104: 151-6.
283. Mukamal, KJ, Maclure, M, Muller, JE, Sherwood, JB, and Mittleman, MA, Tea consumption and mortality after acute myocardial infarction. Circulation, 2002; 105: 2476-81.
284. Woodward, M and Tunstall-Pedoe, H, Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health, 1999; 53: 481-7.
285. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. Jama, 2002; 288: 2015-22
286. Bissoli, L, Di Francesco, V, Ballarin, A, et al., Effect of vegetarian diet on homocysteine levels. Ann Nutr Metab, 2002; 46: 73-9
287. Mann, NJ, Li, D, Sinclair, AJ, et al., The effect of diet on plasma homocysteine concentrations in healthy male subjects. Eur J Clin Nutr, 1999; 53: 895-9.
288. McLean, RM, Magnesium and its therapeutic uses: a review. Am J Med, 1994; 96: 63-76
289. He, FJ and MacGregor, GA, Fortnightly review: Beneficial effects of potassium. BMJ, 2001; 323: 497-501.
290. Ma, G, Young, DB, and Clower, BR, Inverse relationship between potassium intake and coronary artery disease in the cholesterol-fed rabbit. Am J Hypertens, 1999; 12: 821-5.
291. de Lorgeril, M, Dietary arginine and the prevention of cardiovascular diseases. Cardiovasc Res, 1998; 37: 560-3.
292. Briggs, RD, Rubenberg, ML, O'Neal, R, M., Thomas, WA, and Hartroft, WS, Myocardial infarction in patients treated with Sippy and other high-milk diets. Circulation, 1960; 21: 538-42
293. Seely, S, Diet and coronary disease: a survey of mortality rates and food consumption statistics of 24 countries. Med Hypotheses, 1981; 7: 907-18.
294. McLachlan, CN, beta-casein A1, ischaemic heart disease mortality, and other illnesses. Med Hypotheses, 2001; 56: 262-72.
295. Moss, M and Freed, DLJ, Survival trends, coronary event rates, and the MONICA project. Lancet, 1999; 354: 862
296. Segall, JJ, Cardiovascular disease in South Asians. Lancet, 2000; 356: 1853.
297. Salomaa, VV, Lundberg, V, Agnarsson, U, Radisauskas, R, Kirchhoff, M, and Wilhelmsen, L, Fatalities from myocardial infarction in Nordic countries and Lithuania. The MONICA Investigators. Eur Heart J, 1997; 18: 91-8.
298. Elliott, RB, Harris, DP, Hill, JP, Bibby, NJ, and Wasmuth, HE, Type I (insulin-dependent) diabetes mellitus and cow milk: casein variant consumption. Diabetologia, 1999; 42: 292-6.
299. Lien, S, Kantanen, J, Olsaker, I, et al., Comparison of milk protein allele frequencies in Nordic cattle breeds. Anim Genet, 1999; 30: 85-91.
300. Thorsdottir, I, Birgisdottir, BE, Johannsdottir, IM, et al., Different beta-casein fractions in Icelandic versus Scandinavian cow's milk may influence diabetogenicity of cow's milk in infancy and explain low incidence of insulin-dependent diabetes mellitus in Iceland. Pediatrics, 2000; 106: 719-24.
301. Ness, AR, Smith, GD, and Hart, C, Milk, coronary heart disease and mortality. J Epidemiol Community Health, 2001; 55: 379-82
302. Tavani, A, Gallus, S, Negri, E, and La Vecchia, C, Milk, dairy products, and coronary heart disease. J Epidemiol Community Health, 2002; 56: 471-2
303. Sacks, FM, Svetkey, LP, Vollmer, WM, et al., Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med, 2001; 344: 3-10.
304. Pereira, MA, Jacobs, DR, Jr., Van Horn, L, Slattery, ML, Kartashov, AI, and Ludwig, DS, Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. Jama, 2002; 287: 2081-9.
305. Hooper, L, Summerbell, CD, Higgins, JP, et al., Dietary fat intake and prevention of cardiovascular disease: systematic review. Bmj, 2001; 322: 757-63.
306. Krauss, RM, Deckelbaum, RJ, Ernst, N, et al., Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation, 1996; 94: 1795-800.
307. Krauss, RM, Eckel, RH, Howard, B, et al., AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation, 2000; 102: 2284-99.
308. Charnock, JS, Dietary fats and cardiac arrhythmia in primates. Nutrition, 1994; 10: 161-9.
309. Kromhout, D, Epidemiology of cardiovascular diseases in Europe. Public Health Nutr, 2001; 4: 441-57.
310. Ravnskov, U, The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J Clin Epidemiol, 1998; 51: 443-60.
311. Clinical Evidence. A compendium of the best acvailable evidence for effective health care. 2001, London: BMJ Publishing Group.
312. Willett, WC, Stampfer, MJ, Manson, JE, et al., Intake of trans fatty acids and risk of coronary heart disease among women. Lancet, 1993; ii: 581-5
313. Ascherio, A, Hennekens, CH, Buring, JE, Master, C, Stampfer, MJ, and Willett, WC, Trans-fatty acids intake and risk of myocardial infarction. Circulation, 1994; 89: 94-101
314. Bolton-Smith, C, Woodward, M, Fenton, S, and Brown, CA, Does dietary trans fatty acid intake relate to the prevalence of coronary heart disease in Scotland? Eur Heart J, 1996; 17: 837-45.
315. Pietinen, P, Ascherio, A, Korhonen, P, et al., Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol, 1997; 145: 876-87.
316. Oomen, CM, Ocke, MC, Feskens, EJ, van Erp-Baart, MA, Kok, FJ, and Kromhout, D, Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet, 2001; 357: 746-51.
317. Pedersen, JI, Ringstad, J, Almendingen, K, Haugen, TS, Stensvold, I, and Thelle, DS, Adipose tissue fatty acids and risk of myocardial infarction--a case- control study. Eur J Clin Nutr, 2000; 54: 618-25.
318. Hodgson, JM, Wahlqvist, ML, Boxall, JA, and Balazs, ND, Platelet trans fatty acids in relation to angiographically assessed coronary artery disease. Atherosclerosis, 1996; 120: 147-54.
319. de Roos, NM, Bots, ML, and Katan, MB, Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol, 2001; 21: 1233-7.
320. Aro, A, Complexity of issue of dietary trans fatty acids. Lancet, 2001; 357: 732-3.
321. Katan, MB, Trans fatty acids and plasma lipoproteins. Nutr Rev, 2000; 58: 188-91.
322. Lemaitre, RN, King, IB, Raghunathan, TE, et al., Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation, 2002; 105: 697-701.
323. Simpson, HC, Barker, K, Carter, RD, Cassels, E, and Mann, JI, Low dietary intake of linoleic acid predisposes to myocardial infarction. Br Med J Clin Res Ed, 1982; 285: 683-4
324. Oliver, MF, Cigarette smoking, polyunsaturated fats, linoleic acid, and coronary heart disease [published erratum appears in Lancet 1989 Jun 24;1(8652):1464]. Lancet, 1989; i: 1241-3
325. Nikkari, T, Serum fatty acids and coronary heart disease in Finnish populations. Prog Lipid Res, 1986; 25: 437-50
326. Lands, WE, Dose-response relationships for omega 3/omega 6 effects. World Rev Nutr Diet, 1991; 66: 177-94
327. Hodgson, JM, Wahlqvist, ML, Boxall, JA, and Balazs, D, Can linoleic acid contribute to coronary artery disease? Am J Clin Nutr, 1993; 58: 228-34
328. Sarkkinen, ES, Uusitupa, MIJ, Nyyssönen, K, Parviainen, M, Penttilä, I, and Salonen, JT, Effects of two low-fat diets, high and low in polyunsaturated fatty acids, on plasma lipid peroxides and serum vitamin E levels in free-living hypercholesterolaemic men. Eur J Clin Nutr, 1993; 47: 623-30
329. McNamara, DJ, Dietary cholesterol and atherosclerosis. Biochim Biophys Acta, 2000; 1529: 310-20.
330. Hu, FB, Stampfer, MJ, Rimm, EB, et al., A prospective study of egg consumption and risk of cardiovascular disease in men and women. Jama, 1999; 281: 1387-94.
331. Lakka, HM, Lakka, TA, Tuomilehto, J, and Salonen, JT, Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J, 2002; 23: 706-13.
332. Rexrode, KM, Buring, JE, and Manson, JE, Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord, 2001; 25: 1047-56.
333. McGill, HC, Jr., McMahan, CA, Herderick, EE, et al., Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation, 2002; 105: 2712-8.
334. Alexander, JK, Obesity and coronary heart disease. Am J Med Sci, 2001; 321: 215-24.
335. Leeds, AR, Glycemic index and heart disease. Am J Clin Nutr, 2002; 76: 286S-9S.
336. Haffner, SM, Epidemiology of insulin resistance and its relation to coronary artery disease. Am J Cardiol, 1999; 84: 11J-14J.
337. Järvi, AE, Karlstrom, BE, Granfeldt, YE, Bjorck, IE, Asp, NG, and Vessby, BO, Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care, 1999; 22: 10-8.
338. Ford, ES and Liu, S, Glycemic index and serum high-density lipoprotein cholesterol concentration among us adults. Arch Intern Med, 2001; 161: 572-6.
339. Tuomilehto, J, Jousilahti, P, Rastenyte, D, et al., Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet, 2001; 357: 848-51.
340. He, J, Ogden, LG, Vupputuri, S, Bazzano, LA, Loria, C, and Whelton, PK, Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. Jama, 1999; 282: 2027-34.
341. Ammaturo, V, Perricone, C, Canazio, A, et al., Caffeine stimulates in vivo platelet reactivity. Acta Med Scand, 1988; 224: 245-7
342. De Caterina, R, Gazzetti, P, Mazzone, A, Marzilli, M, and L'Abbate, A, Platelet activation in angina at rest. Evidence by paired measurement of plasma beta-thromboglobulin and platelet factor 4. Eur Heart J, 1988; 9: 913-22.
343. Thelle, DS, Coffee, tea and coronary heart disease. Curr Opin Lipidol, 1995; 6: 25-7.
344. Christensen, B, Mosdol, A, Retterstol, L, Landaas, S, and Thelle, DS, Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol--a randomized controlled trial. Am J Clin Nutr, 2001; 74: 302-7.
345. Wilhelmsen, L, Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J, 1988; 115: 242-9
346. Shinton, R and Beevers, G, Meta-analysis of relation between cigarette smoking and stroke. B M J, 1989; 298: 789-94
347. McGill, HJ, The cardiovascular pathology of smoking. Am Heart J, 1988; 115: 250-7
348. Sugiishi, M and Takatsu, F, Cigarette smoking is a major risk factor for coronary spasm. Circulation, 1993; 87: 76-9
349. Laustiola, KE, Atherothrombotic mechanisms in smoking [editorial]. J Intern Med, 1991; 230: 469-70
350. Eliasson, B, Attvall, S, Taskinen, MR, and Smith, U, Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest, 1997; 27: 450-6.
351. Rogers, WR, Bass, RL, 3rd, Johnson, DE, et al., Atherosclerosis-related responses to cigarette smoking in the baboon. Circulation, 1980; 61: 1188-93
352. Wilhelmsen, L, Risk factors for disease according to population studies in Göteborg, Sweden., in Medical aspects of mortality statistics, Skandia International Symposium 1980, J. Waldenström, T. Larsson, and L. N., Editors. 1981, Almqvist & Wiksell International: Stockholm. p. 73-85.
353. Department of Health, Dietary Reference Values for Food, Energy and Nutrients for the United Kingdom. 1991, London: HMSO.
354. Nationella riktlinjer för strokesjukvård. 2000, Stockholm: Socialstyrelsen.
355. Hornabrook, RW, Editorial: neurology in Papua New Guinea. P N G Med J, 1975; 18: 193-6
356. Nagurney, JT, Neurological admissions to Goroka Base Hospital - an eight month survey. P N G Med J, 1975; 18: 220-6
357. Hutton, PW, Neurological disease in Uganda. East Afr Med J, 1956; 33: 209-223
358. Billinghurst, JR, The pattern of adult neurological admissions to Mulago hospital, Kampala. East Afr Med J, 1970; 47: 653-63
359. Feigin, VL, Lawes, CMM, Bennett, DA, and Anderson, CS, Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol, 2003; 2: 43–53
360. Thorvaldsen, P, Davidsen, M, Bronnum-Hansen, H, and Schroll, M, Stable stroke occurrence despite incidence reduction in an aging population: stroke trends in the danish monitoring trends and determinants in cardiovascular disease (MONICA) population. Stroke, 1999; 30: 2529-34.
361. Menotti, A, Blackburn, H, Kromhout, D, et al., The inverse relation of average population blood pressure and stroke mortality rates in the seven countries study: a paradox. Eur J Epidemiol, 1997; 13: 379-86.
362. Reed, DM, The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol, 1990; 131: 579-88.
363. Stegmayr, B, Asplund, K, Kuulasmaa, K, Rajakangas, AM, Thorvaldsen, P, and Tuomilehto, J, Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations. Stroke, 1997; 28: 1367-74.
364. Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet, 1998; 352: 1801-7.
365. Clinical Evidence writers on stroke prevention, Stroke prevention. Clinical Evidence, 2002; 7: 175-98
366. Hollander, M, Bots, ML, Del Sol, AI, et al., Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation, 2002; 105: 2872-7.
367. Pearson, TA, Blair, SN, Daniels, SR, et al., AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation, 2002; 106: 388-91
368. Lindahl, B, Dinesen, B, Eliasson, M, Roder, M, Hallmans, G, and Stegmayr, B, High proinsulin levels precede first-ever stroke in a nondiabetic population. Stroke, 2000; 31: 2936-41.
369. Goldstein, LB, Adams, R, Becker, K, et al., Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke, 2001; 32: 280-99.
370. Nadareishvili, ZG, Rothwell, PM, Beletsky, V, Pagniello, A, and Norris, JW, Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis. Arch Neurol, 2002; 59: 1162-6.
371. Henschen, F, Sjukdomarnas historia och geografi. 1962: Bonniers.
372. Walker, ARP, Mortality from coronary heart disease and from cerebral vascular disease in the different racial populations in South Africa. South Afr Med J, 1963; 37: 1155-9
373. Muna, WF, Cardiovascular disorders in Africa. World Health Stat Q, 1993; 46: 125-33
374. Solberg, LA and McGarry, PA, Cerebral atherosclerosis in Negroes and Caucasians. Atherosclerosis, 1972; 16: 141-54
375. D'Agostino, RB, Jr., Burke, G, O'Leary, D, et al., Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study. Stroke, 1996; 27: 1744-9.
376. Gubitz, G and Sandercock, P, Prevention of ischaemic stroke. Bmj, 2000; 321: 1455-9.
377. Joshipura, KJ, Ascherio, A, Manson, JE, et al., Fruit and vegetable intake in relation to risk of ischemic stroke. Jama, 1999; 282: 1233-9.
378. Perry, IJ and Beevers, DG, Salt intake and stroke: a possible direct effect. J Hum Hypertens, 1992; 6: 23-5
379. Ueshima, H, Zhang, XH, and Choudhury, SR, Epidemiology of hypertension in China and Japan. J Hum Hypertens, 2000; 14: 765-9.
380. Shimamoto, T, Komachi, Y, Inada, H, et al., Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation, 1989; 79: 503-15
381. Iso, H, Stampfer, MJ, Manson, JE, et al., Prospective study of fat and protein intake and risk of intraparenchymal hemorrhage in women. Circulation, 2001; 103: 856-63.
382. Zhang, J, Sasaki, S, Amano, K, and Kesteloot, H, Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study. Prev Med, 1999; 28: 520-9.
383. Kitamura, A, Iso, H, Iida, M, et al., Trends in the incidence of coronary heart disease and stroke and the prevalence of cardiovascular risk factors among Japanese men from 1963 to 1994. Am J Med, 2002; 112: 104-9.
384. Tanaka, H, Tanaka, Y, Hayashi, M, et al., Secular trends in mortality for cerebrovascular diseases in Japan, 1960 to 1979. Stroke, 1982; 13: 574-81.
385. Mizushima, S and Yamori, Y, Nutritional improvement, cardiovascular diseases and longevity in Japan. Nutr Health, 1992; 8: 97-105
386. Gillman, MW, Cupples, LA, Millen, BE, Ellison, RC, and Wolf, PA, Inverse association of dietary fat with development of ischemic stroke in men. Jama, 1997; 278: 2145-50.
387. Iso, H, Stampfer, MJ, Manson, JE, et al., Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke, 1999; 30: 1772-9.
388. Gale, CR, Martyn, CN, Winter, PD, and Cooper, C, Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Bmj, 1995; 310: 1563-6.
389. Khaw, KT and Woodhouse, P, Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. Bmj, 1995; 310: 1559-63.
390. Kurl, S, Tuomainen, TP, Laukkanen, JA, et al., Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke, 2002; 33: 1568-73.
391. Tobian, L, High-potassium diets markedly protect against stroke deaths and kidney disease in hypertensive rats, an echo from prehistoric days. J Hypertens Suppl, 1986; 4: S67-76.
392. Green, DM, Ropper, AH, Kronmal, RA, Psaty, BM, and Burke, GL, Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology, 2002; 59: 314-20.
393. Virmani, R, Kolodgie, FD, Burke, AP, Farb, A, and Schwartz, SM, Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 2000; 20: 1262-75.
394. Glass, CK and Witztum, JL, Atherosclerosis. the road ahead. Cell, 2001; 104: 503-16.
395. Glagov, S, Bassiouny, HS, Sakaguchi, Y, Goudet, CA, and Vito, RP, Mechanical determinants of plaque modeling, remodeling and disruption. Atherosclerosis, 1997; 131 Suppl: S13-4.
396. Levine, HD, Rheumatic Heart Disease in New Guinea: Including a Cardiovascular Survey of 200 Native Papuans. Ann Intern Med, 1946; 24: 826-
397. Higginson, J and Pepler, WJ, Fat intake, serum cholesterol, and atherosclerosis in the South African Bantu. Part II. Atherosclerosis and coronary artery disease. J Clin Invest, 1954; 33: 1366-71
398. Weinehall, L, Hellsten, G, Boman, K, Hallmans, G, Asplund, K, and Wall, S, Can a sustainable community intervention reduce the health gap?--10- year evaluation of a Swedish community intervention program for the prevention of cardiovascular disease. Scand J Public Health, 2001; Suppl: 59-68.
399. Stary, HC, Lipid and macrophage accumulations in arteries of children and the development of atherosclerosis. Am J Clin Nutr, 2000; 72: 1297S-306S.
400. McGill, HC, Jr., McMahan, CA, Herderick, EE, et al., Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol, 2000; 20: 836-45.
401. Tuzcu, EM, Kapadia, SR, Tutar, E, et al., High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation, 2001; 103: 2705-10.
402. Nissen, SE and Yock, P, Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation, 2001; 103: 604-16.
403. Velican, D and Velican, C, Study of fibrous plaques occurring in the coronary arteries of children. Atherosclerosis, 1979; 33: 201-5
404. Velican, D and Velican, C, Atherosclerotic involvement of the coronary arteries of adolescents and young adults. Atherosclerosis, 1980; 36: 449-60
405. Velican, C and Velican, D, Incidence, topography and light-microscopic feature of coronary atherosclerotic plaques in adults 26--35 years old. Atherosclerosis, 1980; 35: 111-22
406. Lesauskaite, V, Tanganelli, P, Bianciardi, G, Simoes, C, Toti, P, and Weber, G, World Health Organization (WHO) and the World Heart Federation (WHF) Pathobiological Determinants of Atherosclerosis in Youth (PBDAY) Study. Histomorphometric investigation of the aorta and coronary arteries in young people from different geographical locations. Nutr Metab Cardiovasc Dis, 1999; 9: 266-76.
407. Homma, S, Hirose, N, Ishida, H, Ishii, T, and Araki, G, Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke, 2001; 32: 830-5.
408. A pathological survey of atherosclerotic lesions of coronary artery and aorta in China. A coordination group in China. Pathol Res Pract, 1985; 180: 457-62.
409. Robinson, WF and Maxie, MG, The cardiovascular system, in Pathology of domesticated animals, K.V.F. Jubb, P.C. Kennedy, and N. Palmer, Editors. 1985, Academic Press: New York.
410. Whitney, JC, The spontaneous cardiovascular diseases of animals, in The pathology of the heart, A. Pomerance and M.J. Davies, Editors. 1975, Blackwell: Oxford. p. 579-610.
411. Stout, LC and Bohorquez, F, Significance of intimal arterial changes in non-human vertebrates. Med Clin North Am, 1974; 58: 245-55
412. McCullagh, KG, Arteriosclerosis in the African elephant. Atherosclerosis, 1972; 16: 307-35
413. Armstrong, ML and Heistad, DD, Animal models of atherosclerosis. Atherosclerosis, 1990; 85: 15-23
414. Moncada, S, Martin, JF, and Higgs, A, Symposium on regression of atherosclerosis. Eur J Clin Invest, 1993; 23: 385-98
415. Kaplan, JR, Manuck, SB, Adams, MR, Williams, JK, Register, TC, and Clarkson, TB, Plaque changes and arterial enlargement in atherosclerotic monkeys after manipulation of diet and social environment. Arterioscler Thromb, 1993; 13: 254-63
416. Malinow, MR, Experimental models of atherosclerosis regression. Atherosclerosis, 1983; 48: 105-18
417. McCullagh, KG, Arteriosclerosis in the African elephant. I. Intimal atherosclerosis and its possible causes. Atherosclerosis, 1972; 16: 307-35.
418. Sikes, SK, The disturbed habitat and its effect on the health of animal populations, with special reference to cardiovascular disease in elephants. Proc R Soc Med, 1968; 61: 160-1
419. Palinski, W and Napoli, C, Pathophysiological events during pregnancy influence the development of atherosclerosis in humans. Trends Cardiovasc Med, 1999; 9: 205-14
420. Jönsson, L, Coronary arterial lesions and myocardial infarcts in the dog. A pathologic and microangiographic study. Acta Vet Scand Suppl, 1972; 38: 1-80
421. Grundy, SM, Barrett-Connor, E, Rudel, LL, Miettinen, T, and Spector, AA, Workshop on the impact of dietary cholesterol on plasma lipoproteins and atherogenesis. Arteriosclerosis, 1988; 8: 95-101.
422. Maldonado, EN, Romero, JR, Ochoa, B, and Aveldano, MI, Lipid and fatty acid composition of canine lipoproteins. Comp Biochem Physiol B Biochem Mol Biol, 2001; 128: 719-29
423. Maldonado, EN, Casanave, EB, and Aveldano, MI, Major plasma lipids and fatty acids in four HDL mammals. Comp Biochem Physiol A Mol Integr Physiol, 2002; 132: 297-303
424. Liu, SK, Tilley, LP, Tappe, JP, and Fox, PR, Clinical and pathologic findings in dogs with atherosclerosis: 21 cases (1970-1983). J Am Vet Med Assoc, 1986; 189: 227-32.
425. Olsen, S, Origins of the Domestic Dog. 1985, Tucson: University of Arizona Press.
426. Ornish, D, Brown, SE, Scherwitz, LW, et al., Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial [see comments]. Lancet, 1990; 336: 129-33
427. Ornish, D, Scherwitz, LW, Billings, JH, et al., Intensive lifestyle changes for reversal of coronary heart disease. JAMA, 1998; 280: 2001-7
428. Watts, GF, Lewis, B, Brunt, JN, et al., Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) [see comments]. Lancet, 1992; 339: 563-9
429. Schuler, G, Hambrecht, R, Schlierf, G, et al., Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol, 1992; 19: 34-42
430. Rudel, LL, Parks, JS, Hedrick, CC, Thomas, M, and Williford, K, Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates. Role of cholesterol and fatty acids. Prog Lipid Res, 1998; 37: 353-70.
431. Kritchevsky, D, Diet and atherosclerosis. J Nutr Health Aging, 2001; 5: 155-9
432. Aguilera, CM, Ramirez-Tortosa, MC, Mesa, MD, Ramirez-Tortosa, CL, and Gil, A, Sunflower, virgin-olive and fish oils differentially affect the progression of aortic lesions in rabbits with experimental atherosclerosis. Atherosclerosis, 2002; 162: 335-44.
433. Rudel, LL, Parks, JS, and Sawyer, JK, Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol, 1995; 15: 2101-10.
434. Rudel, LL, Kelley, K, Sawyer, JK, Shah, R, and Wilson, MD, Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice. Arterioscler Thromb Vasc Biol, 1998; 18: 1818-27.
435. Blankenhorn, DH, Johnson, RL, Mack, WJ, el, ZH, and Vailas, LI, The influence of diet on the appearance of new lesions in human coronary arteries. Jama, 1990; 263: 1646-52
436. Koutis, AD, Isacsson, A, Lionis, CD, Lindholm, LH, Svenninger, K, and Fioretos, M, Differences in the diagnose panorama in primary health care in Dalby, Sweden and Spili, Crete. Scand J Soc Med, 1993; 21: 51-8
437. Kritchevsky, D, Tepper, SA, and Klurfeld, DM, Lectin may contribute to the atherogenicity of peanut oil. Lipids, 1998; 33: 821-3.
438. Prasad, K, Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis, 1997; 132: 69-76.
439. Axel, DI, Frigge, A, Dittmann, J, et al., All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovasc Res, 2001; 49: 851-62.
440. Claudel, T, Leibowitz, MD, Fievet, C, et al., Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Acad Sci U S A, 2001; 98: 2610-5.
441. Hsueh, WA and Law, RE, PPARgamma and atherosclerosis: effects on cell growth and movement. Arterioscler Thromb Vasc Biol, 2001; 21: 1891-5.
442. Laudet, V and Gronemeyer, H, The nuclear receptor facts book. 2002: Academic Press.
443. Kritchevsky, D, Dietary protein, cholesterol and atherosclerosis: a review of the early history. J Nutr, 1995; 125: 589S-593S.
444. Kritchevsky, D, Tepper, SA, Williams, DE, and Story, JA, Experimental atherosclerosis in rabbits fed cholesterol-free diets. Part 7. Interaction of animal or vegetable protein with fiber. Atherosclerosis, 1977; 26: 397-403
445. Kritchevsky, D, Diet and cholesteremia. Lipids, 1977; 12: 49-52.
446. Carroll, KK, The role of dietary protein in hypercholesterolemia and atherosclerosis. Lipids, 1978; 13: 360-5.
447. Kritchevsky, D, Tepper, SA, Czarnecki, SK, Klurfeld, DM, and Story, JA, Experimental atherosclerosis in rabbits fed cholesterol-free diets. Part 9. Beef protein and textured vegetable protein. Atherosclerosis, 1981; 39: 169-75.
448. Huff, MW, Roberts, DC, and Carroll, KK, Long-term effects of semipurified diets containing casein or soy protein isolate on atherosclerosis and plasma lipoproteins in rabbits. Atherosclerosis, 1982; 41: 327-36.
449. Carroll, KK, Hypercholesterolemia and atherosclerosis: effects of dietary protein. Fed Proc, 1982; 41: 2792-6.
450. Bauer, JE and Covert, SJ, The influence of protein and carbohydrate type on serum and liver lipids and lipoprotein cholesterol in rabbits. Lipids, 1984; 19: 844-50.
451. Lo, GS, Evans, RH, Phillips, KS, Dahlgren, RR, and Steinke, FH, Effect of soy fiber and soy protein on cholesterol metabolism and atherosclerosis in rabbits. Atherosclerosis, 1987; 64: 47-54.
452. Kritchevsky, D, Tepper, SA, Weber, MM, and Klurfeld, DM, Influence of soy protein or casein on pre-established atherosclerosis in rabbits. Artery, 1988; 15: 163-9
453. Kritchevsky, D, Tepper, SA, Davidson, LM, Fisher, EA, and Klurfeld, DM, Experimental atherosclerosis in rabbits fed cholesterol-free diets. 13. Interaction of proteins and fat. Atherosclerosis, 1989; 75: 123-7.
454. Bergeron, N and Jacques, H, Influence of fish protein as compared to casein and soy protein on serum and liver lipids, and serum lipoprotein cholesterol levels in the rabbit. Atherosclerosis, 1989; 78: 113-21.
455. Kritchevsky, D, Protein and atherosclerosis. J Nutr Sci Vitaminol (Tokyo), 1990; 36 Suppl 2: S81-6.
456. DiFrancesco, L, Percy, DH, and Mercer, NH, Long-term feeding of casein or soy protein with or without cholesterol in Mongolian gerbils. I. Morphologic effects. Acta Cardiol, 1990; 45: 257-71
457. DiFrancesco, L, Allen, OB, and Mercer, NH, Long-term feeding of casein or soy protein with or without cholesterol in Mongolian gerbils. II. Plasma lipid and liver cholesterol responses. Acta Cardiol, 1990; 45: 273-90
458. Sanchez, A and Hubbard, RW, Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis. Med Hypotheses, 1991; 35: 324-9.
459. Sanchez, A and Hubbard, RW, Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis. Med Hypotheses, 1991; 36: 27-32.
460. Richardson, M, Kurowska, EM, and Carroll, KK, Early lesion development in the aortas of rabbits fed low-fat, cholesterol-free, semipurified casein diet. Atherosclerosis, 1994; 107: 165-78.
461. Wagner, JD, Cefalu, WT, Anthony, MS, Litwak, KN, Zhang, L, and Clarkson, TB, Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism, 1997; 46: 698-705.
462. Anthony, MS, Clarkson, TB, Bullock, BC, and Wagner, JD, Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol, 1997; 17: 2524-31.
463. Anthony, MS, Clarkson, TB, and Williams, JK, Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am J Clin Nutr, 1998; 68: 1390S-1393S.
464. Wagner, JD, Zhang, L, Greaves, KA, Shadoan, MK, and Schwenke, DC, Soy protein reduces the arterial low-density lipoprotein (LDL) concentration and delivery of LDL cholesterol to the arteries of diabetic and nondiabetic male cynomolgus monkeys. Metabolism, 2000; 49: 1188-96.
465. Damasceno, NR, Goto, H, Rodrigues, FM, et al., Soy protein isolate reduces the oxidizability of LDL and the generation of oxidized LDL autoantibodies in rabbits with diet-induced atherosclerosis. J Nutr, 2000; 130: 2641-7.
466. Damasceno, NR, Gidlund, MA, Goto, H, Dias, CT, Okawabata, FS, and Abdalla, DS, Casein and soy protein isolate in experimental atherosclerosis: influence on hyperlipidemia and lipoprotein oxidation. Ann Nutr Metab, 2001; 45: 38-46
467. Adams, MR, Golden, DL, Anthony, MS, Register, TC, and Williams, JK, The inhibitory effect of soy protein isolate on atherosclerosis in mice does not require the presence of LDL receptors or alteration of plasma lipoproteins. J Nutr, 2002; 132: 43-9.
468. Wilson, TA, Nicolosi, RJ, Marchello, MJ, and Kritchevsky, D, Consumption of ground bison does not increase early atherosclerosis development in hypercholesterolemic hamsters. Nutr Res, 2000; 20: 707-19
469. Macdonald, D, The Encyclopedia of Mammals. 1984, New York: Facts on File Publishing.
470. Stills, HF, Jr., Bullock, BC, and Clarkson, TB, Increased atherosclerosis and glomerulonephritis in cynomolgus monkeys (Macaca fascicularis) given injections of BSA over an extended period of time. Am J Pathol, 1983; 113: 222-34.
471. Muscari, A, Volta, U, Bonazzi, C, et al., Association of serum IgA antibodies to milk antigens with severe atherosclerosis. Atherosclerosis, 1989; 77: 251-6
472. Hansson, GK, Libby, P, Schonbeck, U, and Yan, ZQ, Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res, 2002; 91: 281-91.
473. Kritchevsky, D, Davidson, LM, Kim, HK, et al., Influence of type of carbohydrate on atherosclerosis in baboons fed semipurified diets plus 0.1% cholesterol. Am J Clin Nutr, 1980; 33: 1869-87
474. Hugi, D, Tappy, L, Sauerwein, RM, Bruckmaier, RM, and Blum, JW, Insulin-dependent glucose utilization in intensively milk-fed veal calves is modulated by supplementing lactose in an age-depenedent manner. J Nutr, 1998; 128: 1023-30
475. Mann, GV, Spoerry, A, Gray, M, and Jarashow, D, Atherosclerosis in the Masai. Am J Epidemiol, 1972; 95: 26-37
476. Ito, M, Toda, T, Kummerow, FA, and Nishimori, I, Effect of magnesium deficiency on ultrastructural changes in coronary arteries of swine. Acta Pathol Jpn, 1986; 36: 225-34.
477. Dwyer, JH, Navab, M, Dwyer, KM, et al., Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study. Circulation, 2001; 103: 2922-7.
478. Hennig, B, Meerarani, P, Ramadass, P, et al., Zinc nutrition and apoptosis of vascular endothelial cells: implications in atherosclerosis. Nutrition, 1999; 15: 744-8.
479. Stuhlinger, MC, Tsao, PS, Her, JH, Kimoto, M, Balint, RF, and Cooke, JP, Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation, 2001; 104: 2569-75.
480. Young, DB and Ma, G, Vascular protective effects of potassium. Semin Nephrol, 1999; 19: 477-86.
481. Murakami, S, Kondo, Y, Sakurai, T, Kitajima, H, and Nagate, T, Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis, 2002; 163: 79-87.
482. Fiennes, RNT-W, Atherosclerosis in wild animals, in Comparative atherosclerosis. The morphology of spontaneous and induced atherosclerotic lesions in animals and its relation to human disease, J. Roberts and R. Straus, Editors. 1965, Harper & Row. p. 113-26.
483. Cordain, L, Toohey, L, Smith, MJ, and Hickey, MS, Modulation of immune function by dietary lectins in rheumatoid arthritis. Br J Nutr, 2000; 83: 207-17.
484. Hansson, GK, Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol, 2001; 21: 1876-90.
485. Liener, IE, Nutritional significance of lectins in the diet, in The lectins: Properties, Functions and Applications in Biology and Medicine, I.E. Liener, N. Sharon, and I.J. Goldstein, Editors. 1986, Academic Press. p. 527-52.
486. Pusztai, A, Dietary lectins are metabolic signals for the gut and modulate immune and hormone functions. Eur J Clin Nutr, 1993; 47: 691-9.
487. Davis, HR and Glagov, S, Lectin binding to distinguish cell types in fixed atherosclerotic arteries. Atherosclerosis, 1986; 61: 193-203.
488. Kagami, H, Uryu, K, Okamoto, K, Sakai, H, Kaneda, T, and Sakanaka, M, Differential lectin binding on walls of thoraco-cervical blood vessels and lymphatics in rats. Okajimas Folia Anat Jpn, 1991; 68: 161-70.
489. Ohmori, T, Yatomi, Y, Wu, Y, Osada, M, Satoh, K, and Ozaki, Y, Wheat germ agglutinin-induced platelet activation via platelet endothelial cell adhesion molecule-1: involvement of rapid phospholipase C gamma 2 activation by Src family kinases. Biochemistry, 2001; 40: 12992-3001.
490. Cyrus, T, Tang, LX, Rokach, J, FitzGerald, GA, and Pratico, D, Lipid peroxidation and platelet activation in murine atherosclerosis. Circulation, 2001; 104: 1940-5.
491. Barbeau, WE, Novascone, MA, and Elgert, KD, Is celiac disease due to molecular mimicry between gliadin peptide-HLA class II molecule-T cell interactions and those of some unidentified superantigen? Mol Immunol, 1997; 34: 535-41.
492. Wang, XY, Bergdahl, K, Heijbel, A, Liljebris, C, and Bleasdale, JE, Analysis of in vitro interactions of protein tyrosine phosphatase 1B with insulin receptors. Mol Cell Endocrinol, 2001; 173: 109-20.
493. Vacaresse, N, Vieira, O, Robbesyn, F, Jurgens, G, Salvayre, R, and Negre-Salvayre, A, Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL- induced EGF-receptor activation. Br J Pharmacol, 2001; 132: 1777-88.
494. Cheryan, M, Phytic acid interactions in food systems. Crit Rev Food Sci Nutr, 1980; 13: 297-335
495. Chiang, JY, Kimmel, R, and Stroup, D, Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene, 2001; 262: 257-65.
496. Anonymous, Report of the Task Group on Reference Man. 1992, Oxford: Pergamon.
497. Nagaev, I and Smith, U, Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun, 2001; 285: 561-4.
498. Aziz, A and Anderson, GH, Exendin-4, a GLP-1 receptor agonist, modulates the effect of macronutrients on food intake by rats. J Nutr, 2002; 132: 990-5
499. Laffitte, BA, Joseph, SB, Walczak, R, et al., Autoregulation of the human liver X receptor alpha promoter. Mol Cell Biol, 2001; 21: 7558-68.
500. Lothrop, C, Harrison, GJ, Schultz, D, and Utteridge, T, Miscellaneous diseases, in Clinical Avian Medicine and Surgery, G.J. Harrison and L.R. Harrison, Editors. 1986, Saunders: Philadelphia. p. 525-36.
501. Hu, FB, Stampfer, MJ, Haffner, SM, Solomon, CG, Willett, WC, and Manson, JE, Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes. Diabetes Care, 2002; 25: 1129-1134.
502. Stamler, J, Vaccaro, O, Neaton, JD, and Wentworth, D, Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 1993; 16: 434-44.
503. Donnan, PT, Boyle, DI, Broomhall, J, et al., Prognosis following first acute myocardial infarction in Type 2 diabetes: a comparative population study. Diabet Med, 2002; 19: 448-55
504. Qiao, Q, Pyorala, K, Pyorala, M, et al., Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J, 2002; 23: 1267.
505. Kuzuya, T, Nakagawa, S, Satoh, J, et al., Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract, 2002; 55: 65-85
506. Spielman, RS, Fajans, SS, Neel, JV, Pek, S, Floyd, JC, and Oliver, WJ, Glucose tolerance in two unacculturated Indian tribes of Brazil. Diabetologia, 1982; 23: 90-3
507. Merimee, TJ, Rimoin, DL, and Cavalli, SL, Metabolic studies in the African pygmy. J Clin Invest, 1972; 51: 395-401
508. Joffe, BI, Jackson, WP, Thomas, ME, Toyer, MG, Keller, P, and Pimstone, BL, Metabolic responses to oral glucose in the Kalahari Bushmen. B M J, 1971; 4: 206-8
509. Lindeberg, S, Eliasson, M, Lindahl, B, and Ahrén, B, Low serum insulin in traditional Pacific Islanders--the Kitava Study. Metabolism, 1999; 48: 1216-9
510. King, H and Rewers, M, Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care, 1993; 16: 157-77
511. Cooper, RS, Rotimi, CN, Kaufman, JS, et al., Prevalence of NIDDM among populations of the African diaspora. Diabetes Care, 1997; 20: 343-8.
512. Cruickshank, JK, Mbanya, JC, Wilks, R, Balkau, B, McFarlane-Anderson, N, and Forrester, T, Sick genes, sick individuals or sick populations with chronic disease? The emergence of diabetes and high blood pressure in African-origin populations. Int J Epidemiol, 2001; 30: 111-7.
513. Trowell, HC, Hypertension, obesity diabetes mellitus and coronary heart disease, in Western diseases: their emergence and prevention, H.C. Trowell and D.P. Burkitt, Editors. 1981, Edward Arnold: London. p. 3-32.
514. Bennett, PH, Type 2 diabetes among the Pima Indians of Arizona: an epidemic attributable to environmental change? Nutr Rev, 1999; 57: S51-4.
515. Buse, JB, Polonsky, KS, and Burant, CF, Type 2 diabetes mellitus, in Larsen: Williams Textbook of Endocrinology, 10th ed., Copyright © 2003 W. B. Saunders Company, P.R. Larsen, et al., Editors. 2003, Saunders. p. 1427-83.
516. Gerich, JE, Is insulin resistance the principal cause of type 2 diabetes? Diabetes Obes Metab, 1999; 1: 257-63.
517. van Haeften, TW, Pimenta, W, Mitrakou, A, et al., Disturbances in beta-Cell Function in Impaired Fasting Glycemia. Diabetes, 2002; 51 Suppl 1: S265-S270.
518. Lindeberg, S, Soderberg, S, Ahren, B, and Olsson, T, Large differences in serum leptin levels between nonwesternized and westernized populations: the Kitava study. J Intern Med, 2001; 249: 553-8.
519. Mann, J, Hermansen, K, Vessby, B, and Toeller, M, Evidence-Based Nutritional Recommendations for the Treatment and Prevention of Diabetes and Related Complications: A European perspective. Diabetes Care, 2002; 25: 1256-1258.
520. Franz, MJ, Bantle, JP, Beebe, CA, et al., Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care, 2002; 25: 148-98.
521. Wolever, TM, American diabetes association evidence-based nutrition principles and recommendations are not based on evidence. Diabetes Care, 2002; 25: 1263-4.
522. Tuomilehto, J, Lindstrom, J, Eriksson, JG, et al., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med, 2001; 344: 1343-50.
523. Knowler, WC, Barrett-Connor, E, Fowler, SE, et al., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 2002; 346: 393-403.
524. Lean, ME and Ha, TKK, Nutrition and dietary advice for diabetes, in Human Nutrition and Dietetics, J.S. Garrow and W.P.T. James, Editors. 2000, Churchill Livingstone. p. 605-20.
525. Vessby, B, Unsitupa, M, Hermansen, K, et al., Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia, 2001; 44: 312-9.
526. Reaven, GM, Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against. Curr Opin Lipidol, 1997; 8: 23-27
527. Parks, EJ and Hellerstein, MK, Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr, 2000; 71: 412-33.
528. Jeppesen, J, Schaaf, P, Jones, C, Zhou, MY, Chen, YD, and Reaven, GM, Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women. Am J Clin Nutr, 1997; 65: 1027-33.
529. Liljeberg, H and Bjorck, I, Delayed gastric emptying rate may explain improved glycaemia in healthy subjects to a starchy meal with added vinegar. Eur J Clin Nutr, 1998; 52: 368-71.
530. Heilbronn, LK, Noakes, M, and Clifton, PM, The effect of high- and low-glycemic index energy restricted diets on plasma lipid and glucose profiles in type 2 diabetic subjects with varying glycemic control. J Am Coll Nutr, 2002; 21: 120-7.
531. Lindeberg, S, Berntorp, E, Carlsson, R, Eliasson, M, and Marckmann, P, Haemostatic variables in Pacific Islanders apparently free from stroke and ischaemic heart disease. Thromb Haemost, 1997; 77: 94-8
532. Salmeron, J, Ascherio, A, Rimm, EB, et al., Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care, 1997; 20: 545-50.
533. Salmeron, J, Manson, JE, Stampfer, MJ, Colditz, GA, Wing, AL, and Willett, WC, Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. Jama, 1997; 277: 472-7.
534. Liu, S, Manson, JE, Buring, JE, Stampfer, MJ, Willett, WC, and Ridker, PM, Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr, 2002; 75: 492-8.
535. Liu, S, Manson, JE, Stampfer, MJ, et al., Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr, 2001; 73: 560-6.
536. Kennedy, ET, Bowman, SA, Spence, JT, Freedman, M, and King, J, Popular diets: correlation to health, nutrition, and obesity. J Am Diet Assoc, 2001; 101: 411-20.
537. St Jeor, ST, Howard, BV, Prewitt, TE, Bovee, V, Bazzarre, T, and Eckel, RH, Dietary protein and weight reduction: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation, 2001; 104: 1869-74.
538. Elliott, SS, Keim, NL, Stern, JS, Teff, K, and Havel, PJ, Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr, 2002; 76: 911-22
539. Stilling, B, Mehlsen, J, Hamberg, O, Larsen, JJ, Gram, NC, and Madsbad, S, Effect of starch-free bread on metabolic control in type 2 diabetes. Lancet, 1998; 352: 369-70.
540. Stilling, B, Mehlsen, J, Hamberg, O, Larsen, JJ, Gram, NC, and Madsbad, S, Effect of a new starch-free bread on metabolic control in NIDDM patients. Nutr Metab Cardiovasc Dis, 1999; 9: 98-101
541. Brand-Miller, JC, Colagiuri, S, and Gan, ST, Insulin sensitivity predicts glycemia after a protein load. Metabolism, 2000; 49: 1-5
542. Schmid, R, Schulte-Frohlinde, E, Schusdziarra, V, et al., Contribution of postprandial amino acid levels to stimulation of insulin, glucagon, and pancreatic polypeptide in humans. Pancreas, 1992; 7: 698-704
543. O'Dea, K, Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. Diabetes, 1984; 33: 596-603
544. Parker, B, Noakes, M, Luscombe, N, and Clifton, P, Effect of a high-protein, high--monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care, 2002; 25: 425-30.
545. Meloni, C, Morosetti, M, Suraci, C, et al., Severe dietary protein restriction in overt diabetic nephropathy: Benefits or risks? J Ren Nutr, 2002; 12: 96-101. t&artType=abs&id=ajren0120096&target=
546. Hansen, HP, Tauber-Lassen, E, Jensen, BR, and Parving, HH, Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int, 2002; 62: 220-8.
547. Fouque, D, Wang, P, Laville, M, and Boissel, JP, Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. Nephrol Dial Transplant, 2000; 15: 1986-92.
548. Narita, T, Koshimura, J, Meguro, H, Kitazato, H, Fujita, H, and Ito, S, Determination of optimal protein contents for a protein restriction diet in type 2 diabetic patients with microalbuminuria. Tohoku J Exp Med, 2001; 193: 45-55.
549. Tapp, DC, Wortham, WG, Addison, JF, Hammonds, DN, Barnes, JL, and Venkatachalam, MA, Food restriction retards body growth and prevents end-stage renal pathology in remnant kidneys of rats regardless of protein intake. Lab Invest, 1989; 60: 184-95.
550. Kobayashi, S and Venkatachalam, MA, Differential effects of calorie restriction on glomeruli and tubules of the remnant kidney. Kidney Int, 1992; 42: 710-7.
551. Roper, NA, Bilous, RW, Kelly, WF, Unwin, NC, and Connolly, VM, Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. Diabetes Care, 2002; 25: 43-8.
552. Aktiv uremivård i Sverige. 2001: Svenskt Register för Aktiv uremivård (SRAU).
553. Dikow, R, Adamczak, M, Henriquez, DE, and Ritz, E, Strategies to decrease cardiovascular mortality in patients with end- stage renal disease. Kidney Int, 2002; 61 Suppl 80: 5-10.
554. Levin, A, Prevalence of cardiovascular damage in early renal disease. Nephrol Dial Transplant, 2001; 16: 7-11.
555. Stenvinkel, P, Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif, 2001; 19: 53-61
556. Foley, RN, Parfrey, PS, and Sarnak, MJ, Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol, 1998; 9: S16-23.
557. Spoelstra-de Man, AM, Brouwer, CB, Stehouwer, CD, and Smulders, YM, Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care, 2001; 24: 2097-101.
558. Maddox, DA, Alavi, FK, Silbernick, EM, and Zawada, ET, Protective effects of a soy diet in preventing obesity-linked renal disease. Kidney Int, 2002; 61: 96-104.
559. Lavigne, C, Tremblay, F, Asselin, G, Jacques, H, and Marette, A, Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats. Am J Physiol Endocrinol Metab, 2001; 281: E62-71.
560. Allen, TJ, Waldron, MJ, Casley, D, Jerums, G, and Cooper, ME, Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes, 1997; 46: 19-24.
561. Yu, HC, Burrell, LM, Black, MJ, et al., Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation, 1998; 98: 2621-8.
562. Gregersen, S, Rasmussen, O, Larsen, S, and Hermansen, K, Glycaemic and insulinaemic responses to orange and apple compared with white bread in non-insulin-dependent diabetic subjects. Eur J Clin Nutr, 1992; 46: 301-3.
563. Ercan, N, Nuttall, FQ, Gannon, MC, Lane, JT, Burmeister, LA, and Westphal, SA, Plasma glucose and insulin responses to bananas of varying ripeness in persons with noninsulin-dependent diabetes mellitus. J Am Coll Nutr, 1993; 12: 703-9
564. Hermansen, K, Rasmussen, O, Gregersen, S, and Larsen, S, Influence of ripeness of banana on the blood glucose and insulin response in type 2 diabetic subjects. Diabet Med, 1992; 9: 739-43.
565. Uusitupa, MI, Fructose in the diabetic diet. Am J Clin Nutr, 1994; 59: 753S-757S.
566. Gannon, MC, Nuttall, FQ, Krezowski, PA, Billington, CJ, and Parker, S, The serum insulin and plasma glucose responses to milk and fruit products in type 2 (non-insulin-dependent) diabetic patients. Diabetologia, 1986; 29: 784-91
567. Östman, EM, Liljeberg Elmstahl, HG, and Bjorck, IM, Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. Am J Clin Nutr, 2001; 74: 96-100.
568. Yevdokimova, NY and Yefimov, AS, Effects of wheat germ agglutinin and concanavalin A on the accumulation of glycosaminoglycans in pericellular matrix of human dermal fibroblasts. A comparison with insulin. Acta Biochim Pol, 2001; 48: 563-72
569. Freed, DLJ, Lectins in food: their importance in health and disease. J Nutr med, 1991; 2: 45-64
570. Evans, WJ, What is sarcopenia? J Gerontol A Biol Sci Med Sci, 1995; 50 Spec No: 5-8.
571. Oliveira, JTA, Pusztai, A, and Grant, G, Changes in organs and tissues induced by feeding of purified kidney bean (Phaseolus vulgaris) lectins. Nutr Res, 1988; 8: 943-7
572. Mann, GV, Roels, OA, Price, DL, and Merrill, JM, Cardiovascular disease in African Pygmies. A survey of the health status, serum lipids and diet of pygmies in Congo. J Chron Dis, 1961; 15: 341-71
573. Shaper, A, Cardiovascular studies in the Samburu tribe of northern Kenya. Am Heart J, 1962; 63: 437-442
574. Maddocks, I, Dietary factors in the genesis of hypertension, in Proceedings of the Sixth International Congress of Nutrition, C.F. Mills and R. Passmore, Editors. 1964, Livingstone: Edinburgh. p. 137-47.
575. Shaper, AG, Wright, DH, and Kyobe, J, Blood pressure and body build in three nomadic tribes of northern Kenya. East Afr Med J, 1969; 46: 273-81
576. Barnicot, NA, Bennett, FJ, Woodburn, JC, Pilkington, TR, and Antonis, A, Blood pressure and serum cholesterol in the Hadza of Tanzania. Hum Biol, 1972; 44: 87-116
577. Sinnett, PF and Whyte, HM, Epidemiological studies in a highland population of New Guinea: environment, culture, and health status. Human Ecology, 1973; 1: 245-77
578. Little, MA, Galvin, K, and Mugambi, M, Cross-sectional growth of nomadic Turkana pastoralists. Hum Biol, 1983; 55: 811-30
579. Jenkins, C, Medical anthropology in the Western Scrader range, Papua New Guinea. Nat Geogr Res, 1987; 3: 412-30
580. James, GD and Baker, PT, Human Population Biology and Hypertension: Evolutionary and Ecological Aspects of Blood Pressure, in Hypertension: Pathophysiology, Diagnosis, and Management, J.H. Laragh and B.M. Brenner, Editors. 1990, Raven Press, Ltd: New York. p. 137-145.
581. Strickland, SS and Ulijaszek, SJ, Body mass index, ageing and differential reported morbidity in rural Sarawak. Eur J Clin Nutr, 1993; 47: 9-19
582. Lindeberg, S, Berntorp, E, Nilsson-Ehle, P, Terent, A, and Vessby, B, Age relations of cardiovascular risk factors in a traditional Melanesian society: the Kitava Study. Am J Clin Nutr, 1997; 66: 845-52
583. Gallagher, D, Ruts, E, Visser, M, et al., Weight stability masks sarcopenia in elderly men and women. Am J Physiol Endocrinol Metab, 2000; 279: E366-75.
584. Rundgren, Å, Människans funktionella åldrande. 1991, Lund: Studentlitteratur.
585. Fox, C, Esparza, J, Nicolson, M, et al., Plasma leptin concentrations in Pima Indians living in drastically different environments. Diabetes Care, 1999; 22: 413-7
586. Prior, IA, Davidson, F, Salmond, CE, and Czochanska, Z, Cholesterol, coconuts, and diet on Polynesian atolls: a natural experiment: the Pukapuka and Tokelau island studies. Am J Clin Nutr, 1981; 34: 1552-61
587. Ahren, B, Larsson, H, Wilhelmsson, C, Nasman, B, and Olsson, T, Regulation of circulating leptin in humans. Endocrine, 1997; 7: 1-8
588. Friedman, JM and Halaas, JL, Leptin and the regulation of body weight in mammals. Nature, 1998; 395: 763-70
589. Unger, RH, Zhou, YT, and Orci, L, Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci U S A, 1999; 96: 2327-32
590. Unger, RH, Lipotoxic diseases. Annu Rev Med, 2002; 53: 319-36
591. Mann, GV, The serum lipoprotein and cholesterol concentrations of Central and North Americans with different dietary habits. Am J Med, 1955; 19: 25
592. Walker, ARP, Overweight and hypertension in emerging populations. Am Heart J, 1964; 68: 581-5
593. Edwards, FM, Wise, PH, Thomas, DW, Murchland, JB, and Craig, RJ, Blood pressures and electrocardiographic findings in the South Australian Aborigines. Aust N Z J Med, 1976; 6: 197-205
594. Eason, RJ, Pada, J, Wallace, R, Henry, A, and Thornton, R, Changing patterns of hypertension, diabetes, obesity and diet among Melanesians and Micronesians in the Solomon Islands. Med J Aust, 1987; 146: 465-9
595. Taylor, R, Bennett, P, Uili, R, et al., Hypertension and indicators of coronary heart disease in Wallis Polynesians: an urban-rural comparison. Eur J Epidemiol, 1987; 3: 247-56
596. Salmond, CE, Prior, IA, and Wessen, AF, Blood pressure patterns and migration: a 14-year cohort study of adult Tokelauans. Am J Epidemiol, 1989; 130: 37-52
597. Collins, V, Dowse, G, and Zimmet, P, Prevalence of obesity in Pacific and Indian Ocean populations. Diabetes Res Clin Pract, 1990;
598. Ahmed, ME, Blood pressure in a multiracial urban Sudanese community. J Hum Hypertens, 1990; 4: 621-4
599. Thouez, JP, Ekoé, JM, Foggin, PM, et al., Obesity, hypertension, hyperuricemia and diabetes mellitus among the Cree and Inuit of Northern Cuébec. Arct Med Res, 1990; 49: 180-8
600. Alpert, JS, Goldberg, R, Ockene, IS, and Taylor, P, Heart disease in native Americans. Cardiology, 1991; 78: 3-12
601. Taylor, R, Badcock, J, King, H, et al., Dietary intake, exercise, obesity and noncommunicable disease in rural and urban populations of three Pacific Island countries. J Am Coll Nutr, 1992; 11: 283-93
602. O'Dea, K, Patel, M, Kubisch, D, Hopper, J, and Traianedes, K, Obesity, diabetes, and hyperlipidemia in a central Australian aboriginal community with a long history of acculturation. Diabetes Care, 1993; 16: 1004-10
603. Nan, L, Tuomilehto, J, Dowse, G, Virtala, E, and Zimmet, P, Prevalence of coronary heart disease indicated by electrocardiogram abnormalities and risk factors in developing countries. J Clin Epidemiol, 1994; 47: 599-611
604. SBU, Fetma - problem och åtgärder. 2002: Statens beredning för medicinsk utvärdering.
605. Rose, G, Sick individuals and sick populations. Int J Epidemiol, 1985; 14: 32-8
606. Statens beredning för utvärdering av medicinsk teknik, Fetma – problem och åtgärder. 2002, Stockholm: SBU.
607. Deurenberg-Yap, M, Chew, SK, and Deurenberg, P, Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians. Obes Rev, 2002; 3: 209-15
608. Dudeja, V, Misra, A, Pandey, RM, Devina, G, Kumar, G, and Vikram, NK, BMI does not accurately predict overweight in Asian Indians in northern India. Br J Nutr, 2001; 86: 105-12
609. Sanchez-Castillo, CP, Velazquez-Monroy, O, Berber, A, Lara-Esqueda, A, Tapia-Conyer, R, and James, WP, Anthropometric cutoff points for predicting chronic diseases in the Mexican National Health Survey 2000. Obes Res, 2003; 11: 442-51
610. Nilsson, P, Nilsson, JA, and Lindgarde, F, Kan viktreduktion avhjälpa fetmans problem? Studier antyder ökad dödlighet efter viktnedgång. Läkartidningen, 2000; 97: 2645-6.
611. Allison, DB, Zhu, SK, Plankey, M, Faith, MS, and Heo, M, Differential associations of body mass index and adiposity with all- cause mortality among men in the first and second National Health and Nutrition Examination Surveys (NHANES I and NHANES II) follow-up studies. Int J Obes Relat Metab Disord, 2002; 26: 410-6.
612. Allison, DB, Zannolli, R, Faith, MS, et al., Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies. Int J Obes Relat Metab Disord, 1999; 23: 603-11
613. Roth, GS, Ingram, DK, and Lane, MA, Caloric restriction in primates and relevance to humans. Ann N Y Acad Sci, 2001; 928: 305-15.
614. Pirozzo, S, Summerbell, C, Cameron, C, and Glasziou, P, Advice on low-fat diets for obesity (Cochrane Review). Cochrane Database Syst Rev, 2002; 2
615. Porrini, M, Santangelo, A, Crovetti, R, Riso, P, Testolin, G, and Blundell, JE, Weight, protein, fat, and timing of preloads affect food intake. Physiol Behav, 1997; 62: 563-70.
616. Crovetti, R, Porrini, M, Santangelo, A, and Testolin, G, The influence of thermic effect of food on satiety. Eur J Clin Nutr, 1998; 52: 482-8.
617. Skov, AR, Toubro, S, Ronn, B, Holm, L, and Astrup, A, Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord, 1999; 23: 528-36
618. Johnston, CS, Day, CS, and Swan, PD, Postprandial thermogenesis is increased 100% on a high-protein, low-fat diet versus a high-carbohydrate, low-fat diet in healthy, young women. J Am Coll Nutr, 2002; 21: 55-61.
619. Diez, M, Nguyen, P, Jeusette, I, Devois, C, Istasse, L, and Biourge, V, Weight loss in obese dogs: evaluation of a high-protein, low- carbohydrate diet. J Nutr, 2002; 132: 1685S-7S.
620. Hannah, JS, Dubey, AK, and Hansen, BC, Postingestional effects of a high-protein diet on the regulation of food intake in monkeys. Am J Clin Nutr, 1990; 52: 320-5
621. Pearcey, SM and De Castro, JM, Food intake and meal patterns of weight-stable and weight-gaining persons. Am J Clin Nutr, 2002; 76: 107-12.
622. Klem, ML, Wing, RR, McGuire, MT, Seagle, HM, and Hill, JO, A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr, 1997; 66: 239-46.
623. Brand-Miller, JC, Holt, SH, Pawlak, DB, and McMillan, J, Glycemic index and obesity. Am J Clin Nutr, 2002; 76: 281S-5S.
624. Lavin, JH, Wittert, GA, Andrews, J, et al., Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate. Am J Clin Nutr, 1998; 68: 591-8.
625. Raben, A, Should obese patients be counselled to follow a low-glycaemic index diet? No. Obes Rev, 2002; 3: 245-56
626. Harrison, GJ and Harrison, LR, Nutritional diseases, in Clinical Avian Medicine and Surgery, G.J. Harrison and L.R. Harrison, Editors. 1986, Saunders: Philadelphia. p. 397-407.
627. Reese, DE, Nutrient deficiencies and excesses, in Diseases of swine, B.E. Straw, et al., Editors. 1999, Blackwell Science. p. 743-55.
628. Banting, W, Letter on corpulence, addressed to the public. 5 ed. 1865, New York: Mohun & Ebbs.
629. Fogelholm, M and Kukkonen-Harjula, K, Does physical activity prevent weight gain--a systematic review. Obes Rev, 2000; 1: 95-111
630. Kitabchi, AE, Shea, JJ, Duckworth, WC, and Adams, F, High incidence of diabetes and glucose intolerance in fluctuant hearing loss. J Lab Clin Med, 1971; 78: 995-6
631. Kitabchi, AE and Shea, JJ, Diabetes mellitus in fluctuant hearing loss. Otolaryngol Clin North Am, 1975; 8: 357-68
632. Furushima, M, Imaizumi, M, and Nakatsuka, K, Changes in refraction caused by induction of acute hyperglycemia in healthy volunteers. Jpn J Ophthalmol, 1999; 43: 398-403
633. Lipsky, BA, Pecoraro, RE, Chen, MS, and Koepsell, TD, Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care, 1987; 10: 483-6
634. Rayfield, EJ, Ault, MJ, Keusch, GT, Brothers, MJ, Nechemias, C, and Smith, H, Infection and diabetes: the case for glucose control. Am J Med, 1982; 72: 439-50
635. Godsland, IF and Stevenson, JC, Insulin resistance: syndrome or tendency? Lancet, 1995; 346: 100-3
636. Barnard, RJ, Youngren, JF, and Martin, DA, Diet, not aging, causes skeletal muscle insulin resistance. Gerontology, 1995; 41: 205-11
637. O'Dea, K, Clinical implications of the 'thrifty genotype' hypothesis: Where do we stand now? Nutr Metab Cardiovasc Dis, 1997; 7: 281-4
638. Zimmet, PZ, Hyperinsulinemia--how innocent a bystander? Diabetes Care, 1993; 3: 56-70
639. Feldhahn, JR, Rand, JS, and Martin, G, Insulin sensitivity in normal and diabetic cats. J Feline Med Surg, 1999; 1: 107-15.
640. Mordes, JP and Rossini, AA, Animal models of diabetes. Am J Med, 1981; 70: 353-60.
641. Neel, JV, Diabetes mellitus: a thrifty genotype rendered detrimental by "progress"? Am J Hum Genet, 1962; 14: 353-62
642. Neel, JV, The thrifty genotype revisited, in The genetics of diabetes mellitus, J. Kobberlong and R. Tattersall, Editors. 1992, Academic Press: London. p. 283-93.
643. Hayden, B, Subsistence and ecological adaptations of modern hunter-gatherers, in Omnivorous primates: gathering and hunting in human evolution, R.D.S. Harding and G. Teleki, Editors. 1981, Columbia University Press: New York. p. 344-421.
644. Brand-Miller, JC and Colagiuri, S, Evolutionary aspects of diet and insulin resistance. World Rev Nutr Diet, 1999; 84: 74-105
645. Travers, SH, Jeffers, BW, and Eckel, RH, Insulin resistance during puberty and future fat accumulation. J Clin Endocrinol Metab, 2002; 87: 3814-8
646. Swinburn, BA, Nyomba, BL, Saad, MF, et al., Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest, 1991; 88: 168-73.
647. King, H, Finch, C, Koki, G, King, LF, Alpers, M, and Zimmet, P, Glucose tolerance in Papua New Guinea: comparison of Austronesian and non-Austronesian communities of Karkar Island. Diabet Med, 1991; 8: 481-8
648. Lillioja, S, Impaired glucose tolerance in Pima Indians. Diabet Med, 1996; 13: S127-32
649. Owen, OE, Smalley, KJ, D'Alessio, DA, Mozzoli, MA, and Dawson, EK, Protein, fat, and carbohydrate requirements during starvation: anaplerosis and cataplerosis]. Am J Clin Nutr, 1998; 68: 12-34.
650. Milton, K, Hunter-gatherer diets-a different perspective. Am J Clin Nutr, 2000; 71: 665-7.
651. Gower, BA, Syndrome X in children: Influence of ethnicity and visceral fat. Am J Human Biol, 1999; 11: 249-257
652. Abate, N and Chandalia, M, Ethnicity and type 2 diabetes: focus on Asian Indians. J Diabetes Complications, 2001; 15: 320-7.
653. Cruz, ML, Evans, K, and Frayn, KN, Postprandial lipid metabolism and insulin sensitivity in young Northern Europeans, South Asians and Latin Americans in the UK. Atherosclerosis, 2001; 159: 441-9.
654. Araneta, MR, Wingard, DL, and Barrett-Connor, E, Type 2 diabetes and metabolic syndrome in Filipina-American women : a high-risk nonobese population. Diabetes Care, 2002; 25: 494-9.
655. Gunton, JE, Hitchman, R, and McElduff, A, Effects of ethnicity on glucose tolerance, insulin resistance and beta cell function in 223 women with an abnormal glucose challenge test during pregnancy. Aust N Z J Obstet Gynaecol, 2001; 41: 182-6.
656. Kalhan, R, Puthawala, K, Agarwal, S, Amini, SB, and Kalhan, SC, Altered lipid profile, leptin, insulin, and anthropometry in offspring of South Asian immigrants in the United States. Metabolism, 2001; 50: 1197-202. t&artType=abs&id=ameta0501197&target=
657. Braudel, F, The structures of everyday life: The limits of the possible., ed. S. Reynolds. 1981, London: Collins.
658. Garnsey, P, Famine and food supply in the Graeco-Roman world: Responses to risk and crisis. 1988, Cambridge: Cambridge University Press.
659. Hagen, A, A handbook of Anglo-Saxon food: Processing and consumption. 1992, Middlesex: Anglo-Saxon Books.
660. Minnis, PE, Social adaptiations to food stress. 1985, Chicago: University of Chicago Press.
661. Allen, JS and Cheer, SM, The Non-Thrifty Genotype. Current Anthropology, 1996; 37: 831-42
662. Ercan, N, Nuttall, FQ, Gannon, MC, Redmon, JB, and Sheridan, KJ, Effects of glucose, galactose, and lactose ingestion on the plasma glucose and insulin response in persons with non-insulin-dependent diabetes mellitus. Metabolism, 1993; 42: 1560-7
663. Hugi, D, Gut, SH, and Blum, JW, Blood metabolites and hormones -- especially glucose and insulin -- in veal calves: effects of age and nutrition. Zentralbl Veterinarmed A, 1997; 44: 407-16
664. Palmquist, DL, Doppenberg, J, Roehrig, KL, and Kinsey, DJ, Glucose and insulin metabolism in ruminating and veal calves fed high and low fat diets. Domest Anim Endocrinol, 1992; 9: 233-41
665. Storlien, LH, Higgins, JA, Thomas, TC, et al., Diet composition and insulin action in animal models. Br J Nutr, 2000; 83 Suppl 1: S85-90.
666. Hales, CN and Barker, DJP, Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia, 1992; 35: 595-601
667. Ozanne, SE and Hales, CN, The long-term consequences of intra-uterine protein malnutrition for glucose metabolism. Proc Nutr Soc, 1999; 58: 615-9
668. Boujendar, S, Reusens, B, Merezak, S, et al., S. Boujendar et al.: Taurine supplementation to low protein diet and islet development. Diabetologia, 2002; 45: 856-66.
669. Stipanuk, MH, Homocysteine, cysteine, and taurine, in Modern nutrition in health and disease, M.E. Shils, et al., Editors. 1999, Lippincott Williams & Wilkins. p. 543-58.
670. Sinaiko, AR, Steinberger, J, Moran, A, Prineas, RJ, and Jacobs, DR, Jr., Relation of insulin resistance to blood pressure in childhood. J Hypertens, 2002; 20: 509-17.
671. Sinaiko, AR, Jacobs, DR, Jr., Steinberger, J, et al., Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr, 2001; 139: 700-7. t&artType=abs&id=a118535&target=
672. Groop, LC, Insulin resistance: the fundamental trigger of type 2 diabetes. Diabetes Obes Metab, 1999; 1 Suppl 1: S1-7.
673. Ford, ES, Giles, WH, and Dietz, WH, Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama, 2002; 287: 356-9.
674. Bloomgarden, ZT, Obesity, hypertension, and insulin resistance. Diabetes Care, 2002; 25: 2088-97
675. Fendri, S, Roussel, B, Lormeau, B, Tribout, B, and Lalau, JD, Insulin sensitivity, insulin action, and fibrinolysis activity in nondiabetic and diabetic obese subjects. Metabolism, 1998; 47: 1372-5.
676. Garg, A and Misra, A, Hepatic steatosis, insulin resistance, and adipose tissue disorders. J Clin Endocrinol Metab, 2002; 87: 3019-22.
677. Arcaro, G, Cretti, A, Balzano, S, et al., Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation, 2002; 105: 576-82.
678. Hulthe, J, Bokemark, L, Wikstrand, J, and Fagerberg, B, The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol, 2000; 20: 2140-7.
679. Larsson, B, Bengtsson, C, Bjorntorp, P, et al., Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Goteborg, Sweden. Am J Epidemiol, 1992; 135: 266-73
680. Norhammar, A, Tenerz, A, Nilsson, G, et al., Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet, 2002; 359: 2140-4.
681. Wortmann, RL, Gout and hyperuricemia. Curr Opin Rheumatol, 2002; 14: 281-6.
682. Whitelaw, DC, O'Kane, M, Wales, JK, and Barth, JH, Risk factors for coronary heart disease in obese non-diabetic subjects. Int J Obes Relat Metab Disord, 2001; 25: 1042-6.
683. Chou, P, Lin, KC, Lin, HY, and Tsai, ST, Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes. J Rheumatol, 2001; 28: 571-6.
684. Cigolini, M, Targher, G, Tonoli, M, Manara, F, Muggeo, M, and De Sandre, G, Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord, 1995; 19: 92-6
685. Prior, IA, Welby, TJ, Ostbye, T, Salmond, CE, and Stokes, YM, Migration and gout: the Tokelau Island migrant study. Br Med J Clin Res Ed, 1987; 295: 457-61
686. Rich, MW, Uric acid: is it a risk factor for cardiovascular disease? Am J Cardiol, 2000; 85: 1018-21.
687. Fang, J and Alderman, MH, Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. Jama, 2000; 283: 2404-10
688. Wannamethee, SG, Serum uric acid is not an independent risk factor for coronary heart disease. Curr Hypertens Rep, 2001; 3: 190-6.
689. Waring, WS, Webb, DJ, and Maxwell, SR, Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol, 2001; 38: 365-71.
690. Maxwell, AJ and Bruinsma, KA, Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol, 2001; 38: 1850-1858.
691. Becker, BF, Reinholz, N, Leipert, B, Raschke, P, Permanetter, B, and Gerlach, E, Role of uric acid as an endogenous radical scavenger and antioxidant. Chest, 1991;
692. Rosell, M, Regnstrom, J, Kallner, A, and Hellenius, ML, Serum urate determines antioxidant capacity in middle-aged men - a controlled, randomized diet and exercise intervention study. J Intern Med, 1999; 246: 219-26
693. Ip, MS, Lam, B, Ng, MM, Lam, WK, Tsang, KW, and Lam, KS, Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med, 2002; 165: 670-6.
694. Malhotra, A and White, DP, Obstructive sleep apnoea. Lancet, 2002; 360: 237-45.
695. Barnes, DJ, Obstructive sleep apnoea: a new disease for Papua New Guinea? P N G Med J, 1990; 33: 225-7.
696. Cordain, L, Syndrom X - det metabola syndromet. Hyperinsulinemin bakom en mångfald sjukdomar. Medikament, 2001: 48-51
697. Nam, SY, Lee, EJ, Kim, KR, et al., Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord, 1997; 21: 355-9.
698. Attia, N, Tamborlane, WV, Heptulla, R, et al., The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab, 1998; 83: 1467-71.
699. Ferry, RJ, Jr., Cerri, RW, and Cohen, P, Insulin-like growth factor binding proteins: new proteins, new functions. Horm Res, 1999; 51: 53-67
700. Evans, TR and Kaye, SB, Retinoids: present role and future potential. Br J Cancer, 1999; 80: 1-8.
701. Liu, B, Lee, HY, Weinzimer, SA, et al., Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem, 2000; 275: 33607-13.
702. Thacher, SM, Vasudevan, J, and Chandraratna, RA, Therapeutic applications for ligands of retinoid receptors. Curr Pharm Des, 2000; 6: 25-58.
703. Simoni, D and Tolomeo, M, Retinoids, apoptosis and cancer. Curr Pharm Des, 2001; 7: 1823-37.
704. Tallman, MS, Nabhan, C, Feusner, JH, and Rowe, JM, Acute promyelocytic leukemia: evolving therapeutic strategies. Blood, 2002; 99: 759-67.
705. Cordain, L, Eaton, SB, Brand Miller, J, Lindeberg, S, and Jensen, C, An evolutionary analysis of the aetiology and pathogenesis of juvenile-onset myopia. Acta Ophthalmol Scand, 2002; 80: 125-35
706. Cordain, L, Lindeberg, S, Hurtado, M, Hill, K, Eaton, SB, and Brand Miller, J, Acne vulgaris: a disease of civilization. Arch Dermatol, 2002; 138: 1584-90.
707. Juul, A, Scheike, T, Nielsen, CT, Krabbe, S, Muller, J, and Skakkebaek, NE, Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). J Clin Endocrinol Metab, 1995; 80: 3059-67.
708. Blum, WF, Albertsson-Wikland, K, Rosberg, S, and Ranke, MB, Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab, 1993; 76: 1610-6.
709. Gourmelen, M, Le Bouc, Y, Girard, F, and Binoux, M, Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescents. J Clin Endocrinol Metab, 1984; 59: 1197-203.
710. Binoux, M and Gourmelen, M, Statural development parallels IGF I levels in subjects of constitutionally variant stature. Acta Endocrinol (Copenh), 1987; 114: 524-30.
711. Lindgren, BF, Segovia, B, Lassarre, C, Binoux, M, and Gourmelen, M, Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability. Growth Regul, 1996; 6: 158-64.
712. Camacho-Hubner, C, Woods, KA, Miraki-Moud, F, et al., Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion. J Clin Endocrinol Metab, 1999; 84: 1611-6.
713. De Luca, F, Uyeda, JA, Mericq, V, et al., Retinoic acid is a potent regulator of growth plate chondrogenesis. Endocrinology, 2000; 141: 346-53.
714. Roche, AF, Secular trends in human growth, maturation, and development. Monogr Soc Res Child Dev, 1979; 44: 1-120
715. Ziegler, E, Secular changes in the stature of adults and the secular trend of the modern sugar consumption. Z Kinderheilkd, 1967; 99: 146-66
716. Ziegler, E, Height and weight of British men. Lancet, 1969; 1: 1318.
717. Schaefer, O, Pre- and post-natal growth acceleration and increased sugar consumption in Canadian Eskimos. Can Med Assoc J, 1970; 103: 1059-68.
718. Graham, GG, MacLean, WC, Jr., Brown, KH, Morales, E, Lembcke, J, and Gastanaduy, A, Protein requirements of infants and children: growth during recovery from malnutrition. Pediatrics, 1996; 97: 499-505
719. Black, RE, Williams, SM, Jones, IE, and Goulding, A, Children who avoid drinking cow milk have low dietary calcium intakes and poor bone health. Am J Clin Nutr, 2002; 76: 675-80
720. Leighton, G and Clark, ML, Milk consumption and the growth of school-children; second preliminary report on tests to Scottish Board of Health. Lancet, 1929; 1: 40-3
721. Tanner, JM, Hayashi, T, Preece, MA, and Cameron, N, Increase in length of leg relative to trunk in Japanese children and adults from 1957 to 1977: comparison with British and with Japanese Americans. Ann Hum Biol, 1982; 9: 411-23.
722. Eveleth, PB and Tanner, JM, Worldwide variation in human growth. 1990: Cambridge University press.
723. McDonald, P, Edwards, RA, Greenhalgh, JFD, and Morgan, CA, Animal Nutrition. 1995: Longman.
724. Ibanez, L, Dimartino-Nardi, J, Potau, N, and Saenger, P, Premature adrenarche--normal variant or forerunner of adult disease? Endocr Rev, 2000; 21: 671-96.
725. Wong, WW, Copeland, KC, Hergenroeder, AC, Hill, RB, Stuff, JE, and Ellis, KJ, Serum concentrations of insulin, insulin-like growth factor-I and insulin-like growth factor binding proteins are different between white and African American girls. J Pediatr, 1999; 135: 296-300
726. Travers, SH, Labarta, JI, Gargosky, SE, Rosenfeld, RG, Jeffers, BW, and Eckel, RH, Insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children. J Clin Endocrinol Metab, 1998; 83: 1935-9.
727. Ibanez, L, Potau, N, Chacon, P, Pascual, C, and Carrascosa, A, Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia, 1998; 41: 1057-63.
728. Wilson, ME, Premature elevation in serum insulin-like growth factor-I advances first ovulation in rhesus monkeys. J Endocrinol, 1998; 158: 247-57.
729. Vuguin, P, Saenger, P, and Dimartino-Nardi, J, Fasting glucose insulin ratio: a useful measure of insulin resistance in girls with premature adrenarche. J Clin Endocrinol Metab, 2001; 86: 4618-21.
730. Proos, LA, Hofvander, Y, and Tuvemo, T, Menarcheal age and growth pattern of Indian girls adopted in Sweden. I. Menarcheal age. Acta Paediatr Scand, 1991; 80: 852-8.
731. Worthman, CM, Evolutionary aspects on the onset of puberty, in Evolutionary Medicine, W.R. Trevathan, E.O. Smith, and J.J. McKenna, Editors. 1999, Oxford University press. p. 135-63.
732. Villarreal, MG, Ohlsson, J, Abrahamsson, M, Sjostrom, A, and Sjostrand, J, Myopisation: the refractive tendency in teenagers. Prevalence of myopia among young teenagers in Sweden. Acta Ophthalmol Scand, 2000; 78: 177-81.
733. Bengtsson, B and Grodum, K, Refractive changes in the elderly. Acta Ophthalmol Scand, 1999; 77: 37-9.
734. Holm, S, The ocular refractive state of the Palae-Negroids in Gabon, French Equatorial Africa. Acta Ophtalmol, 1937; Suppl 13: 1-299
735. Skeller, E, Anthropological and ophthalmological studies on the Angmagssalik Eskimos. Meddelelser om Grønland, 1954; 107: 167-211
736. Young, FA, Beattle, R, and Newby, FJ, The Pullman study: a visual survey of Pullman school children. Am J Opt, 1954; 31: 111
737. Verlee, DL, Ophthalmic survey in the Solomon Islands. Am J Ophthalmol, 1968; 66: 304-19
738. Au Eong, KG, Tay, TH, and Lim, MK, Race, culture and Myopia in 110,236 young Singaporean males. Singapore Med J, 1993; 34: 29-32.
739. McCarty, CA, Livingston, PM, and Taylor, HR, Prevalence of myopia in adults: implications for refractive surgeons. J Refract Surg, 1997; 13: 229-34
740. Wallman, J, Myopia and the control of eye growth. Introduction. Ciba Found Symp, 1990; 155: 1-4
741. Johnson, GL and Smith, E, Contributions to the comparative anatomy of the mammalian eye, based chiefly on ophthalmoscopic examination. Phil Trans Royal Soc, 1901; B194: 1-82
742. Mutti, DO, Zadnik, K, and Murphy, CJ, Naturally occurring vitreous chamber-based myopia in the Labrador retriever. Invest Ophthalmol Vis Sci, 1999; 40: 1577-84.
743. Will, JM, Johnson, JV, and White, AL, Nutrition of the dog. J Vet Med, 1992; 1: 1-15
744. Mutti, DO, Zadnik, K, and Adams, AJ, Myopia. The nature versus nurture debate goes on. Invest Ophthalmol Vis Sci, 1996; 37: 952-7.
745. Norton, TT and Siegwart, JT, Jr., Animal models of emmetropization: matching axial length to the focal plane. J Am Optom Assoc, 1995; 66: 405-14.
746. Raviola, E and Wiesel, TN, An animal model of myopia. N Engl J Med, 1985; 312: 1609-15.
747. Troilo, D and Wallman, J, The regulation of eye growth and refractive state: an experimental study of emmetropization. Vision Res, 1991; 31: 1237-50
748. Meyer, C, Mueller, MF, Duncker, GI, and Meyer, HJ, Experimental animal myopia models are applicable to human juvenile- onset myopia. Surv Ophthalmol, 1999; 44 Suppl 1: S93-102.
749. Bitzer, M, Feldkaemper, M, and Schaeffel, F, Visually induced changes in components of the retinoic acid system in fundal layers of the chick. Exp Eye Res, 2000; 70: 97-106.
750. Mertz, JR and Wallman, J, Choroidal retinoic acid synthesis: a possible mediator between refractive error and compensatory eye growth. Exp Eye Res, 2000; 70: 519-27.
751. Gardiner, PA, The relation of myopia to growth. Lancet, 1954; i: 476-9
752. Gardiner, PA, Observations on the food habits of myopic children. BMJ, 1956; 2: 699-700
753. Gardiner, PA, The diet of growing myopes. Trans Ophthalmol Soc, 1956; 76: 171-80
754. Gardiner, PA, Dietary treatment of myopia in children. Lancet, 1958; i: 1152-5
755. Walkingshaw, R. Control of progressive myopia through modification of diet. in The First International Conference on Myopia. 1964. Chicago: The Professional press.
756. Gardiner, PA and MacDonald, I, Relationship between refraction of the eye and nutrition. Clin Sci, 1957; 16: 435-42
757. Bardiger, M and Stock, AL, The effects of sucrose-containing diets low in protein on ocular refraction in the rat. Proc Nutr Soc, 1972; 31: 4A-5A.
758. Robinson, BE, Factors associated with the prevalence of myopia in 6-year-olds. Optom Vis Sci, 1999; 76: 266-71.
759. Smithard, A, Glazebrook, C, and Williams, HC, Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol, 2001; 145: 274-9.
760. Larsson, PA and Liden, S, Prevalence of skin diseases among adolescents 12--16 years of age. Acta Derm Venereol, 1980; 60: 415-23
761. Thiboutot, D, Hormones and acne: pathophysiology, clinical evaluation, and therapies. Semin Cutan Med Surg, 2001; 20: 144-53.
762. Nestler, JE, Insulin regulation of human ovarian androgens. Hum Reprod, 1997; 12 Suppl 1: 53-62.
763. Itami, S, Kurata, S, and Takayasu, S, Androgen induction of follicular epithelial cell growth is mediated via insulin-like growth factor-I from dermal papilla cells. Biochem Biophys Res Commun, 1995; 212: 988-94.
764. Klinger, B, Anin, S, Silbergeld, A, Eshet, R, and Laron, Z, Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome. Clin Endocrinol (Oxf), 1998; 48: 81-7.
765. Aizawa, H and Niimura, M, Mild insulin resistance during oral glucose tolerance test (OGTT) in women with acne. J Dermatol, 1996; 23: 526-9.
766. Aizawa, H and Niimura, M, Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol, 1995; 22: 249-52.
767. Hobbs, CJ, Plymate, SR, Rosen, CJ, and Adler, RA, Testosterone administration increases insulin-like growth factor-I levels in normal men. J Clin Endocrinol Metab, 1993; 77: 776-9.
768. Scott, MJ, 3rd and Scott, AM, Effects of anabolic-androgenic steroids on the pilosebaceous unit. Cutis, 1992; 50: 113-6.
769. Schaefer, O, When the Eskimo comes to town. Nutr Today, 1971; 6: 8-16
770. Steiner, PE, Necropsies on Okinawans. Anantomic and pathologic observations. Arch Pathol, 1946; 42: 359-80
771. Bechelli, LM, Haddad, N, Pimenta, WP, et al., Epidemiological survey of skin diseases in schoolchildren living in the Purus Valley (Acre State, Amazonia, Brazil). Dermatologica, 1981; 163: 78-93
772. Freyre, EA, Rebaza, RM, Sami, DA, and Lozada, CP, The prevalence of facial acne in Peruvian adolescents and its relation to their ethnicity. J Adolesc Health, 1998; 22: 480-4.
773. Park, RG, The age distribution of common skin disorders in the Bantu of Pretoria, Transvaal. Br J Dermatol, 1968; 80: 758-61.
774. Kousta, E, White, DM, Cela, E, McCarthy, MI, and Franks, S, The prevalence of polycystic ovaries in women with infertility. Hum Reprod, 1999; 14: 2720-3.
775. Druckmann, R and Rohr, UD, IGF-1 in gynaecology and obstetrics: update 2002. Maturitas, 2002; 41 Suppl 1: 65-83.
776. Elting, MW, Korsen, TJ, and Schoemaker, J, Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome. Clin Endocrinol (Oxf), 2001; 55: 767-76.
777. Kousta, E, Cela, E, Lawrence, N, et al., The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clin Endocrinol (Oxf), 2000; 53: 501-7.
778. Falsetti, L and Eleftheriou, G, Hyperinsulinemia in the polycystic ovary syndrome: a clinical, endocrine and echographic study in 240 patients. Gynecol Endocrinol, 1996; 10: 319-26.
779. Wild, RA, Polycystic ovary syndrome: a risk for coronary artery disease? Am J Obstet Gynecol, 2002; 186: 35-43. t&artType=abs&id=a119180&target=
780. Legro, RS, Polycystic ovary syndrome: the new millenium. Mol Cell Endocrinol, 2002; 186: 219-25.
781. Jialal, I, Naiker, P, Reddi, K, Moodley, J, and Joubert, SM, Evidence for insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab, 1987; 64: 1066-9.
782. Rodin, DA, Bano, G, Bland, JM, Taylor, K, and Nussey, SS, Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Clin Endocrinol (Oxf), 1998; 49: 91-9.
783. Hammarsten, J and Hogstedt, B, Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press, 1999; 8: 29-36
784. Hammarsten, J and Hogstedt, B, Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol, 2001; 39: 151-8. UR&action=render&rendertype=fulltext&uid=EUR.eur39151
785. Gyftopoulos, K, Sotiropoulou, G, Varakis, I, and Barbalias, GA, Cellular distribution of retinoic acid receptor-alpha in benign hyperplastic and malignant human prostates: comparison with androgen, estrogen and progesterone receptor status. Eur Urol, 2000; 38: 323-30. UR&action=render&rendertype=fulltext&uid=EUR.eur38323
786. Fulton, B, Wagstaff, AJ, and Sorkin, EM, Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia. Drugs, 1995; 49: 295-320.
787. Barss, PG, Prostatic disease in rural Melanesians. Papua New Guinea Med J, 1985; 28: 279-82
788. Farnworth, ER, Areca catechu and Piper betle in Papua New Guinea: an elemental analysis. Sci N Guinea, 1975; 3: 211-4
789. Melander, A, Fenomenet med (över)kompensation är inte apart utan normalt. Läkartidningen, 2003; 100: 923
790. Berry, SJ, Strandberg, JD, Saunders, WJ, and Coffey, DS, Development of canine benign prostatic hyperplasia with age. Prostate, 1986; 9: 363-73
791. Brendler, CB, Berry, SJ, Ewing, LL, et al., Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate. J Clin Invest, 1983; 71: 1114-23.
792. Kaaks, R and Lukanova, A, Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc, 2001; 60: 91-106.
793. Wolk, A, Mantzoros, CS, Andersson, SO, et al., Insulin-like growth factor 1 and prostate cancer risk: a population- based, case-control study. J Natl Cancer Inst, 1998; 90: 911-5.
794. Mantzoros, CS, Tzonou, A, Signorello, LB, Stampfer, M, Trichopoulos, D, and Adami, HO, Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer, 1997; 76: 1115-8
795. Chan, JM, Stampfer, MJ, Giovannucci, E, et al., Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science, 1998; 279: 563-6.
796. Harman, SM, Metter, EJ, Blackman, MR, Landis, PK, and Carter, HB, Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF- binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab, 2000; 85: 4258-65.
797. Chokkalingam, AP, Pollak, M, Fillmore, CM, et al., Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev, 2001; 10: 421-7.
798. Swerdlow, AJ, Higgins, CD, Adlard, P, and Preece, MA, Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet, 2002; 360: 273-7.
799. Friedenreich, CM, Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev, 2001; 10: 15-32.
800. Moseson, M, Koenig, KL, Shore, RE, and Pasternack, BS, The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol, 1993; 22: 1000-9.
801. Sun, SY and Lotan, R, Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol, 2002; 41: 41-55.
802. Wu, K, Kim, HT, Rodriquez, JL, et al., Suppression of mammary tumorigenesis in transgenic mice by the RXR- selective retinoid, LGD1069. Cancer Epidemiol Biomarkers Prev, 2002; 11: 467-74.
803. Porter, A, Ben-Josef, E, Crawford, ED, Garde, S, Huhtaniemi, I, and Pontes, JE, Advancing perspectives on prostate cancer: multihormonal influences in pathogenesis. Mol Urol, 2001; 5: 181-8.
804. Hammarsten, J, Klinisk prostatacancer bör ses som en livsstilssjukdom. Medikament, 2002; 6: 23-4
805. Colangelo, LA, Gapstur, SM, Gann, PH, Dyer, AR, and Liu, K, Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev, 2002; 11: 385-91.
806. Schoen, RE, Tangen, CM, Kuller, LH, et al., Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst, 1999; 91: 1147-54.
807. Stoll, BA, Upper abdominal obesity, insulin resistance and breast cancer risk. Int J Obes Relat Metab Disord, 2002; 26: 747-53.
808. Stout, RW and Vallance-Owen, J, Insulin and atheroma. Lancet, 1969; 1: 1078-80.
809. Bokemark, L, Wikstrand, J, Attvall, S, Hulthe, J, Wedel, H, and Fagerberg, B, Insulin resistance and intima-media thickness in the carotid and femoral arteries of clinically healthy 58-year-old men. The Atherosclerosis and Insulin Resistance Study (AIR). J Intern Med, 2001; 249: 59-67.
810. Vessby, B, Gustafsson, IB, Tengblad, S, Boberg, M, and Andersson, A, Desaturation and elongation of Fatty acids and insulin action. Ann N Y Acad Sci, 2002; 967: 183-95.
811. Vessby, B, Dietary fat and insulin action in humans. Br J Nutr, 2000; 83 Suppl 1: S91-6.
812. Louheranta, AM, Sarkkinen, ES, Vidgren, HM, Schwab, US, and Uusitupa, MI, Association of the fatty acid profile of serum lipids with glucose and insulin metabolism during 2 fat-modified diets in subjects with impaired glucose tolerance. Am J Clin Nutr, 2002; 76: 331-7.
813. Dessein, PH, Shipton, EA, Stanwix, AE, Joffe, BI, and Ramokgadi, J, Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis, 2000; 59: 539-43
814. Jenkins, DJ, Kendall, CW, Vidgen, E, et al., High-protein diets in hyperlipidemia: effect of wheat gluten on serum lipids, uric acid, and renal function. Am J Clin Nutr, 2001; 74: 57-63.
815. Emmerson, BT, The management of gout [see comments]. N Engl J Med, 1996; 334: 445-51
816. Seegmiller, JE, Dixon, RM, Kemp, GJ, et al., Fructose-induced aberration of metabolism in familial gout identified by 31P magnetic resonance spectroscopy. Proc Natl Acad Sci U S A, 1990; 87: 8326-30.
817. Lindeberg, S, Randomiserade studier bör tolkas med omsorg. Läkartidningen, 2000; 97: 1004-7
818. Mulrow, PJ, Hypertension: a worldwide epidemic, in Hypertension primer: the essentials of high blood pressure, J.L. Izzo, H.R. Black, and T.L. Goodfriend, Editors. 1999, Williams and Wilkins: Baltimore. p. 271-273.
819. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med, 1997; 157: 2413-46.
820. Kean, BH and Hamill, JF, Anthropology of arterial tension. Arch Intern Med, 1949; 83: 355-62
821. Kaminer, B and Lutz, WPW, Blood pressure in Bushmen of the Kalahari desert. Circulation, 1960; 22: 289-95
822. Lowenstein, FH, Blood-pressure in relation to age and sex in the tropics and subtropics. A review of the literature and an investigation in two tribes of Brazil Indians. Lancet, 1961; i: 389-92
823. Maddocks, I, Blood pressures in Melanesians. Med J Aust, 1967; 1: 1123-6
824. Stanhope, JM, Blood pressures of the Tinam-Aigram people, near Simbai, Madang District. P N G Med J, 1968; 11: 60-1
825. Truswell, AS, Kennelly, BM, Hansen, JD, and Lee, RB, Blood pressures of Kung bushmen in Northern Botswana. Am Heart J, 1972; 84: 5-12
826. Prior, IAM and Stanhope, JM, Blood pressure patterns, salt use and migration in the Pacific, in Epidemiology of Arterial Blood Pressure, H. Kesteloot and J.V. Joosens, Editors. 1980, Martinus Nijhoff: The Hague. p. 243-62.
827. Gee, RW, The epidemiology of hypertension in the South Pacific. P N G Med J, 1983; 26: 55-8
828. He, J, Klag, MJ, Whelton, PK, et al., Migration, blood pressure pattern, and hypertension: the Yi Migrant Study. Am J Epidemiol, 1991; 134: 1085-101
829. Terént, A and Breig-Åsberg, E, Epidemiological perspectives of body position and arm level in blood pressure measurement. Blood Pressure, 1994; 3: 156-63
830. Lindeberg, S and Terent, A, Bristande standardisering vid blodtrycksmätning allvarlig felkälla. Läkartidningen, 2001; 98: 1429-31.
831. Cruz-Coke, R, Etcheverry, R, and Nagel, R, Influence of migration on blood pressure of Easter Islanders. Lancet, 1964; i: 697-9.
832. Miall, WE, Del, CE, Fodor, J, et al., Longitudinal study of heart disease in a Jamaican rural population. I. Prevalence, with special reference to ECG findings. Bull World Health Organ, 1972; 46: 429-41
833. Zimmet, PZ, Taylor, R, Jackson, L, Whitehouse, SL, Faaivaso, S, and Ainuu, J, Blood pressure studies in rural and urban Western Samoa. Med J Aust, 1980; 2: 202-5
834. Zimmet, P, Jackson, L, and Whitehouse, S, Blood pressure studies in two Pacific populations with varying degrees of modernisation. N Z Med J, 1980; 91: 249-52
835. Poulter, N, Blood pressure in urban and rural East Africa: the Kenyan Luo Migrant Study, in Ethnic Factors in Health and Disease, J.K. Cruickshank and D.G. Beevers, Editors. 1989, Wright: Oxford. p. 61-8.
836. Poulter, NR, Khaw, KT, and Sever, PS, Higher blood pressures of urban migrants from an African low-blood pressure population are not due to selective migration. Am J Hypertens, 1988; 1: 143S-145S.
837. Nadim, A, Amini, H, and Malek-Afzali, H, Blood pressure and rural--urban migration in Iran. Int J Epidemiol, 1978; 7: 131-8.
838. Elford, J, Phillips, A, Thomson, AG, and Shaper, AG, Migration and geographic variations in blood pressure in Britain. Bmj, 1990; 300: 291-5.
839. He, J, Tell, GS, Tang, YC, Mo, PS, and He, GQ, Effect of migration on blood pressure: the Yi People Study. Epidemiology, 1991; 2: 88-97
840. Bjerregaard, P, Jorgensen, ME, Lumholt, P, Mosgaard, L, and Borch-Johnsen, K, Higher blood pressure among Inuit migrants in Denmark than among the Inuit in Greenland. J Epidemiol Community Health, 2002; 56: 279-84.
841. John, JH, Ziebland, S, Yudkin, P, Roe, LS, and Neil, HA, Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet, 2002; 359: 1969-74.
842. Appel, LJ, Moore, TJ, Obarzanek, E, et al., A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med, 1997; 336: 1117-24.
843. Conlin, PR, Dietary modification and changes in blood pressure. Curr Opin Nephrol Hypertens, 2001; 10: 359-63.
844. Law, MR, Frost, CD, and Wald, NJ, By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction [published erratum appears in BMJ 1991 Apr 20;302(6782):939]. B M J, 1991; 302: 819-24
845. Meneely, GR and Dahl, LK, Electrolytes in hypertension: the effects of sodium chloride. The evidence from animal and human studies. Med Clin North Am, 1961; 45: 271-83
846. He, J and Whelton, PK, Role of sodium reduction in the treatment and prevention of hypertension. Curr Opin Cardiol, 1997; 12: 202-7.
847. Denton, D, Weisinger, R, Mundy, NI, et al., The effect of increased salt intake on blood pressure of chimpanzees. Nat Med, 1995; 1: 1009-16.
848. Corbett, WT, Kuller, LH, Blaine, EH, and Damico, FJ, Utilization of swine to study the risk factor of an elevated salt diet on blood pressure. Am J Clin Nutr, 1979; 32: 2068-75.
849. Toal, CB and Leenen, FH, Dietary sodium restriction, blood pressure and sympathetic activity in spontaneously hypertensive rats. J Hypertens, 1987; 5: 107-13.
850. Takishita, S, Fukiyama, K, Eto, T, et al., Blood pressure and its regulation in spontaneously hypertensive rats bred on the lowest sodium diet for normal growth. Hypertension, 1996; 27: 90-5.
851. Vollmer, WM, Sacks, FM, Ard, J, et al., Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med, 2001; 135: 1019-28.
852. Law, MR, Frost, CD, and Wald, NJ, By how much does dietary salt reduction lower blood pressure? I--Analysis of observational data among populations. B M J, 1991; 302: 811-5
853. Cheng, TO, Systolic and diastolic blood pressures and urinary sodium excretion in mainland China. Qjm, 2000; 93: 557-8.
854. INTERSALT, Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. B M J, 1988; 297: 319-28
855. Luft, FC and Weinberger, MH, Heterogeneous responses to changes in dietary salt intake: the salt- sensitivity paradigm. Am J Clin Nutr, 1997; 65: 612S-617S.
856. Cowley, AW, Jr., Genetic and nongenetic determinants of salt sensitivity and blood pressure. Am J Clin Nutr, 1997; 65: 587S-593S.
857. Melander, O, Groop, L, and Hulthen, UL, Effect of salt on insulin sensitivity differs according to gender and degree of salt sensitivity. Hypertension, 2000; 35: 827-31.
858. Rocchini, AP, The relationship of sodium sensitivity to insulin resistance. Am J Med Sci, 1994; 307: S75-80
859. Morimoto, A, Uzu, T, Fujii, T, et al., Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet, 1997; 350: 1734-7.
860. Appel, LJ, Espeland, MA, Easter, L, Wilson, AC, Folmar, S, and Lacy, CR, Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med, 2001; 161: 685-93.
861. Cappuccio, FP, Markandu, ND, Carney, C, Sagnella, GA, and MacGregor, GA, Double-blind randomised trial of modest salt restriction in older people. Lancet, 1997; 350: 850-4.
862. Whelton, PK, He, J, Cutler, JA, et al., Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. Jama, 1997; 277: 1624-32.
863. Gu, D, He, J, Wu, X, Duan, X, and Whelton, PK, Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial. J Hypertens, 2001; 19: 1325-31.
864. Kurtz, TW and Morris, RC, Jr., Dietary chloride as a determinant of "sodium-dependent" hypertension. Science, 1983; 222: 1139-41.
865. Kurtz, TW, Al-Bander, HA, and Morris, RC, Jr., "Salt-sensitive" essential hypertension in men. Is the sodium ion alone important? N Engl J Med, 1987; 317: 1043-8.
866. Luft, FC, Steinberg, H, Ganten, U, et al., Effect of sodium chloride and sodium bicarbonate on blood pressure in stroke-prone spontaneously hypertensive rats. Clin Sci (Lond), 1988; 74: 577-85.
867. Luft, FC, Zemel, MB, Sowers, JA, Fineberg, NS, and Weinberger, MH, Sodium bicarbonate and sodium chloride: effects on blood pressure and electrolyte homeostasis in normal and hypertensive man. J Hypertens, 1990; 8: 663-70.
868. Tanaka, M, Schmidlin, O, Olson, JL, Yi, SL, and Morris, RC, Chloride-sensitive renal microangiopathy in the stroke-prone spontaneously hypertensive rat. Kidney Int, 2001; 59: 1066-76.
869. Morris, RC, Jr., Schmidlin, O, Tanaka, M, Forman, A, Frassetto, L, and Sebastian, A, Differing effects of supplemental KCl and KHCO3: pathophysiological and clinical implications. Semin Nephrol, 1999; 19: 487-93.
870. Liu, L, Ikeda, K, and Yamori, Y, Inverse relationship between urinary markers of animal protein intake and blood pressure in Chinese: results from the WHO Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study. Int J Epidemiol, 2002; 31: 227-33.
871. Stamler, J, Elliott, P, Kesteloot, H, et al., Inverse relation of dietary protein markers with blood pressure. Findings for 10,020 men and women in the INTERSALT Study. INTERSALT Cooperative Research Group. INTERnational study of SALT and blood pressure. Circulation, 1996; 94: 1629-34.
872. Burke, V, Beilin, LJ, and Sciarrone, S, Vegetarian diets, protein and fibre, in Textbook of Hypertension, J.D. Swales, Editor. 1994, Blackwell: Oxford. p. 619-32.
873. Sjolin, J, Hjort, G, Friman, G, and Hambraeus, L, Urinary excretion of 1-methylhistidine: a qualitative indicator of exogenous 3-methylhistidine and intake of meats from various sources. Metabolism, 1987; 36: 1175-84.
874. Yamori, Y, Horie, R, Nara, Y, et al., Dietary prevention of hypertension in animal models and its applicability to human. Ann Clin Res, 1984; 43: 28-31
875. Burke, V, Hodgson, JM, Beilin, LJ, Giangiulioi, N, Rogers, P, and Puddey, IB, Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension, 2001; 38: 821-6.
876. Beilin, LJ, Burke, V, Puddey, IB, Mori, TA, and Hodgson, JM, Recent developments concerning diet and hypertension. Clin Exp Pharmacol Physiol, 2001; 28: 1078-82.
877. Bao, DQ, Mori, TA, Burke, V, Puddey, IB, and Beilin, LJ, Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension, 1998; 32: 710-7.
878. Peacock, JM, Folsom, AR, Arnett, DK, Eckfeldt, JH, and Szklo, M, Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol, 1999; 9: 159-65.
879. Berthelot, A and Esposito, J, Effects of dietary magnesium on the development of hypertension in the spontaneously hypertensive rat. J Am Coll Nutr, 1983; 2: 343-53
880. Block, G, Ascorbic acid, blood pressure, and the American diet. Ann N Y Acad Sci, 2002; 959: 180-7.
881. Massey, LK, Dairy food consumption, blood pressure and stroke. J Nutr, 2001; 131: 1875-8.
882. Steinberg, D, Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med, 2002; 8: 1211-7
883. Bronte-Stewart, B, Keys, A, and Brock, JE, Serum-cholesterol, diet and coronary heart disease: Inter-racial survey in Cape Peninsula. Lancet, 1955; 2: 1103
884. De Wolfe, MS and Whyte, HM, Serum cholesterol and lipoproteins in natives of New Guinea and Australians. Aust Ann Med, 1958; 7: 47-54
885. Luyken, R and Jansen, AAJ, The cholesterol level in the blood serum of some population groups in New-Guinea. Trop Geogr Med, 1960; 2: 145-8
886. Pazzanese, D, Portugal, OP, Ramos, OL, et al., Serum-lipid levels in a Brazilian Indian population. Lancet, 1964; 2: 615-7
887. Truswell, AS and Mann, JI, Epidemiology of serum lipids in Southern Africa. Atherosclerosis, 1972; 16: 15-29
888. Mancilha-Carvalho, JJ and Crews, DE, Lipid profiles of Yanomamo Indians of Brazil. Prev Med, 1990; 19: 66-75
889. Hunter, JD, Diet, body build, blood pressure, and serum cholesterol levels in coconut-eating Polynesians. Fed Proc, 1962; 21: 36-43
890. Mensink, RP, Effects of the individual saturated fatty acids on serum lipids and lipoprotein concentrations. Am J Clin Nutr, 1993; 57: 711S-714S
891. Norum, KR, Dietary fat and blood lipids. Nutr Rev, 1992; 50: 30-7
892. Denke, MA and Grundy, SM, Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins. Am J Clin Nutr, 1992; 56: 895-8
893. Shaper, AG, Jonea, KW, Jones, M, and Kyobe, J, Serum lipids in three nomadic tribes of Northern Kenya. Am J Clin Nutr, 1963; 13: 135-46
894. Knuiman, JT, West, CE, Katan, MB, and Hautvast, JG, Total cholesterol and high density lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake. Arteriosclerosis, 1987; 7: 612-9
895. Scrimgeour, EM, McCall, MG, Smith, DE, and Masarei, JR, Levels of serum cholesterol, triglyceride, HDL-cholesterol, apoproteins A-I and B, and plasma glucose, and prevalence of diastolic hypertension and cigarette smoking in Papua New Guinea highlanders. Pathology, 1989; 21: 46-50
896. West, CE, Sullivan, DR, Katan, MB, Halferkamps, IL, and van der Torre, HW, Boys from populations with high-carbohydrate intake have higher fasting triglyceride levels than boys from populations with high-fat intake. Am J Epidemiol, 1990; 131: 271-82
897. Lindholm, LH, Koutis, AD, Lionis, CD, Vlachonikolis, IG, Isacsson, A, and Fioretos, M, Risk factors for ischaemic heart disease in a Greek population. A cross- sectional study of men and women living in the village of Spili in Crete. Eur Heart J, 1992; 13: 291-8.
898. Balanza Galindo, S and Mestre Molto, F, [Cardiovascular risk factors in the fishing environment of Cartagena and Castellon]. Rev Esp Salud Publica, 1995; 69: 295-303.
899. Capuano, V, Lamaida, N, Fattore, L, D'Antonio, V, and Di Quacquaro, GS, The increased frequency of hypercholesterolemia in southern Italy is induced only by changing diet quality? Panminerva Med, 1998; 40: 55-7.
900. Cambien, F, Warnet, JM, Vernier, V, et al., An epidemiologic appraisal of the associations between the fatty acids esterifying serum cholesterol and some cardiovascular risk factors in middle-aged men. Am J Epidemiol, 1988; 127: 75-86
901. Stanhope, JM, Sampson, VM, and Prior, IA, The Tokelau Island Migrant Study: serum lipid concentration in two environments. J Chronic Dis, 1981; 34: 45-55
902. Ho, KJ, Biss, K, Mikkelson, B, Lewis, LA, and Taylor, CB, The Masai of East Africa: some unique biological characteristics. Arch Pathol, 1971; 91: 387-410
903. Day, J, Carruthers, M, Bailey, A, and Robinson, D, Anthropometric, physiological and biochemical differences between urban and rural Maasai. Atherosclerosis, 1976; 23: 357-61
904. Taylor, CB and Ho, KJ, Studies on the Masai. Am J Clin Nutr, 1971; 24: 1291-3
905. Yoshikawa, T, Shimano, H, Amemiya-Kudo, M, et al., Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol, 2001; 21: 2991-3000.
906. Simons, LA, Interrelationships of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol, 1986; 57: 5G-10G
907. Assman, G, Schulte, H, and von Eckardstein, A, Hypertriglyceridemia/low high-density lipoprotein cholesterol syndrome. Nutr Metab Cardiovasc Dis, 1993; 3: 1-4
908. Law, MR and Wald, NJ, An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990. Eur J Clin Nutr, 1994; 48: 305-25
909. Law, M, Lipids and cardiovascular disease, in Evidence based cardiology, S. Yusuf, et al., Editors. 1998, BMJ Books. p. 191-205.
910. Brunner, D, Weisbort, J, Meshulam, N, et al., Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am J Cardiol, 1987; 59: 1271-6
911. Chen, Z, Peto, R, Collins, R, MacMahon, S, Lu, J, and Li, W, Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations [see comments]. B M J, 1991; 303: 276-82
912. Berenson, GS, Srinivasan, SR, Bao, W, Newman, WP, 3rd, Tracy, RE, and Wattigney, WA, Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med, 1998; 338: 1650-6.
913. Reed, DM, Strong, JP, Resch, J, and Hayashi, T, Serum lipids and lipoproteins as predictors of atherosclerosis. An autopsy study. Arteriosclerosis, 1989; 9: 560-4.
914. McGill, HC, Jr., McMahan, CA, Kruski, AW, and Mott, GE, Relationship of lipoprotein cholesterol concentrations to experimental atherosclerosis in baboons. Arteriosclerosis, 1981; 1: 3-12.
915. Samuelsson, O, Wilhelmsen, L, Andersson, OK, Pennert, K, and Berglund, G, Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Goteborg, Sweden. Jama, 1987; 258: 1768-76
916. Stamler, J, Wentworth, D, and Neaton, JD, Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). Jama, 1986; 256: 2823-8
917. Hulthe, J and Fagerberg, B, Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines (AIR Study). Arterioscler Thromb Vasc Biol, 2002; 22: 1162-7.
918. Wilson, PW, Abbott, RD, and Castelli, WP, High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis, 1988; 8: 737-41
919. Stampfer, MJ, Sacks, FM, Salvini, S, Willett, WC, and Hennekens, CH, A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction [see comments]. N Engl J Med, 1991; 325: 373-81
920. Abbott, RD, Wilson, PW, Kannel, WB, and Castelli, WP, High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis, 1988; 8: 207-11
921. Rich-Edwards, JW, Manson, JE, Hennekens, CH, and Buring, JE, The primary prevention of coronary heart disease in women. N Engl J Med, 1995; 332: 1758-66
922. Kitamura, A, Iso, H, Naito, Y, et al., High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation, 1994; 89: 2533-9
923. Romm, PA, Green, CE, Reagan, K, and Rackley, C, Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. Am J Cardiol, 1991; 67: 479-83
924. Nikkilä, M, Koivula, T, Niemelä, K, and Sisto, T, High density lipoprotein cholesterol and triglycerides as markers of angiographically assessed coronary artery disease. Br Heart J, 1990; 63: 78-81
925. Nofer, JR, Kehrel, B, Fobker, M, Levkau, B, Assmann, G, and von Eckardstein, A, HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis, 2002; 161: 1-16
926. Doggrell, SA, Gemfibrozil prevents major coronary events by increasing HDL- cholesterol and more. Expert Opin Pharmacother, 2001; 2: 1187-9.
927. Austin, MA, Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype. Curr Atheroscler Rep, 2000; 2: 200-7.
928. Tanne, D, Koren-Morag, N, Graff, E, and Goldbourt, U, Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation, 2001; 104: 2892-7.
929. Griffin, BA, Freeman, DJ, Tait, GW, et al., Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis, 1994; 106: 241-53.
930. Austin, MA and Hokanson, JE, Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease. Med Clin North Am, 1994; 78: 99-115
931. Cobb, MM, Teitelbaum, HS, and Breslow, JL, Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high- vs low-fat diets. Jama, 1991; 265: 997-1001
932. Schaefer, EJ, Lamon-Fava, S, Ausman, LM, et al., Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am J Clin Nutr, 1997; 65: 823-30
933. Lairon, D, Dietary fibres: effects on lipid metabolism and mechanisms of action. Eur J Clin Nutr, 1996; 50: 125-33
934. Jones, PJ, Cholesterol-lowering action of plant sterols. Curr Atheroscler Rep, 1999; 1: 230-5.
935. Pelletier, X, Belbraouet, S, Mirabel, D, et al., A diet moderately enriched in phytosterols lowers plasma cholesterol concentrations in normocholesterolemic humans. Ann Nutr Metab, 1995; 39: 291-5
936. Miettinen, TA, Puska, P, Gylling, H, Vanhanen, H, and Vartiainen, E, Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population [see comments]. N Engl J Med, 1995; 333: 1308-12
937. Gylling, H, Radhakrishnan, R, and Miettinen, TA, Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol. Circulation, 1997; 96: 4226-31
938. Ntanios, FY, Jones, PJ, and Frohlich, JJ, Dietary sitostanol reduces plaque formation but not lecithin cholesterol acyl transferase activity in rabbits [In Process Citation]. Atherosclerosis, 1998; 138: 101-10
939. Normen, L, Johnsson, M, Andersson, H, van Gameren, Y, and Dutta, P, Plant sterols in vegetables and fruits commonly consumed in Sweden. Eur J Nutr, 1999; 38: 84-9.
940. Doerge, DR and Sheehan, DM, Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect, 2002; 110 Suppl 3: 349-53.
941. Yellayi, S, Naaz, A, Szewczykowski, MA, et al., The phytoestrogen genistein induces thymic and immune changes: A human health concern? Proc Natl Acad Sci U S A, 2002; 99: 7616-21
942. Teede, HJ, Dalais, FS, Kotsopoulos, D, Liang, YL, Davis, S, and McGrath, BP, Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab, 2001; 86: 3053-60.
943. Divi, RL and Doerge, DR, Inhibition of thyroid peroxidase by dietary flavonoids. Chem Res Toxicol, 1996; 9: 16-23.
944. Nieminen, P, Mustonen, AM, Lindstrom-Seppa, P, Asikainen, J, Mussalo-Rauhamaa, H, and Kukkonen, JV, Phytosterols act as endocrine and metabolic disruptors in the European polecat (Mustela putorius). Toxicol Appl Pharmacol, 2002; 178: 22-8.
945. Verdery, RB and Walford, RL, Changes in plasma lipids and lipoproteins in humans during a 2-year period of dietary restriction in Biosphere 2. Arch Intern Med, 1998; 158: 900-6
946. O'Dea, K, Sinclair, AJ, Niall, M, and Traianedes, K, Lean meat as part of a cholesterol-lowering diet. Prog Lipid Res, 1986; 25: 219-20
947. Newbold, HL, Reducing the serum cholesterol level with a diet high in animal fat. South Med J, 1988; 81: 61-3
948. Watts, GF, Ahmed, W, Quiney, J, et al., Effective lipid lowering diets including lean meat. Br Med J (Clin Res Ed), 1988; 296: 235-7
949. Kestin, M, Rouse, IL, Correll, RA, and Nestel, PJ, Cardiovascular disease risk factors in free-living men: comparison of two prudent diets, one based on lactoovovegetarianism and the other allowing lean meat. Am J Clin Nutr, 1989; 50: 280-7
950. Scott, LW, Kimball, KT, Wittels, EH, et al., Effects of a lean beef diet and of a chicken and fish diet on lipoprotein profiles. Nutr Metab Cardiovasc Dis, 1991; 1: 25-30
951. Keenan, JM and Morris, DH, Hypercholesterolemia. Dietary advice for patients regarding meat [see comments]. Postgrad Med, 1995; 98: 113-4, 117-8, 120-1 passim
952. Davidson, MH, Hunninghake, D, Maki, KC, Kwiterovich, PO, Jr., and Kafonek, S, Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among free-living persons with hypercholesterolemia: a long-term, randomized clinical trial. Arch Intern Med, 1999; 159: 1331-8.
953. Jenkins, DJ, Kendall, CW, Jackson, CJ, et al., Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr, 2002; 76: 365-72.
954. Mensink, RP and Katan, MB, Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb, 1992; 12: 911-9
955. Knopp, RH, Retzlaff, B, Walden, C, Fish, B, Buck, B, and McCann, B, One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living subjects. Proc Soc Exp Biol Med, 2000; 225: 191-9.
956. Denke, MA, Dietary determinants of high-density-lipoprotein-cholesterol levels. Cardiovascular Risk Factors, 1993; 3: 274-8
957. Adeli, K, Taghibiglou, C, Van Iderstine, SC, and Lewis, GF, Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc Med, 2001; 11: 170-6.
958. Grundy, SM and Denke, MA, Dietary influences on serum lipids and lipoproteins. J Lipid Res, 1990; 31: 1149-72
959. Wolfe, BM and Piche, LA, Replacement of carbohydrate by protein in a conventional-fat diet reduces cholesterol and triglyceride concentrations in healthy normolipidemic subjects. Clin Invest Med, 1999; 22: 140-8.
960. Hopkins, PN, Effects of dietary cholesterol on serum cholesterol: a meta-analysis and review. Am J Clin Nutr, 1992; 55: 1060-70
961. Vorster, HH, Benade, AJ, Barnard, HC, et al., Egg intake does not change plasma lipoprotein and coagulation profiles. Am J Clin Nutr, 1992; 55: 400-10
962. Clifton, PM, Kestin, M, Abbey, M, Drysdale, M, and Nestel, PJ, Relationship between sensitivity to dietary fat and dietary cholesterol. Arteriosclerosis, 1990; 10: 394-401
963. Weggemans, RM, Zock, PL, and Katan, MB, Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis. Am J Clin Nutr, 2001; 73: 885-91.
964. Stewart, S, MacIntyre, K, Hole, DJ, Capewell, S, and McMurray, JJ, More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail, 2001; 3: 315-22.
965. Lakatta, EG and Levy, D, Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation, 2003; 107: 346-54
966. Lakatta, EG, Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation, 2003; 107: 490-7
967. Colucci, WS and Braunwald, E, Pathophysiology of Heart Failure, in Heart disease. A textbook of cardiovascular medicine, E. Braunwald, D.P. Zipes, and P. Libby, Editors. 2001, W.B. Saunders Co: London. p. 503-33.
968. Grodzicki, T, Michalewicz, L, and Messerli, FH, Aging and essential hypertension: effect of left ventricular hypertrophy on cardiac function. Am J Hypertens, 1998; 11: 425-9
969. Ghali, JK, 3rd, Liao, Y, and Cooper, RS, Left Ventricular Hypertrophy in the Elderly. Am J Geriatr Cardiol, 1997; 6: 38-49
970. Gerstenblith, G, Frederiksen, J, Yin, FC, Fortuin, NJ, Lakatta, EG, and Weisfeldt, ML, Echocardiographic assessment of a normal adult aging population. Circulation, 1977; 56: 273-8
971. McKelvie, RS, Benedict, CR, and Yusuf, S, Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction. Bmj, 1999; 318: 1400-2.
972. Nichols, GA, Hillier, TA, Erbey, JR, and Brown, JB, Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care, 2001; 24: 1614-9.
973. Wilhelmsen, L, Rosengren, A, Eriksson, H, and Lappas, G, Heart failure in the general population of men--morbidity, risk factors and prognosis. J Intern Med, 2001; 249: 253-61.
974. Kenchaiah, S, Evans, JC, Levy, D, et al., Obesity and the risk of heart failure. N Engl J Med, 2002; 347: 305-13.
975. Doehner, W, Anker, SD, and Coats, AJ, Defects in insulin action in chronic heart failure. Diabetes Obes Metab, 2000; 2: 203-12.
976. Arnlov, J, Lind, L, Zethelius, B, et al., Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up. Am Heart J, 2001; 142: 720-4. t&artType=abs&id=a116957&target=
977. Paolisso, G, De Riu, S, Marrazzo, G, Verza, M, Varricchio, M, and D'Onofrio, F, Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism, 1991; 40: 972-7.
978. Galvan, AQ, Galetta, F, Natali, A, et al., Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans. Circulation, 2000; 102: 2233-8.
979. Bikhazi, AB, Azar, ST, Birbari, AE, et al., Characterization of insulin-resistance: role of receptor alteration in insulin-dependent diabetes mellitus, essential hypertension and cardiac hypertrophy. Eur J Pharm Sci, 2000; 11: 299-306.
980. Yamamoto, K, Ohki, R, Lee, RT, Ikeda, U, and Shimada, K, Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation, 2001; 104: 1670-5.
981. Morgan, T, Aubert, JF, and Brunner, H, Interaction between sodium intake, angiotensin II, and blood pressure as a cause of cardiac hypertrophy. Am J Hypertens, 2001; 14: 914-20.
982. Devereux, RB, Echocardiography, hypertension, and left ventricular mass. Health Psychol, 1988;
983. Redfield, MM, Jacobsen, SJ, Burnett, JC, Jr., Mahoney, DW, Bailey, KR, and Rodeheffer, RJ, Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. Jama, 2003; 289: 194-202.
984. Ramirez-Gil, JF, Delcayre, C, Robert, V, et al., In vivo left ventricular function and collagen expression in aldosterone/salt-induced hypertension. J Cardiovasc Pharmacol, 1998; 32: 927-34.
985. Leenen, FH and Yuan, B, Dietary-sodium-induced cardiac remodeling in spontaneously hypertensive rat versus Wistar-Kyoto rat. J Hypertens, 1998; 16: 885-92.
986. Dang, A, Zheng, D, Wang, B, et al., The role of the renin-angiotensin and cardiac sympathetic nervous systems in the development of hypertension and left ventricular hypertrophy in spontaneously hypertensive rats. Hypertens Res, 1999; 22: 217-21.
987. Frohlich, ED, Chien, Y, Sesoko, S, and Pegram, BL, Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WKY rats. Am J Physiol, 1993; 264: R30-4.
988. Sugimoto, K, Fujimura, A, Takasaki, I, et al., Effects of renin-angiotensin system blockade and dietary salt intake on left ventricular hypertrophy in Dahl salt-sensitive rats. Hypertens Res, 1998; 21: 163-8.
989. Kupari, M, Koskinen, P, and Virolainen, J, Correlates of left ventricular mass in a population sample aged 36 to 37 years. Focus on lifestyle and salt intake. Circulation, 1994; 89: 1041-50
990. Liebson, PR, Grandits, G, Prineas, R, et al., Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation, 1993; 87: 476-86.
991. Blake, J, Devereux, RB, Borer, JS, Szulc, M, Pappas, TW, and Laragh, JH, Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension. Am J Med, 1990; 88: 477-85.
992. Schmieder, RE, Messerli, FH, Garavaglia, GE, and Nunez, BD, Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation, 1988; 78: 951-6.
993. Fagerberg, B, Berglund, A, Andersson, OK, Berglund, G, and Wikstrand, J, Cardiovascular effects of weight reduction versus antihypertensive drug treatment: a comparative, randomized, 1-year study of obese men with mild hypertension. J Hypertens, 1991; 9: 431-9.
994. Jula, AM and Karanko, HM, Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Circulation, 1994; 89: 1023-31
995. Ozkahya, M, Ok, E, Cirit, M, et al., Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant, 1998; 13: 1489-93.
996. He, J, Ogden, LG, Bazzano, LA, Vupputuri, S, Loria, C, and Whelton, PK, Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med, 2002; 162: 1619-24.
997. Vescovo, G, Ravara, B, Gobbo, V, et al., L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. Am J Physiol Cell Physiol, 2002; 283: C802-10.
998. Brass, EP and Hiatt, WR, The role of carnitine and carnitine supplementation during exercise in man and in individuals with special needs. J Am Coll Nutr, 1998; 17: 207-15.
999. Carr, JG, Stevenson, LW, Walden, JA, and Heber, D, Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol, 1989; 63: 709-13.
1000. Sharma, R and Anker, SD, From tissue wasting to cachexia: changes in peripheral blood flow and skeletal musculature. Eur Heart J Suppl, 2002; 4: D12-7
1001. Bales, CW and Ritchie, CS, Sarcopenia, weight loss, and nutritional frailty in the elderly. Annu Rev Nutr, 2002; 22: 309-23
1002. Evans, WJ, Reversing sarcopenia: how weight training can build strength and vitality. Geriatrics, 1996; 51: 46-7, 51-3; quiz 54.
1003. Anker, SD, Ponikowski, P, Varney, S, et al., Wasting as independent risk factor for mortality in chronic heart failure. Lancet, 1997; 349: 1050-3.
1004. Anker, SD, Leyva, F, Poole-Wilson, PA, and Coats, AJS, Uric acid independent predictor of impaired prognosis in patients with chronic heart failure. J Am Coll cardiol, 1998; 31: 154A
1005. de la Torre, JC, Alzheimer disease as a vascular disorder: nosological evidence. Stroke, 2002; 33: 1152-62
1006. Convit, A, Wolf, OT, Tarshish, C, and de Leon, MJ, Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A, 2003; 100: 2019-22
1007. Puglielli, L, Tanzi, RE, and Kovacs, DM, Alzheimer's disease: the cholesterol connection. Nat Neurosci, 2003; 6: 345-351
1008. Kumari, M, Brunner, E, and Fuhrer, R, Minireview: mechanisms by which the metabolic syndrome and diabetes impair memory. J Gerontol A Biol Sci Med Sci, 2000; 55: B228-32.
1009. Kilander, L, Nyman, H, Boberg, M, Hansson, L, and Lithell, H, Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension, 1998; 31: 780-6.
1010. Snowdon, DA, Kemper, SJ, Mortimer, JA, Greiner, LH, Wekstein, DR, and Markesbery, WR, Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. Jama, 1996; 275: 528-32.
1011. Matthews, FE and Dening, T, Prevalence of dementia in institutional care. Lancet, 2002; 360: 225-6.
1012. Andreasen, N, Blennow, K, Sjodin, C, Winblad, B, and Svardsudd, K, Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Pitea Dementia Project. Neuroepidemiology, 1999; 18: 144-55
1013. Palmer, K, Wang, HX, Backman, L, Winblad, B, and Fratiglioni, L, Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. Am J Psychiatry, 2002; 159: 436-42.
1014. Kilander, L, Nyman, H, Boberg, M, and Lithell, H, Cognitive function, vascular risk factors and education. A cross- sectional study based on a cohort of 70-year-old men. J Intern Med, 1997; 242: 313-21.
1015. Forette, F, Seux, ML, Staessen, JA, et al., Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet, 1998; 352: 1347-51.
1016. Scott, HD and Laake, K, Statins for the prevention of Alzheimer's disease. Cochrane Database Syst Rev, 2001; 4
1017. Ball, LJ and Birge, SJ, Prevention of brain aging and dementia. Clin Geriatr Med, 2002; 18: 485-503
1018. Gasparini, L, Netzer, WJ, Greengard, P, and Xu, H, Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol Sci, 2002; 23: 288-93.
1019. Hardy, J and Selkoe, DJ, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 2002; 297: 353-6.
1020. Poirier, J, Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Ann N Y Acad Sci, 2000; 924: 81-90
1021. Craft, S, Asthana, S, Schellenberg, G, et al., Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann N Y Acad Sci, 2000; 903: 222-8.
1022. Frautschy, SA, Hu, W, Kim, P, et al., Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging, 2001; 22: 993-1005.
1023. Meguro, K, Ishii, H, Yamaguchi, S, et al., Prevalence of dementia and dementing diseases in Japan: the tajiri project. Arch Neurol, 2002; 59: 1109-14.
1024. Kalmijn, S, Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies. J Nutr Health Aging, 2000; 4: 202-7
1025. Luchsinger, JA, Tang, MX, Shea, S, and Mayeux, R, Caloric intake and the risk of Alzheimer disease. Arch Neurol, 2002; 59: 1258-63.
1026. McCarty, MF, Vascular nitric oxide may lessen Alzheimer's risk. Med Hypotheses, 1998; 51: 465-76.
1027. Engelhart, MJ, Geerlings, MI, Ruitenberg, A, et al., Dietary intake of antioxidants and risk of Alzheimer disease. Jama, 2002; 287: 3223-9.
1028. Morris, MC, Evans, DA, Bienias, JL, et al., Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. Jama, 2002; 287: 3230-7.
1029. Morris, MC, Evans, DA, Bienias, JL, Tangney, CC, and Wilson, RS, Vitamin e and cognitive decline in older persons. Arch Neurol, 2002; 59: 1125-32.
1030. Swedish Cancer Committee: Cancer: Causes and prevention. 1992, Washington DC: Taylor & Francis.
1031. Draper, HH, The aboriginal Eskimo diet in modern perspective. Am Anthropol, 1977; 79: 309-16
1032. Higginson, J, Cancer and environment: Higginson speaks out. Science, 1979; 205: 1363-4, 1366.
1033. Food, nutrition and the prevention of cancer: a global perspective. 1997, Washington, DC: World Cancer Research Fund in association with American Institute for Cancer Research.
1034. Meyer, WM and Neafie, RC, Tropical phagedenic ulcer, in Tropical Medicine, G.T. Strickland, Editor. 1991, W. B. Saunders: Philadelphia. p. 310-1.
1035. Ziegler, JL, Malignant disease, in Hunter's Tropical Medicine, G.T. Strickland, Editor. 1991, W. B. Saunders: Philadelphia. p. 103-14.
1036. Wallington, M, Cancer in Papua New Guinea, 1985. P N G Med J, 1986; 29: 333-6
1037. Atkinson, L, Chester, IC, Smyth, FG, and ten Seldam, REJ, Oral cancer in New Guinea. A study in demography and etiology. Cancer, 1964; 17: 1289-98
1038. Henderson, BE and Aiken, GH, Cancer in Papua New Guinea. Natl Cancer Inst Monogr, 1979;
1039. MacLennan, R, Paissat, D, Ring, A, and Thomas, S, Possible aetiology of oral cancer in Papua New Guinea. P N G Med J, 1985; 28: 3-8
1040. Thomas, SJ and MacLennan, R, Slaked lime and betel nut cancer in Papua New Guinea. Lancet, 1992; ii: 577-8
1041. Boyle, P, Macfarlane, GJ, Maisonneuve, P, Zheng, T, Scully, C, and Tedesco, B, Epidemiology of mouth cancer in 1989: a review [see comments]. J R Soc Med, 1990; 83: 724-30
1042. Nair, UJ, Friesen, M, Richard, I, MacLennan, R, Thomas, S, and Bartsch, H, Effect of lime composition on the formation of reactive oxygen species from areca nut extract in vitro. Carcinogenesis, 1990; 11: 2145-8
1043. Prokopczyk, B, Rivenson, A, and Hoffmann, D, A study of betel quid carcinogenesis. IX. Comparative carcinogenicity of 3-(methylnitrosamino)propionitrile and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone upon local application to mouse skin and rat oral mucosa. Cancer Lett, 1991; 60: 153-7
1044. Stich, HF, Mathew, B, Sankaranarayanan, R, and Nair, MK, Remission of oral precancerous lesions of tobacco/areca nut chewers following administration of beta-carotene or vitamin A, and maintenance of the protective effect. Cancer Detect Prev, 1991; 15: 93-8
1045. Nishikawa, A, Prokopczyk, B, Rivenson, A, Zang, E, and Hoffmann, D, A study of betel quid carcinogenesis--VIII. Carcinogenicity of 3-(methylnitrosamino)propionaldehyde in F344 rats. Carcinogenesis, 1992; 13: 369-72
1046. Sharan, RN and Wary, KK, Study of unscheduled DNA synthesis following exposure of human cells to arecoline and extracts of betel nut in vitro. Mutat Res, 1992; 278: 271-6
1047. Sundqvist, K and Grafstrom, RC, Effects of areca nut on growth, differentiation and formation of DNA damage in cultured human buccal epithelial cells. Int J Cancer, 1992; 52: 305-10
1048. Mola, G and McGoldrick, I, Epidemiology of gynaecological and female breast neoplasms in Papua New Guinea. P N G Med J, 1982; 25: 143-50
1049. Heintz, AP, Hacker, NF, and Lagasse, LD, Epidemiology and etiology of ovarian cancer: a review. Obstet Gynecol, 1985; 66: 127-35
1050. Stout, SD, Methods of determining age at death using bone microstructure, in Skeletal biology of past peoples: research methods, S.R. Saunders and A. Katzenberg, Editors. 1992, Wiley-Liss. p. 21-35.
1051. Jurmain, RD and Kilgore, L, Skeletal evidence of osteoarthritis: a palaeopathological perspective. Ann Rheum Dis, 1995; 54: 443-50
1052. Lindeberg, S, Hälsa och ohälsa under forntiden - om evolutionsmedicinens möjligheter, in Ajvide och den moderna arkeologin, G. Burenhult, Editor. 1997, Natur och Kultur: Stockholm. p. 134-51.
1053. Roberts, C and Manchester, K, The Archaeology of Disease. 1995: Cornell University press.
1054. Webb, S, Palaeopathology of Aboriginal Australians. Health and disease across a hunter-gatherer continent. 1995: Cambridge University press.
1055. Rothschild, B and Martin, L, Paleolpathology: disease in the fossil record. 1993, London: CRC Press.
1056. Cockburn, A, Cockburn, E, and Reyman, TA, Mummies, disease & ancient cultures. 1998: Cambridge University Press.
1057. Cohen, MN, Health and the rise of Civilization. 1989, New Haven: Yale University Press.
1058. Rothschild, BM, Witzke, BJ, and Hershkovitz, I, Metastatic cancer in the Jurassic. Lancet, 1999; 354: 398.
1059. McKinnell, RG, Parchment, RE, Perantoni, AO, and Pierce, GB, The Biological Basis of Cancer. 1998: Cambridge University press.
1060. Schulze, MB, Hoffmann, K, Kroke, A, and Boeing, H, Dietary patterns and their association with food and nutrient intake in the European Prospective Investigation into Cancer and Nutrition (EPIC)- Potsdam study. Br J Nutr, 2001; 85: 363-73.
1061. Elmståhl, S, Holmqvist, O, Gullberg, B, Johansson, U, and Berglund, G, Dietary patterns in high and low consumers of meat in a Swedish cohort study. Appetite, 1999; 32: 191-206.
1062. Sandhu, MS, White, IR, and McPherson, K, Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev, 2001; 10: 439-46.
1063. Carroll, KK and Khor, HT, Dietary fat in relation to tumorigenesis. Prog Biochem Pharmacol, 1975; 10: 308-53
1064. Byrne, C, Rockett, H, and Holmes, MD, Dietary Fat, Fat Subtypes, and Breast Cancer Risk: Lack of an Association among Postmenopausal Women with No History of Benign Breast Disease. Cancer Epidemiol Biomarkers Prev, 2002; 11: 261-5.
1065. Smith-Warner, SA, Spiegelman, D, Adami, HO, et al., Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer, 2001; 92: 767-74.
1066. Willett, WC, Dietary fat and breast cancer. Toxicol Sci, 1999; 52: 127-46.
1067. Hakkak, R, Korourian, S, Ronis, MJ, Johnston, JM, and Badger, TM, Dietary whey protein protects against azoxymethane-induced colon tumors in male rats. Cancer Epidemiol Biomarkers Prev, 2001; 10: 555-8.
1068. Hawrylewicz, EJ, Huang, HH, and Blair, WH, Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr, 1991; 121: 1693-8.
1069. Hjartaker, A, Laake, P, and Lund, E, Childhood and adult milk consumption and risk of premenopausal breast cancer in a cohort of 48,844 women - the Norwegian women and cancer study. Int J Cancer, 2001; 93: 888-93.
1070. Allred, CD, Allred, KF, Ju, YH, Virant, SM, and Helferich, WG, Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res, 2001; 61: 5045-50.
1071. Coffey, DS, Similarities of prostate and breast cancer: Evolution, diet, and estrogens. Urology, 2001; 57: 31-8.
1072. Chan, JM, Stampfer, MJ, Ma, J, Gann, PH, Gaziano, JM, and Giovannucci, EL, Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr, 2001; 74: 549-54.
1073. Grant, WB, An ecologic study of dietary links to prostate cancer. Altern Med Rev, 1999; 4: 162-9.
1074. Gupta, RA and Dubois, RN, Controversy: PPARgamma as a target for treatment of colorectal cancer. Am J Physiol Gastrointest Liver Physiol, 2002; 283: G266-9.
1075. Schatzkin, A, Lanza, E, Corle, D, et al., Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med, 2000; 342: 1149-55.
1076. Alberts, DS, Martinez, ME, Roe, DJ, et al., Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med, 2000; 342: 1156-62.
1077. Fuchs, CS, Giovannucci, EL, Colditz, GA, et al., Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med, 1999; 340: 169-76.
1078. MacLennan, R, Macrae, F, Bain, C, et al., Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J Natl Cancer Inst, 1995; 87: 1760-6.
1079. Jones, JL, Daley, BJ, Enderson, BL, Zhou, JR, and Karlstad, MD, Genistein inhibits tamoxifen effects on cell proliferation and cell cycle arrest in T47D breast cancer cells. Am Surg, 2002; 68: 575-7; discussion 577-8.
1080. Ju, YH, Doerge, DR, Allred, KF, Allred, CD, and Helferich, WG, Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res, 2002; 62: 2474-7.
1081. Ames, BN, Magaw, R, and Gold, LS, Ranking possible carcinogenic hazards. Science, 1987; 236: 271-80.
1082. Begum, NM, Nakashiro, K, Kawamata, H, et al., Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines. Int J Oncol, 2002; 20: 599-605.
1083. Issemann, I and Green, S, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 1990; 347: 645-50.
1084. Jimenez, MJ, Balbin, M, Alvarez, J, et al., A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation. J Cell Biol, 2001; 155: 1333-44.
1085. McKinnell, RG, Metastasis, in The Biological Basis of Cancer, R.G. McKinnell, et al., Editors. 1998, Cambridge University press. p. 50-78.
1086. Zeng, FY, Benguria, A, Kafert, S, Andre, S, Gabius, HJ, and Villalobo, A, Differential response of the epidermal growth factor receptor tyrosine kinase activity to several plant and mammalian lectins. Mol Cell Biochem, 1995; 142: 117-24.
1087. Raymond, E, Faivre, S, and Armand, JP, Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy. Drugs, 2000; 60: 15-23; discussion 41-2.
1088. Gabor, F, Klausegger, U, and Wirth, M, The interaction between wheat germ agglutinin and other plant lectins with prostate cancer cells Du-145. Int J Pharm, 2001; 221: 35-47.
1089. Evans, RC, Fear, S, Ashby, D, et al., Diet and colorectal cancer: an investigation of the lectin/galactose hypothesis. Gastroenterology, 2002; 122: 1784-92. t&artType=abs&id=a0070201784&target=
1090. Berard, A, Bravo, G, and Gauthier, P, Meta-analysis of the effectiveness of physical activity for the prevention of bone loss in postmenopausal women. Osteoporos Int, 1997; 7: 331-7
1091. Michaelsson, K, Bergstrom, R, Holmberg, L, Mallmin, H, Wolk, A, and Ljunghall, S, A high dietary calcium intake is needed for a positive effect on bone density in Swedish postmenopausal women. Osteoporos Int, 1997; 7: 155-61
1092. Raisz, LG, Pathogenesis of postmenopausal osteoporosis. Rev Endocr Metab Disord, 2001; 2: 5-12.
1093. Marshall, D, Johnell, O, and Wedel, H, Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures [see comments]. Bmj, 1996; 312: 1254-9
1094. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study group. 1994, Geneva: World Health Organization.
1095. Bailey, AJ, Sims, TJ, Ebbesen, EN, Mansell, JP, Thomsen, JS, and Mosekilde, L, Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int, 1999; 65: 203-10.
1096. Johansson, P, Benskörhet på kärlekens öar. Medikament, 2001: 34-8
1097. Scrimgeour, EM, Prevention of fracture of the neck of the femur: evidence from developing countries of the relative unimportance of osteoporosis. Aust N Z J Med, 1992; 22: 85-6.
1098. Adebajo, AO, Cooper, C, and Evans, JG, Fractures of the hip and distal forearm in West Africa and the United Kingdom. Age Ageing, 1991; 20: 435-8
1099. Prentice, A, Laskey, MA, Shaw, J, Cole, TJ, and Fraser, DR, Bone mineral content of Gambian and British children aged 0-36 months. Bone Miner, 1990; 10: 211-24
1100. Barss, P, Fractured hips in rural Melanesians: a nonepidemic. Trop Geogr Med, 1985; 37: 156-9
1101. Bloom, RA and Pogrund, H, Humeral cortical thickness in female Bantu--its relationship to the incidence of femoral neck fracture. Skeletal Radiol, 1982; 8: 59-62
1102. Solomon, L, Bone density in ageing Caucasian and African populations. Lancet, 1979; 2: 1326-30
1103. Hasserius, R, Redlund-Johnell, I, Mellstrom, D, Johansson, C, Nilsson, BE, and Johnell, O, Vertebral deformation in urban Swedish men and women: prevalence based on 797 subjects. Acta Orthop Scand, 2001; 72: 273-8.
1104. Szulc, P, Munoz, F, Marchand, F, and Delmas, PD, Semiquantitative evaluation of prevalent vertebral deformities in men and their relationship with osteoporosis: the MINOS study. Osteoporos Int, 2001; 12: 302-10
1105. Berlemann, U, Gries, NC, and Moore, RJ, The relationship between height, shape and histological changes in early degeneration of the lower lumbar discs. Eur Spine J, 1998; 7: 212-7
1106. Mazess, RB and Mather, W, Bone mineral content of North Alaskan Eskimos. Am J Clin Nutr, 1974; 27: 916-25
1107. Pawson, IG, Radiographic determination of excessive bone loss in Alaskan Eskimos. Hum Biol, 1974; 46: 369-80
1108. Mazess, RB and Mather, WE, Bone mineral content in Canadian Eskimos. Hum Biol, 1975; 47: 44-63
1109. Harper, AB, Laughlin, WS, and Mazess, RB, Bone mineral content in St. Lawrence Island Eskimos. Hum Biol, 1984; 56: 63-78
1110. Mann, G, Letter: Bone mineral content of North Alaskan Eskimos. Am J Clin Nutr, 1975; 28: 566-7
1111. Mann, GV, The health and nutritional status of Alaskan Eskimos. Am J Clin Nutr, 1962; 11: 31-40
1112. Shephard, RJ and Godin, G, Energy balance of an Eskimo community, in Circumpolar health, R.J. Shephard and S. Itoh, Editors. 1976, University of Toronto Press: Toronto. p. 106-12.
1113. Rode, A and Shephard, RJ, Body fat distribution and other cardiac risk factors among circumpolar Inuit and nGanasan. Arct Med Res, 1995; 54: 125-33
1114. Lippe-Stokes, S, Eskimo story-knife tales: reflections of change in food habits, in Food, ecology and culture. Readings in the anthropology of dietary practices, J.R.K. Robson, Editor. 1976, Gordon and Breach. p. 75-82.
1115. Kanis, JA, Johnell, O, De Laet, C, Jonsson, B, Oden, A, and Ogelsby, AK, International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res, 2002; 17: 1237-44.
1116. Ito, M, Lang, TF, Jergas, M, et al., Spinal trabecular bone loss and fracture in American and Japanese women. Calcif Tissue Int, 1997; 61: 123-8.
1117. Fujiwara, S, Mizuno, S, Ochi, Y, et al., The incidence of thoracic vertebral fractures in a Japanese population, Hiroshima and Nagasaki, 1958-86. J Clin Epidemiol, 1991; 44: 1007-14
1118. Neves, WA, Barros, AM, and Costa, MA, Incidence and distribution of postcranial fractures in the prehistoric population of San Pedro de Atacama, Northern Chile. Am J Phys Anthropol, 1999; 109: 253-8.
1119. Merbs, C, Trauma, in Reconstruction of life from the skeleton, M.H. Isçan and K.A.R. Kennedy, Editors. 1989, Wiley-Liss: New York. p. 161-89.
1120. Yesner, DR, Degenerative and traumatic pathologies of the Aleut vertebral column. Arch Calif Chirop Assoc, 1981; 5: 45-57
1121. Cooper, C, O'Neill, T, and Silman, A, The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group. Bone, 1993; 14: S89-97.
1122. Ruff, CB, Biomechanical analyses of archaeological human skeletal samples, in Skeletal biology of past peoples: research methods, S.R. Saunders and A. Katzenberg, Editors. 1992, Wiley-Liss. p. 37-58.
1123. Jackes, M, Paleodemography: problems and techniques, in Skeletal biology of past peoples: research methods, S.R. Saunders and A. Katzenberg, Editors. 1992, Wiley-Liss. p. 189-224.
1124. Eaton, SB and Nelson, DA, Calcium in evolutionary perspective. Am J Clin Nutr, 1991; 54: 281S-287S.
1125. Perzigian, AJ, Osteoporotic bone loss in two prehistoric Indian populations. Am J Phys Anthropol, 1973; 39: 87-95.
1126. Mazess, RB, Bone density in Sadlermiut Eskimo. Hum Biol, 1966; 38: 42-9
1127. Thompson, DD and Gunness, HM, Bone mineral-osteon analysis of Yupik-Inupiaq skeletons. Am J Phys Anthropol, 1981; 55: 1-7
1128. Laughlin, WS, Harper, AB, and Thompson, DD, New approaches to the pre- and post-contact history of Arctic peoples. Am J Phys Anthropol, 1979; 51: 579-87
1129. Richman, EA, Ortner, DJ, and Schulter-Ellis, FP, Differences in intracortical bone remodeling in three aboriginal American populations: possible dietary factors. Calcif Tissue Int, 1979; 28: 209-14
1130. Nordin, BEC, Need, AG, Morris, HA, Horowitz, M, Chatterton, BE, and Sedgwick, AW, Bad habits and bad bones, in Nutritional aspects of osteoporosis '94, P. Burckhardt and R.P. Heaney, Editors. 1995, Ares-Serono Symposia: Rome. p. 1-25.
1131. Melin, AL, Wilske, J, Ringertz, H, and Saaf, M, Vitamin D status, parathyroid function and femoral bone density in an elderly Swedish population living at home. Aging (Milano), 1999; 11: 200-7.
1132. van der Wielen, RP, Lowik, MR, van den Berg, H, et al., Serum vitamin D concentrations among elderly people in Europe. Lancet, 1995; 346: 207-10.
1133. Thomas, MK, Lloyd-Jones, DM, Thadhani, RI, et al., Hypovitaminosis D in medical inpatients. N Engl J Med, 1998; 338: 777-83.
1134. Larsson, CL and Johansson, GK, Dietary intake and nutritional status of young vegans and omnivores in Sweden. Am J Clin Nutr, 2002; 76: 100-6.
1135. Mangels, AR and Messina, V, Considerations in planning vegan diets: infants. J Am Diet Assoc, 2001; 101: 670-7.
1136. Messina, V and Mangels, AR, Considerations in planning vegan diets: children. J Am Diet Assoc, 2001; 101: 661-9.
1137. Smith, R, Clinical nutrition and bone disease, in Human Nutrition and Dietetics, J.S. Garrow and W.P.T. James, Editors. 2000, Churchill Livingstone. p. 641-50.
1138. Weinsier, RL and Krumdieck, CL, Dairy foods and bone health: examination of the evidence. Am J Clin Nutr, 2000; 72: 681-9.
1139. Heaney, RP and Nordin, BE, Calcium effects on phosphorus absorption: implications for the prevention and co-therapy of osteoporosis. J Am Coll Nutr, 2002; 21: 239-44.
1140. Harland, BF, Smith, SA, Howard, MP, Ellis, R, and Smith, JJ, Nutritional status and phytate:zinc and phytate x calcium:zinc dietary molar ratios of lacto-ovo vegetarian Trappist monks: 10 years later. J Am Diet Assoc, 1988; 88: 1562-6
1141. Ellis, R, Kelsay, JL, Reynolds, RD, Morris, ER, Moser, PB, and Frazier, CW, Phytate:zinc and phytate X calcium:zinc millimolar ratios in self-selected diets of Americans, Asian Indians, and Nepalese. J Am Diet Assoc, 1987; 87: 1043-7
1142. Gibson, RS, Content and bioavailability of trace elements in vegetarian diets. Am J Clin Nutr, 1994; 59(5 Suppl): 1223S-1232S
1143. Dewey, CE, Diseases of the nervous system and locomotor system, in Diseases of swine, B.E. Straw, et al., Editors. 1999, Blackwell Science. p. 861-82.
1144. Whitehead, CC and Fleming, RH, Osteoporosis in cage layers. Poult Sci, 2000; 79: 1033-41
1145. Ho, SC, Chen, YM, Woo, JL, Leung, SS, Lam, TH, and Janus, ED, Sodium is the leading dietary factor associated with urinary calcium excretion in Hong Kong Chinese adults. Osteoporos Int, 2001; 12: 723-31
1146. Nordin, BC, Calcium requirement is a sliding scale. Am J Clin Nutr, 2000; 71: 1381-3.
1147. Itoh, R, Suyama, Y, Oguma, Y, and Yokota, F, Dietary sodium, an independent determinant for urinary deoxypyridinoline in elderly women. A cross-sectional study on the effect of dietary factors on deoxypyridinoline excretion in 24-h urine specimens from 763 free-living healthy Japanese. Eur J Clin Nutr, 1999; 53: 886-90.
1148. Evans, C and Eastell, R, Adaptation to high dietary sodium intake, in Nutritional aspects of osteoporosis '94, P. Burckhardt and R.P. Heaney, Editors. 1995, Ares-Serono Symposia: Rome. p. 413-8.
1149. Matkovic, V, Ilich, JZ, Andon, MB, et al., Urinary calcium, sodium, and bone mass of young females. Am J Clin Nutr, 1995; 62: 417-25
1150. Shortt, C and Flynn, A, Sodium-calcium inter-relationships with specific reference to osteoporosis. Nutr Res Rev, 1990; 3: 101-15
1151. Schaafsma, G, van, BE, Raymakers, JA, and Duursma, SA, Nutritional aspects of osteoporosis. World Rev Nutr Diet, 1987; 49: 121-59
1152. Parfitt, AM, Dietary risk factors for age-related bone loss and fractures. Lancet, 1983; 2: 1181-5
1153. Nordin, BE, Calcium and osteoporosis. Nutrition, 1997; 13: 664-86.
1154. Breslau, NA, McGuire, JL, Zerwekh, JE, and Pak, CY, The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab, 1982; 55: 369-73.
1155. Breslau, NA, Sakhaee, K, and Pak, CY, Impaired adaptation to salt-induced urinary calcium losses in postmenopausal osteoporosis. Trans Assoc Am Physicians, 1985; 98: 107-15
1156. Gould, E and Goulding, A, High dietary salt intakes lower bone mineral density in ovariectomised rats: a dual x-ray absorptiometry study. Bone, 1995; 16: 115S(abstr)
1157. Metz, JA, Karanja, N, Young, EW, Morris, CD, and McCarron, DA, Bone mineral density in spontaneous hypertension: differential effects of dietary calcium and sodium. Am J Med Sci, 1990; 300: 225-30
1158. Goulding, A and Campbell, DR, Effects of oral loads of sodium chloride on bone composition in growing rats consuming ample dietary calcium. Miner Electrolyte Metab, 1984; 10: 58-62
1159. Devine, A, Criddle, RA, Dick, IM, Kerr, DA, and Prince, RL, A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr, 1995; 62: 740-5
1160. Cohen, AJ and Roe, FJ, Review of risk factors for osteoporosis with particular reference to a possible aetiological role of dietary salt. Food Chem Toxicol, 2000; 38: 237-53
1161. Lemann, J, Jr., Gray, RW, and Pleuss, JA, Potassium bicarbonate, but not sodium bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy men. Kidney Int, 1989; 35: 688-95.
1162. Lemann, J, Jr., Pleuss, JA, Gray, RW, and Hoffmann, RG, Potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults [corrected]. Kidney Int, 1991; 39: 973-83.
1163. Bell, RR, Eldrid, MM, and Watson, FR, The influence of NaCl and KCl on urinary calcium excretion in healthy young women. Nutr Res, 1992; 12: 17-26
1164. Morris, RC, Jr., Sebastian, A, Forman, A, Tanaka, M, and Schmidlin, O, Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension, 1999; 33: 18-23.
1165. Sellmeyer, DE, Schloetter, M, and Sebastian, A, Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride diet. J Clin Endocrinol Metab, 2002; 87: 2008-12.
1166. New, SA, Bolton-Smith, C, Grubb, DA, and Reid, DM, Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr, 1997; 65: 1831-9.
1167. Tucker, KL, Hannan, MT, Chen, H, Cupples, LA, Wilson, PW, and Kiel, DP, Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr, 1999; 69: 727-36.
1168. Jones, G, Riley, MD, and Whiting, S, Association between urinary potassium, urinary sodium, current diet, and bone density in prepubertal children. Am J Clin Nutr, 2001; 73: 839-44.
1169. Sebastian, A, Harris, ST, Ottaway, JH, Todd, KM, and Morris, RC, Jr., Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med, 1994; 330: 1776-81.
1170. Bushinsky, DA, Acid-base imbalance and the skeleton, in Nutritional aspects of osteoporosis, P. Burckhardt, B. Dawson-Hughes, and R.P. Heaney, Editors. 1998, Springer: New York. p. 208-17.
1171. Lemann, J, Jr., Relationship between urinary calcium and net acid excretion as determined by dietary protein and potassium: a review. Nephron, 1999; 81: 18-25. EF&action=render&rendertype=fulltext&uid=NEF.nef1a018
1172. New, SA, The role of the skeleton in acid-base homeostasis. Proc Nutr Soc, 2002; 61: 151-64.
1173. Vormann, J and Daniel, H, The role of nutrition in human acid-base homeostasis. Eur J Nutr, 2001; 40: 187-8.
1174. Remer, T and Manz, F, Don't forget the acid base status when studying metabolic and clinical effects of dietary potassium depletion. J Clin Endocrinol Metab, 2001; 86: 5996-7.
1175. Tucker, KL, Hannan, MT, and Kiel, DP, The acid-base hypothesis: diet and bone in the Framingham Osteoporosis Study. Eur J Nutr, 2001; 40: 231-7.
1176. Promislow, JH, Goodman-Gruen, D, Slymen, DJ, and Barrett-Connor, E, Protein consumption and bone mineral density in the elderly : the Rancho Bernardo Study. Am J Epidemiol, 2002; 155: 636-44.
1177. Bonjour, JP, Ammann, P, Chevalley, T, and Rizzoli, R, Protein intake and bone growth. Can J Appl Physiol, 2001; 26: S153-66.
1178. Heaney, RP, Protein intake and bone health: the influence of belief systems on the conduct of nutritional science. Am J Clin Nutr, 2001; 73: 5-6.
1179. Ilich, JZ and Kerstetter, JE, Nutrition in bone health revisited: a story beyond calcium. J Am Coll Nutr, 2000; 19: 715-37.
1180. Schurch, MA, Rizzoli, R, Slosman, D, Vadas, L, Vergnaud, P, and Bonjour, JP, Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med, 1998; 128: 801-9.
1181. Kerstetter, JE, Svastisalee, CM, Caseria, DM, Mitnick, ME, and Insogna, KL, A threshold for low-protein-diet-induced elevations in parathyroid hormone. Am J Clin Nutr, 2000; 72: 168-73
1182. Rubin, MR, Cosman, F, Lindsay, R, and Bilezikian, JP, The anabolic effects of parathyroid hormone. Osteoporos Int, 2002; 13: 267-77
1183. Hannan, MT, Tucker, KL, Dawson-Hughes, B, Cupples, LA, Felson, DT, and Kiel, DP, Effect of dietary protein on bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res, 2000; 15: 2504-12.
1184. Munger, RG, Cerhan, JR, and Chiu, BC, Prospective study of dietary protein intake and risk of hip fracture in postmenopausal women [see comments]. Am J Clin Nutr, 1999; 69: 147-52
1185. Heaney, RP and Recker, RR, Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. J Lab Clin Med, 1982; 99: 46-55
1186. Sellmeyer, DE, Stone, KL, Sebastian, A, and Cummings, SR, A high ratio of dietary animal to vegetable protein increases the rate of bone loss and the risk of fracture in postmenopausal women. Study of Osteoporotic Fractures Research Group. Am J Clin Nutr, 2001; 73: 118-22.
1187. Lloyd, T, Schaeffer, JM, Walker, MA, and Demers, LM, Urinary hormonal concentrations and spinal bone densities of premenopausal vegetarian and nonvegetarian women. Am J Clin Nutr, 1991; 54: 1005-10.
1188. Hunt, IF, Murphy, NJ, Henderson, C, et al., Bone mineral content in postmenopausal women: comparison of omnivores and vegetarians. Am J Clin Nutr, 1989; 50: 517-23.
1189. Tesar, R, Notelovitz, M, Shim, E, Kauwell, G, and Brown, J, Axial and peripheral bone density and nutrient intakes of postmenopausal vegetarian and omnivorous women. Am J Clin Nutr, 1992; 56: 699-704.
1190. Marsh, AG, Sanchez, TV, Chaffee, FL, Mayor, GH, and Mickelsen, O, Bone mineral mass in adult lacto-ovo-vegetarian and omnivorous males. Am J Clin Nutr, 1983; 37: 453-6.
1191. Barr, SI, Prior, JC, Janelle, KC, and Lentle, BC, Spinal bone mineral density in premenopausal vegetarian and nonvegetarian women: cross-sectional and prospective comparisons. J Am Diet Assoc, 1998; 98: 760-5.
1192. Lau, EM, Kwok, T, Woo, J, and Ho, SC, Bone mineral density in Chinese elderly female vegetarians, vegans, lacto-vegetarians and omnivores. Eur J Clin Nutr, 1998; 52: 60-4.
1193. Chiu, JF, Lan, SJ, Yang, CY, et al., Long-term vegetarian diet and bone mineral density in postmenopausal Taiwanese women. Calcif Tissue Int, 1997; 60: 245-9.
1194. Arjmandi, BH, Khalil, DA, and Hollis, BW, Soy Protein: Its Effects on Intestinal Calcium Transport, Serum Vitamin D, and Insulin-like Growth Factor-I in Ovariectomized Rats. Calcif Tissue Int, 2002; 70: 483-7.
1195. Harrison, E, Adjei, A, Ameho, C, Yamamoto, S, and Kono, S, The effect of soybean protein on bone loss in a rat model of postmenopausal osteoporosis. J Nutr Sci Vitaminol (Tokyo), 1998; 44: 257-68.
1196. Potter, SM, Baum, JA, Teng, H, Stillman, RJ, Shay, NF, and Erdman, JW, Jr., Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr, 1998; 68: 1375S-1379S.
1197. Liesegang, A, Bürgi, E, Sassi, ML, Risteli, J, and Wanner, M, Influence of a Vegetarian Diet Versus a Diet with Fishmeal on Bone in Growing Pigs. J Vet Med A, 2002; 49: 230-8
1198. Parhami, F, Garfinkel, A, and Demer, LL, Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol, 2000; 20: 2346-8.
1199. Parhami, F, Tintut, Y, Beamer, WG, Gharavi, N, Goodman, W, and Demer, LL, Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res, 2001; 16: 182-8.
1200. Abrahamsen, B, Rohold, A, Henriksen, JE, and Beck-Nielsen, H, Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet Med, 2000; 17: 124-9.
1201. Ivers, RQ, Cumming, RG, Mitchell, P, and Peduto, AJ, Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care, 2001; 24: 1198-203.
1202. Schwartz, AV, Sellmeyer, DE, Ensrud, KE, et al., Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab, 2001; 86: 32-8.
1203. Frayn, KN, Stoner, HB, Barton, RN, Heath, DF, and Galasko, CS, Persistence of high plasma glucose, insulin and cortisol concentrations in elderly patients with proximal femoral fractures. Age Ageing, 1983; 12: 70-6.
1204. Greenfield, DM and Eastell, R, Risk factors for ankle fracture. Osteoporos Int, 2001; 12: 97-103
1205. Yuksel, O, Dokmetas, HS, Topcu, S, Erselcan, T, and Sencan, M, Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome. J Bone Miner Metab, 2001; 19: 257-62
1206. Lidfeldt, J, Holmdahl, L, Samsioe, G, et al., The influence of hormonal status and features of the metabolic syndrome on bone density: a population-based study of Swedish women aged 50 to 59 years. The women's health in the Lund area study. Metabolism, 2002; 51: 267-70. t&artType=abs&id=ameta0510267&target=
1207. Salem, GJ, Zernicke, RF, and Barnard, RJ, Diet-related changes in mechanical properties of rat vertebrae. Am J Physiol, 1992; 262: R318-21.
1208. Zernicke, RF, Salem, GJ, Barnard, RJ, and Schramm, E, Long-term, high-fat-sucrose diet alters rat femoral neck and vertebral morphology, bone mineral content, and mechanical properties. Bone, 1995; 16: 25-31.
1209. Wallach, S, Feinblatt, JD, Carstens, JH, Jr., and Avioli, LV, The bone "quality" problem. Calcif Tissue Int, 1992; 51: 169-72.
1210. Okazaki, R, Toriumi, M, Fukumoto, S, et al., Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro. Endocrinology, 1999; 140: 5060-5.
1211. Herman, JS and Easterbrook, PJ, The metabolic toxicities of antiretroviral therapy. Int J STD AIDS, 2001; 12: 555-62; quiz 563-4
1212. Binkley, N and Krueger, D, Hypervitaminosis A and bone. Nutr Rev, 2000; 58: 138-44.
1213. Johansson, S, Kindmark, A, Michaelsson, K, and Melhus, H, Vitaminer är inte alltid nyttigt! Läkartidningen, 2001; 98: 1252-5.
1214. Kawahara, TN, Krueger, DC, Engelke, JA, Harke, JM, and Binkley, NC, Short-term vitamin A supplementation does not affect bone turnover in men. J Nutr, 2002; 132: 1169-72.
1215. Coin, A, Sergi, G, Beninca, P, et al., Bone mineral density and body composition in underweight and normal elderly subjects. Osteoporos Int, 2000; 11: 1043-50
1216. Ricci, TA, Heymsfield, SB, Pierson, RN, Jr., Stahl, T, Chowdhury, HA, and Shapses, SA, Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr, 2001; 73: 347-52.
1217. Skov, AR, Haulrik, N, Toubro, S, Molgaard, C, and Astrup, A, Effect of protein intake on bone mineralization during weight loss: a 6-month trial. Obes Res, 2002; 10: 432-8
1218. New, SA, Robins, SP, Campbell, MK, et al., Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr, 2000; 71: 142-51.
1219. Browner, WS, Pressman, AR, Nevitt, MC, Cauley, JA, and Cummings, SR, Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke, 1993; 24: 940-6.
1220. Saffran, M, Rickets. Return of an old disease. J Am Podiatr Med Assoc, 1995; 85: 222-5
1221. Klein, GL and Simmons, DJ, Nutritional rickets: thoughts about pathogenesis. Ann Med, 1993; 25: 379-84
1222. Lindeberg, S, Spannmål, salt och engelska sjukan i historiskt perspektiv. Svensk medicinhistorisk tidskrift, 1998; 2: 79-89
1223. Stuart-Macadam, PL, Nutritional deficiency diseases: a survey of scurvy, rickets, and iron-deficiency anemia, in Reconstruction of life from the human skeleton, M.Y. Isçan and K.A.R. Kennedy, Editors. 1989, Wiley-Liss: New York. p. 201-22.
1224. Arcini, C, Health and disease in early Lund: Osteo-pathologic studies of 3,305 individuals buried in the first cemetery area of Lund 990-1536, in Department of Community Health Sciences, Medical history. 1999, Lund: Lund.
1225. Black, J, Rickets and the crippled child: an historical perspective [letter]. J R Soc Med, 1995; 88: 363-4
1226. Hernigou, P, Historical overview of rickets, osteomalacia, and vitamin D. Rev Rhum Engl Ed, 1995; 62: 261-70
1227. Gibbs, D, Rickets and the crippled child: an historical perspective [see comments]. J R Soc Med, 1994; 87: 729-32
1228. Hemberg, P, Ett läkardistrikt berättar. Om gångna tiders sjukvård i Bo och Svennevads socknar. 1987: Country Life AB.
1229. Holick, MF, Vitamin D, in Modern nutrition in health and disease, M.E. Shils, et al., Editors. 1999, Lippincott Williams & Wilkins. p. 329-45.
1230. Pettifor, JM, Privational rickets: a modern perspective [editorial; comment]. J R Soc Med, 1994; 87: 723-5
1231. Norvenius, SG, Rakit, engelska sjukan, riset eller horeskävern. Gammal sjukdom med ny aktualitet i Sverige. Läkartidningen, 1997; 94: 122-5.
1232. DeLucia, MC and Carpenter, TO, Rickets in the sunshine? Nutrition, 2002; 18: 97-9.
1233. Lulseged, S and Fitwi, G, Vitamin D deficiency rickets: socio-demographic and clinical risk factors in children seen at a referral hospital in Addis Ababa. East Afr Med J, 1999; 76: 457-61.
1234. Bhattacharyya, AK, Nutritional rickets in the tropics. World Rev Nutr Diet, 1992; 67: 140-97
1235. Roe, DA, Rickets and osteomalacia, in Hunter's Tropical Medicine, G.T. Strickland, Editor. 1991, W. B. Saunders: Philadelphia. p. 929-32.
1236. el Hag, AI and Karrar, ZA, Nutritional vitamin D deficiency rickets in Sudanese children. Ann Trop Paediatr, 1995; 15: 69-76
1237. Nyakundi, PM, Kinuthia, DW, and Orinda, DA, Clinical aspects and causes of rickets in a Kenyan population. East Afr Med J, 1994; 71: 536-42
1238. Ford, JA, Colhoun, EM, McIntosh, WB, and Dunnigan, MG, Biochemical response of late rickets and osteomalacia to a chupatty-free diet. Br Med J, 1972; 3: 446-7
1239. Fairweather, TS and Wright, AJ, The effects of sugar-beet fibre and wheat bran on iron and zinc absorption in rats. Br J Nutr, 1990; 64: 547-52
1240. Mellanby, E, A story of nutrition research. 1950, Baltimore: Williams & Wilkins Co.
1241. Bruce, H and Callow, R, Cereals and rickets. The role of inositolhexaphosphoric acid. Biochem J, 1934; 28: 517-28
1242. Harrison, D and Mellanby, E, Phytic acid and the rickets-producing action of cereals. Biochem J, 1934; 28: 517-28
1243. McCance, R and Widdowsos, E, Mineral metabolism of healthy adults on white and brown bread dietaries. j Physiol, 1942; 101: 44-85
1244. McCance, R, Edgecombe, C, and Widdowson, E, Mineral metabolism of dephytinized bread. J Physiol, 1942; 101
1245. Sandberg, AS, The effect of food processing on phytate hydrolysis and availability of iron and zinc. Adv Exp Med Biol, 1991; 289: 499-508
1246. Svanberg, U and Sandberg, A-S, Improved iron availability in weaning foods using germination and fermentation, in Nutrient Availability: Chemical and biological aspects, D.A.T. Southgate, I.T. Johnson, and G.R. Fenwick, Editors. 1989, Cambridge University press: Cambridge. p. 179-81.
1247. Larsson, M and Sandberg, A-S, Phytate reduction in bread containing oat flour, oat bran or rye bran. J Cereal Sci, 1991; 14: 141-9
1248. Navert, B, Sandstrom, B, and Cederblad, A, Reduction of the phytate content of bran by leavening in bread and its effect on zinc absorption in man. Br J Nutr, 1985; 53: 47-53
1249. Campbell, Å, Det svenska brödet : en jämförande etnologisk-historisk
undersökning. 1950, Stockholm: Svensk bageritidskrift.
1250. Gamerith, A, Ehrfurcht vor Korn und Brot. 1958: Bad Goisern, Austria.
1251. Sandberg, A-S, Food processing influencing iron bioavailability, in Iron Nutrition in Health and Disease, L. Hallberg and N.-G. Asp, Editors. 1996, John Libbey: London. p. 349-58.
1252. Sandstrom, B, Food processing and trace element supply, in Nutritional Impact of Food Processing. Bibl Nutr Dieta, J.C. Somogyi and H.R. Muller, Editors. 1989, Karger: Basel. p. 165-72.
1253. Nordisk Familjebok. Konversationslexikon och realencyklopedi., ed. T. Westrin. 1904-22, Stockholm: Nordisk Familjeboks Förlags Aktiebolag.
1254. Morell, M, Studier i den svenska livsmedelskonsumtionens historia. Hospitalhjonens livsmedelskonsumtion 1621-1872. 1989, Uppsala: Almqvist & Wiksell.
1255. Thirsk, J, ed. Chapters from the Agrarian History of England and Wales. Vol. 1-5. 1990, Cambridge Univ Press: Cambridge.
1256. Coetzee, MJ, Badenhorst, PN, de Wet, JI, and Joubert, G, Haematological condition of the San (Bushmen) relocated from Namibia to South Africa. S Afr Med J, 1994; 84: 416-20.
1257. Yip, R and Ramakrishnan, U, Experiences and challenges in developing countries. J Nutr, 2002; 132: 827S-30S.
1258. Ramakrishnan, U and Yip, R, Experiences and challenges in industrialized countries: control of iron deficiency in industrialized countries. J Nutr, 2002; 132: 820S-4S.
1259. Hallberg, L and Hulthen, L, Perspectives on iron absorption. Blood Cells Mol Dis, 2002; 29: 562-73
1260. Rushton, DH, Dover, R, Sainsbury, AW, Norris, MJ, Gilkes, JJ, and Ramsay, ID, Why should women have lower reference limits for haemoglobin and ferritin concentrations than men? Bmj, 2001; 322: 1355-7.
1261. Schultz, M, Paleohistopathology of bone: A new approach to the study of ancient diseases. Am J Phys Anthropol, 2001; Suppl: 106-47.
1262. Salvadei, L, Ricci, F, and Manzi, G, Porotic hyperostosis as a marker of health and nutritional conditions during childhood: studies at the transition between Imperial Rome and the Early Middle Ages. Am J Human Biol, 2001; 13: 709-17.
1263. Rothschild, B, Porotic hyperostosis as a marker of health and nutritional conditions. Am J Human Biol, 2002; 14: 417-8; discussion 418-20.
1264. Stuart-Macadam, P, Porotic hyperostosis: a new perspective. Am J Phys Anthropol, 1992; 87: 39-47.
1265. Ulijaszek, SJ, Human dietary change. Philos Trans R Soc Lond B Biol Sci, 1991; 334: 271-8; discussion 278-9.
1266. Macfarlane, B and White, DO, Natural history of infectious disease. 1972, Cambridge: Cambridge University Press. 278.
1267. Ebert, D, The evolution and expression of parasite virulence, in Evolution in health and disease, S.C. Stearns, Editor. 1999, Oxford University Press. p. 161-72.
1268. Bothwell, TH, Iron balance and the capacity of regulatory systems to prevent the development of iron deficiency and overload, in Iron Nutrition in Health and Disease, L. Hallberg and N.-G. Asp, Editors. 1996, John Libbey. p. 3-16.
1269. Hallberg, L, Sandström, B, Ralph, A, and Arthur, J, Diseases of the heart and circulation: the role of dietary factors in aetiology and management, in Human Nutrition and Dietetics, J.S. Garrow and W.P.T. James, Editors. 2000, Churchill Livingstone. p. 177-209.
1270. Rossander-Hulthén, L and Hallberg, L, Dietary factors influencing iron absorption - an overview, in Iron Nutrition in Health and Disease, L. Hallberg and N.-G. Asp, Editors. 1996, John Libbey. p. 105-15.
1271. Yeung, GS and Zlotkin, SH, Efficacy of meat and iron-fortified commercial cereal to prevent iron depletion in cow milk-fed infants 6 to 12 months of age: a randomized controlled trial. Can J Public Health, 2000; 91: 263-7.
1272. Requejo, AM, Navia, B, Ortega, RM, et al., The age at which meat is first included in the diet affects the incidence of iron deficiency and ferropenic anaemia in a group of pre- school children from Madrid. Int J Vitam Nutr Res, 1999; 69: 127-31.
1273. Engelmann, MD, Sandstrom, B, and Michaelsen, KF, Meat intake and iron status in late infancy: an intervention study. J Pediatr Gastroenterol Nutr, 1998; 26: 26-33.
1274. Lucca, P, Hurrell, R, and Potrykus, I, Fighting iron deficiency anemia with iron-rich rice. J Am Coll Nutr, 2002; 21: 184S-190S.
1275. Brune, M, Rossander, L, and Hallberg, L, Iron absorption: no intestinal adaptation to a high-phytate diet. Am J Clin Nutr, 1989; 49: 542-5
1276. Lynch, SR, Dassenko, SA, Cook, JD, Juillerat, MA, and Hurrell, RF, Inhibitory effect of a soybean-protein--related moiety on iron absorption in humans. Am J Clin Nutr, 1994; 60: 567-72.
1277. Gleerup, A, Rossander-Hulthen, L, Gramatkovski, E, and Hallberg, L, Iron absorption from the whole diet: comparison of the effect of two different distributions of daily calcium intake. Am J Clin Nutr, 1995; 61: 97-104.
1278. Gill, DG, Vincent, S, and Segal, DS, Follow-on formula in the prevention of iron deficiency: a multicentre study. Acta Paediatr, 1997; 86: 683-9.
1279. Hallberg, L, Brune, M, Erlandsson, M, Sandberg, AS, and Rossander, HL, Calcium: effect of different amounts on nonheme- and heme-iron absorption in humans. Am J Clin Nutr, 1991; 53: 112-9
1280. Reddy, MB and Cook, JD, Effect of calcium intake on nonheme-iron absorption from a complete diet. Am J Clin Nutr, 1997; 65: 1820-5.
1281. Davidson, A and Diamond, B, Autoimmune diseases. N Engl J Med, 2001; 345: 340-50.
1282. Brändén, H and Andersson, J, Grundläggande immunologi. 1998: Studentlitteratur.
1283. Douglas, MW, Parsons, CM, and Hymowitz, T, Nutritional evaluation of lectin-free soybeans for poultry. Poult Sci, 1999; 78: 91-5.
1284. Liener, IE, Donatucci, DA, and Tarcza, JC, Starch blockers: a potential source of trypsin inhibitors and lectins. Am J Clin Nutr, 1984; 39: 196-200.
1285. Zahnley, JC, Stability of enzyme inhibitors and lectins in foods and the influence of specific binding interactions. Adv Exp Med Biol, 1984; 177: 333-65
1286. Yoshikawa, H, Kotaru, M, Tanaka, C, Ikeuchi, T, and Kawabata, M, Characterization of kintoki bean (Phaseolus vulgaris) alpha-amylase inhibitor: inhibitory activities against human salivary and porcine pancreatic alpha-amylases and activity changes by proteolytic digestion. J Nutr Sci Vitaminol (Tokyo), 1999; 45: 797-802.
1287. Pearce, G, McGinnis, J, and Ryan, CA, Nutritional studies of a carboxypeptidase inhibitor from potato tubers. Adv Exp Med Biol, 1984; 177: 321-32
1288. Pearce, G, McGinnis, J, and Ryan, CA, Effects of feeding a carboxypeptidase inhibitor from potatoes to newly hatched chicks. Proc Soc Exp Biol Med, 1983; 173: 447-53.
1289. Banwell, JG, Howard, R, Kabir, I, and Costerton, JW, Bacterial overgrowth by indigenous microflora in the phytohemagglutinin- fed rat. Can J Microbiol, 1988; 34: 1009-13.
1290. Junqueira, LC, Carneiro, J, and Kelley, RO, Basic Histology. 1995: Lange.
1291. Sjolander, A, Magnusson, KE, and Latkovic, S, The effect of concanavalin A and wheat germ agglutinin on the ultrastructure and permeability of rat intestine. A possible model for an intestinal allergic reaction. Int Arch Allergy Appl Immunol, 1984; 75: 230-6
1292. Greer, F and Pusztai, A, Toxicity of kidney bean (Phaseolus vulgaris) in rats: changes in intestinal permeability. Digestion, 1985; 32: 42-6
1293. Laughlin, RS, Musch, MW, Hollbrook, CJ, Rocha, FM, Chang, EB, and Alverdy, JC, The key role of Pseudomonas aeruginosa PA-I lectin on experimental gut- derived sepsis. Ann Surg, 2000; 232: 133-42.
1294. Patel, B, Schutte, R, Sporns, P, Doyle, J, Jewel, L, and Fedorak, RN, Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease. Inflamm Bowel Dis, 2002; 8: 340-6
1295. Riordan, SM, McIver, CJ, Thomas, DH, Duncombe, VM, Bolin, TD, and Thomas, MC, Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol, 1997; 32: 556-63.
1296. Banks, WA, Ibrahimi, F, Farr, SA, Flood, JF, and Morley, JE, Effects of wheatgerm agglutinin and aging on the regional brain uptake of HIV-1GP120. Life Sci, 1999; 65: 81-9
1297. Villegas, JC and Broadwell, RD, Transcytosis of protein through the mammalian cerebral epithelium and endothelium. II. Adsorptive transcytosis of WGA-HRP and the blood-brain and brain-blood barriers. J Neurocytol, 1993; 22: 67-80.
1298. Mares, V, Borges, LF, and Sidman, RL, Uptake and transport of lectins from the cerebrospinal fluid by cells of the immature mouse brain. Acta Histochem, 1984; 74: 11-9
1299. Albert, LJ and Inman, RD, Molecular mimicry and autoimmunity. N Engl J Med, 1999; 341: 2068-74.
1300. Tuckova, L, Tlaskalova-Hogenova, H, Farre, MA, et al., Molecular mimicry as a possible cause of autoimmune reactions in celiac disease? Antibodies to gliadin cross-react with epitopes on enterocytes. Clin Immunol Immunopathol, 1995; 74: 170-6.
1301. Moustakas, AK, van de Wal, Y, Routsias, J, et al., Structure of celiac disease-associated HLA-DQ8 and non-associated HLA- DQ9 alleles in complex with two disease-specific epitopes. Int Immunol, 2000; 12: 1157-66.
1302. Black, P, Why is the prevalence of allergy and autoimmunity increasing? Trends Immunol, 2001; 22: 354-5.
1303. Emanuel, MB, Hay fever, a post industrial revolution epidemic: a history of its growth during the 19th century. Clin Allergy, 1988; 18: 295-304.
1304. Greene, WC, Goldman, CK, Marshall, ST, Fleisher, TA, and Waldmann, TA, Stimulation of immunoglobulin biosynthesis in human B cells by wheat germ agglutinin. I. Evidence that WGA can produce both a positive and negative signal for activation of human lymphocytes. J Immunol, 1981; 127: 799-804.
1305. van Berge-Henegouwen, GP and Mulder, CJ, Pioneer in the gluten free diet: Willem-Karel Dicke 1905-1962, over 50 years of gluten free diet. Gut, 1993; 34: 1473-5.
1306. Hadjivassiliou, M, Grunewald, RA, Chattopadhyay, AK, et al., Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet, 1998; 352: 1582-5.
1307. Hadjivassiliou, M, Grunewald, RA, and Davies-Jones, GA, Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry, 2002; 72: 560-3.
1308. Hadjivassiliou, M, Grunewald, RA, Lawden, M, Davies-Jones, GA, Powell, T, and Smith, CM, Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology, 2001; 56: 385-8.
1309. Gasbarrini, A, Torre, ES, Trivellini, C, De Carolis, S, Caruso, A, and Gasbarrini, G, Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease. Lancet, 2000; 356: 399-400.
1310. Greco, L, From the neolithic revolution to gluten intolerance: benefits and problems associated with the cultivation of wheat. J Pediatr Gastroenterol Nutr, 1997; 24: S14-6; discussion S16-7.
1311. O'Farrelly, C, Price, R, McGillivray, AJ, and Fernandes, L, IgA rheumatoid factor and IgG dietary protein antibodies are associated in rheumatoid arthritis. Immunol Invest, 1989; 18: 753-64.
1312. Sköldstam, L, Larsson, L, and Lindström, FD, Effect of fasting and lactovegetarian diet on rheumatoid arthritis. Scand J Rheumatol, 1979; 8: 249-55
1313. Welsh, CJ, Hanglow, AC, Conn, P, Barker, TH, and Coombs, RR, Early rheumatoid-like synovial lesions in rabbits drinking cow's milk. I. Joint pathology. Int Arch Allergy Appl Immunol, 1985; 78: 145-51
1314. Hanglow, AC, Welsh, CJ, Conn, P, and Coombs, RR, Early rheumatoid-like synovial lesions in rabbits drinking cow's milk. II. Antibody responses to bovine serum proteins. Int Arch Allergy Appl Immunol, 1985; 78: 152-60
1315. Kjeldsen-Kragh, J, Haugen, M, Borchgrevink, CF, et al., Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet, 1991; 338: 899-902.
1316. Hafstrom, I, Ringertz, B, Spangberg, A, et al., A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens. Rheumatology (Oxford), 2001; 40: 1175-9.
1317. Sköldstam, L, Hagfors, L, and Johansson, G, Reumatoid artrit och kretensisk medelhavskost. Svensk Rehabilitering, 2002: 45-51
1318. Sköldstam, L, Reumatoid artrit, kost och evolutionsmedicin. Medikament, 2002: 68-72
1319. Holst-Jensen, SE, Pfeiffer-Jensen, M, Monsrud, M, et al., Treatment of rheumatoid arthritis with a peptide diet: a randomized, controlled trial. Scand J Rheumatol, 1998; 27: 329-36
1320. Kavanaghi, R, Workman, E, Nash, P, Smith, M, Hazleman, BL, and Hunter, JO, The effects of elemental diet and subsequent food reintroduction on rheumatoid arthritis. Br J Rheumatol, 1995; 34: 270-3.
1321. Haugen, MA, Kjeldsen-Kragh, J, and Forre, O, A pilot study of the effect of an elemental diet in the management of rheumatoid arthritis. Clin Exp Rheumatol, 1994; 12: 275-9.
1322. Grant, WB, The role of meat in the expression of rheumatoid arthritis. Br J Nutr, 2000; 84: 589-95.
1323. Peschken, CA and Esdaile, JM, Rheumatic diseases in North America's indigenous peoples. Semin Arthritis Rheum, 1999; 28: 368-91.
1324. Leden, I and Arcini, C, Doubts about rheumatoid arthritis as a New World disease. Semin Arthritis Rheum, 1994; 23: 354-6.
1325. Del Puente, A, Knowler, WC, Pettitt, DJ, and Bennett, PH, High incidence and prevalence of rheumatoid arthritis in Pima Indians. Am J Epidemiol, 1989; 129: 1170-8.
1326. Åkerblom, HK, Vaarala, O, Hyoty, H, Ilonen, J, and Knip, M, Environmental factors in the etiology of type 1 diabetes. Am J Med Genet, 2002; 115: 18-29.
1327. Dahl-Jørgensen, K, Joner, G, and Hanssen, KF, Relationship between cows' milk consumption and incidence of IDDM in childhood. Diabetes Care, 1991; 14: 1081-3.
1328. Muntoni, S, Cocco, P, Aru, G, and Cucca, F, Nutritional factors and worldwide incidence of childhood type 1 diabetes. Am J Clin Nutr, 2000; 71: 1525-9.
1329. Fava, D, Leslie, RD, and Pozzilli, P, Relationship between dairy product consumption and incidence of IDDM in childhood in Italy. Diabetes Care, 1994; 17: 1488-90.
1330. Goto, Y and Satoh, J, Childhood insulin-dependent diabetes. Adv Exp Med Biol, 1988; 246: 215-9
1331. Wasmuth, HE and Kolb, H, Cow's milk and immune-mediated diabetes. Proc Nutr Soc, 2000; 59: 573-9.
1332. Knip, M and Akerblom, HK, IDDM prevention trials in progress--a critical assessment. J Pediatr Endocrinol Metab, 1998; 11 Suppl 2: 371-7.
1333. Harrison, LC and Honeyman, MC, Cow's milk and type 1 diabetes: the real debate is about mucosal immune function. Diabetes, 1999; 48: 1501-7.
1334. Scott, FW, Food-induced type 1 diabetes in the BB rat. Diabetes Metab Rev, 1996; 12: 341-59.
1335. Visser, J, Brugman, S, Klatter, F, et al., Short-term dietary adjustment with a hydrolyzed casein-based diet postpones diabetes development in the diabetes-prone BB rat. Metabolism, 2003; 52: 333-7
1336. Hauser, SL and Goodkin, DE, Multiple sclerosis and other demyelinating diseases, in Harrison's principles of internal medicine, E. Braunwald, et al., Editors. 2001, McGraw-Hill: New York. p. 2452-61.
1337. Butcher, J, The distribution of multiple sclerosis in relation to the dairy industry and milk consumption. N Z Med J, 1976; 83: 427-30.
1338. Malosse, D, Perron, H, Sasco, A, and Seigneurin, JM, Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study. Neuroepidemiology, 1992; 11: 304-12
1339. Malosse, D and Perron, H, Correlation analysis between bovine populations, other farm animals, house pets, and multiple sclerosis prevalence. Neuroepidemiology, 1993; 12: 15-27
1340. Lauer, K, Diet and multiple sclerosis. Neurology, 1997; 49: S55-61.
1341. Winer, S, Astsaturov, I, Cheung, RK, et al., T cells of multiple sclerosis patients target a common environmental peptide that causes encephalitis in mice. J Immunol, 2001; 166: 4751-6.
1342. Banks, WA and Kastin, AJ, Characterization of lectin-mediated brain uptake of HIV-1 GP120. J Neurosci Res, 1998; 54: 522-9.
1343. Olsson, KS, Genetisk screening avslöjar hemokromatos. Järnorsakade organskador kan förebyggas. Läkartidningen, 1997; 94: 3957-8
1344. Niederau, C, Strohmeyer, G, and Stremmel, W, Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol, 1994; 356: 293-302
1345. Bulaj, ZJ, Griffen, LM, Jorde, LB, Edwards, CQ, and Kushner, JP, Clinical and biochemical abnormalities in people heterozygous for hemochromatosis [see comments]. N Engl J Med, 1996; 335: 1799-805
1346. Crawford, DH, Powell, LW, Leggett, BA, et al., Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet, 1995; 57: 362-7
1347. Tuomainen, TP, Kontula, K, Nyyssonen, K, Lakka, TA, Helio, T, and Salonen, JT, Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland. Circulation, 1999; 100: 1274-9.
1348. Tuomainen, TP, Punnonen, K, Nyyssonen, K, and Salonen, JT, Association between body iron stores and the risk of acute myocardial infarction in men. Circulation, 1998; 97: 1461-6.
1349. Nilsson, J, Lipid oxidation, vascular inflammation, and coronary atherosclerosis. Transplant Proc, 1993; 25: 2063-4.
1350. Hallberg, L, Advantages and disadvantages of an iron-rich diet. Eur J Clin Nutr, 2002; 56 Suppl 1: S12-8.
1351. Rasmussen, LB, Ovesen, L, Bulow, I, et al., Relations between various measures of iodine intake and thyroid volume, thyroid nodularity, and serum thyroglobulin. Am J Clin Nutr, 2002; 76: 1069-76
1352. He, ML, Hollwich, W, and Rambeck, WA, Supplementation of algae to the diet of pigs: a new possibility to improve the iodine content in the meat. J Anim Physiol Anim Nutr (Berl), 2002; 86: 97-104
1353. Lightowler, HJ and Davies, GJ, Iodine intake and iodine deficiency in vegans as assessed by the duplicate-portion technique and urinary iodine excretion. Br J Nutr, 1998; 80: 529-35
1354. Milan, A, Mulatero, P, Rabbia, F, and Veglio, F, Salt intake and hypertension therapy. J Nephrol, 2002; 15: 1-6.
1355. Guo, TL, White, KL, Jr., Brown, RD, et al., Genistein modulates splenic natural killer cell activity, antibody- forming cell response, and phenotypic marker expression in F(0) and F(1) generations of Sprague-Dawley rats. Toxicol Appl Pharmacol, 2002; 181: 219-27.
1356. Eliasson, M, Evidensbaserad medicin ”begins at home”. Incitament för bättre beslutsunderlag finns i den kliniska vardagen. Läkartidningen, 2000; 97: 3860-5.


